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Abstract	  An	  Ebola	  outbreak	  in	  spring	  and	  summer	  2014	  drew	  a	  lot	  of	  public	  attention	  because	  of	  the	  staggering	  amount	  of	  deaths	  it	  caused.	  In	  this	  project,	  the	  proteomes	  of	  Ebola	  and	  its	  deadly	  relatives	   from	   the	   Filoviridae	   (Filovirus)	   family	   are	   studied	   to	   better	   understand	   the	  evolution	  of	  these	  viruses	  that	  may	  help	  in	  developing	  better	  antiviral	  drugs	  and	  vaccines.	  Specifically,	  we	  construct	  three-­‐dimensional	  models	  for	  the	  seven	  proteins	  in	  the	  proteome	  using	  the	  homology	  modeling	  approach.	  Then,	  we	  find	  the	  conserved	  and	  diverse	  regions	  in	  each	  protein	  across	  species	  and	  map	  the	  regions	  back	  to	  the	  models	  we	  have	  constructed	  using	   trident	   score.	   Finally,	   we	   find	   the	   functional	   areas	   in	   each	   homology	   model,	  specifically	  those	  involved	  in	  virus-­‐virus	  interactions	  and	  in	  human-­‐virus	  interactions,	  and	  compare	   these	   areas	  with	   the	   conserved	   and	   diverse	   regions.	   Since	   our	   approach	   relies	  highly	   on	   the	   existing	   related	   structures,	   some	   models	   are	   not	   complete.	   Based	   on	   the	  results,	   we	   draw	   the	   conclusion	   that	   highly	   conserved	   regions	   are	   linked	   to	   the	   areas	  involved	   in	   virus-­‐virus	   interactions,	  while	   the	   highly	   diverse	   regions	   are	   linked	   to	   those	  involved	  in	  human-­‐virus	  interactions.	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Chapter	  1:	  Introduction	  
1.1	  Motivation	  In	  the	  year	  of	  2014,	  Ebola	  has	  drawn	  people’s	  attention	  because	  of	  the	  large	  number	  of	  death	  it	  has	  caused.	  As	  of	  May	  6,	  2015,	  there	  are	  11007	  deaths	  in	  the	  countries	  with	  widespread	  transmission,	  specifically	  Guinea,	  Liberia,	  and	  Sierra	  Leone	  (CDC,	  2015).	  However,	  this	  is	  not	  the	  first	  time	  that	  Ebola	  has	  caused	  problems	  in	  the	  world.	  In	  1976,	  Ebolavirus	  was	  first	  recognized	  for	  its	  outbreak	  in	  Yambuku	  and	  surrounding	  area.	  It	  was	  reported	  that	  318	  people	  were	  infected,	  and	  among	  them,	  280	  people	  died	  (CDC,	  2015).	  	  	  Similarly,	  other	  members	  belonging	  to	  the	  same	  family,	  Filoviridae,	  can	  cause	  hemorrhagic	  fever	  in	  both	  human	  and	  nonhuman	  primates	  (Serena	  A.	  Carroll,	  2013).	  According	  to	  a	  proposal	  for	  revised	  taxonomy	  of	  the	  family	  Filoviridae	  (Kuhn	  JH,	  2010),	  there	  are	  three	  genera	  in	  the	  family	  of	  Filoviridae,	  including	  Ebolavirus,	  Marburgvirus,	  and	  a	  tentative	  genus	  Cuevavirus.	  The	  detailed	  classification	  is	  shown	  in	  Table	  1.	  In	  the	  genus	  of	  Ebolavirus,	  Ebola	  virus	  has	  the	  highest	  case	  fatality	  rate,	  up	  to	  89%.	  The	  species	  of	  Sudan	  Ebolavirus	  was	  also	  discovered	  in	  1976	  in	  Nzara,	  Maridi	  and	  the	  surrounding	  area,	  and	  284	  people	  were	  infected	  and	  151	  of	  them	  died,	  causing	  a	  fatality	  rate	  of	  53%	  (CDC,	  2015).	  	  Reston	  virus	  was	  discovered	  in	  1989	  in	  monkeys	  imported	  from	  Philippines.	  This	  virus	  was	  also	  found	  in	  four	  people	  in	  USA	  and	  three	  people	  in	  Philippines,	  but	  all	  of	  them	  were	  asymptomatic.	  Tai	  Forest	  virus	  was	  found	  in	  1994,	  and	  only	  one	  case	  has	  been	  found	  so	  far.	  The	  infected	  patient	  was	  treated	  in	  Switzerland.	  Bundibugyo	  virus	  is	  the	  most	  recently	  found	  species.	  It	  was	  found	  in	  Uganda,	  in	  2007,	  with	  a	  fatality	  rate	  of	  25%.	  In	  the	  genus	  of	  
Marburgvirus,	  there	  is	  only	  one	  species,	  consisting	  of	  two	  viruses,	  Marbug	  virius	  and	  Ravn	  virus.	  Marburg	  virus	  was	  first	  found	  in	  1967	  in	  Germany	  and	  Yugoslavia	  at	  the	  same	  time.	  In	  large	  outbreaks	  in	  1998-­‐2000	  and	  in	  2004-­‐2005,	  83%	  and	  90%	  infected	  people	  dies	  respectively,	  according	  to	  the	  chronology	  of	  Marburg	  Hemorrhagic	  Fever	  Outbreaks	  summarized	  by	  Centers	  for	  Disease	  Control	  and	  Prevention	  (Centers	  for	  Disease	  Control	  and	  Prevention,	  2014).	  The	  last	  genus,	  Cuevavirus,	  was	  found	  in	  bat	  carcasses	  from	  Spain	  in	  2002	  (Ana	  Negredo,	  2011).	  No	  fatal	  case	  in	  human	  has	  been	  found.	  
Table	  1:	  Taxonomy	  of	  Family	  Filoviridae	  Proposed	  in	  2010	  (Kuhn	  JH,	  2010)	  
Genus Species Virus 
Marburgvirus Marburg marburgvirus Marburg virus (MARV) 
Ravn virus (RAVV) 
Ebolavirus 
Taï Forest ebolavirus Taï Forest virus (TAFV) 
Reston ebolavirus Reston virus (RESTV) 
Sudan ebolavirus Sudan virus (SUDV) 
Zaire ebolavirus Ebola virus (EBOV) 
Bundibugyo ebolavirus Bundibugyo virus (BDBV) 
Cuevavirus  
(tentative) Lloviu cuevavirus (tentative) Lloviu virus (LLOV) Ever	  since	  the	  discovery	  of	  Ebola	  and	  Marburg,	  people	  have	  been	  studying	  the	  pathogenesis,	  genome,	  and	  genome	  products	  of	  them.	  On	  the	  other	  hand,	  the	  genus	  Cuevavirus	  is	  the	  least	  studied,	  simply	  because	  it	  was	  discovered	  only	  a	  couple	  of	  years	  ago.	  	  	  
Triggered	  by	  the	  outbreak	  in	  2014,	  we	  wonder	  whether	  we	  have	  enough	  information	  about	  Ebola	  and	  its	  family	  on	  the	  molecular	  level,	  how	  Ebola	  is	  related	  to	  other	  species	  within	  the	  family	  in	  terms	  of	  molecular	  evolution,	  and	  what	  useful	  information	  we	  can	  find	  out	  based	  on	  the	  structural	  information.	  Unlike	  the	  previous	  studies	  on	  genome	  of	  filovirus,	  which	  mainly	  focus	  on	  the	  two	  dimensional	  sequences	  of	  proteins,	  this	  project	  focuses	  on	  the	  
three	  dimensional	  structures	  of	  proteins.	  The	  advantage	  of	  studying	  the	  three	  dimensional	  structures	  over	  the	  two	  dimensional	  sequences	  lies	  in	  that	  some	  distantly	  related	  amino	  acids	  from	  the	  view	  of	  sequence	  can	  be	  involved	  in	  active	  interactions	  due	  to	  the	  folding	  of	  protein	  sequences.	  Intuitively,	  if	  a	  region	  on	  a	  protein	  is	  very	  consistent	  across	  species,	  it	  is	  likely	  to	  be	  the	  essential	  region	  for	  the	  virus	  to	  survive.	  On	  the	  contrast,	  if	  a	  region	  on	  a	  protein	  changes	  over	  time,	  it	  is	  likely	  to	  have	  evolved	  to	  avoid	  antibodies.	  
	  
Figure	  1:	  	  Genome	  of	  Ebolavirus	  (Extracted	  from	  http://education.expasy.org/images/Filovirus_genome.jpg)	  
Table	  2:	  Proteome	  of	  Zaire	  Ebolavirus.	  The	  organism	  is	  Zaire	  Ebolavirus	  (Strian	  Mayinga-­‐76)	  (ZEBOV)	  (Zaire	  
Ebola	  Virus).	  The	  entry	  ID	  can	  be	  used	  in	  UniProt.	  




RNA-directed RNA polymerase L  
(Protein L) (Large structural protein)  
(Replicase) (Transcriptase)  
[Includes: RNA-directed RNA  
polymerase (EC 2.7.7.48);  
mRNA (guanine-N(7)-)-methyl- 
transferase (EC 2.1.1.56);  
mRNA guanylyltransferase  
(EC 2.7.7.-)] L 2212 
P18272 NCAP_EBOZM 
Nucleoprotein (Nucleocapsid protein)  
(Protein N) NP 739 
Q05320 VGP_EBOZM 
Envelope glycoprotein (GP1,2) (GP)  
[Cleaved into: GP1; GP2; GP2-delta] GP 676 
Q05322 VP24_EBOZM Membrane-associated protein VP24 VP24 251 
Q05323 VP30_EBOZM 
Minor nucleoprotein VP30  
(Transcription activator VP30) VP30 288 
Q05128 VP40_EBOZM 
Matrix protein VP40  
(Membrane-associated protein VP40) VP40 326 
Q05127 VP35_EBOZM Polymerase cofactor VP35 VP35 340 
P60170 VSGP_EBOZM 
Pre-small/secreted glycoprotein  
(pre-sGP)  
[Cleaved into: Small/secreted  
glycoprotein (sGP); Delta-peptide] GP 364 
Q9YMG2 VSSGP_EBOZM 
Super small secreted glycoprotein  
(SsGP) GP 298 	  
1.2	  Previous	  Studies	  
1.2.1	  Sequence	  Information	  In	  order	  to	  solve	  the	  above	  questions,	  we	  studied	  the	  viruses	  in	  the	  family	  Filoviridae,	  which	  are	  nonsegmented,	  negative-­‐strand	  RNA	  viruses	  (Serena	  A.	  Carroll,	  2013).	  Among	  the	  family,	  the	  species	  Zaire	  Ebolavirus	  is	  the	  one	  that	  causes	  the	  2014	  outbreak.	  There	  are	  seven	  genes	  in	  the	  proteome	  of	  Zaire	  Ebola,	  encoding	  the	  following	  proteins:	  nucleoprotein	  (NP),	  polymerase	  cofactor	  VP35	  (VP35),	  matrix	  protein	  VP40	  (VP40),	  glycoprotein	  (GP),	  minor	  nucleoprotein	  VP30	  (VP30),	  membrane-­‐associated	  protein	  VP24	  (VP24),	  and	  RNA-­‐directed	  RNA	  polymerase	  L	  (L).	  Furthermore,	  glycoprotein	  can	  from	  two	  variants,	  pre-­‐small/secreted	  glycoprotein	  (sGP),	  and	  super	  small	  secreted	  glycoprotein	  (ssGP)	  (Swiss-­‐Prot,	  2002-­‐2015).	  Figure	  1	  shows	  the	  genome	  of	  Ebolavirus	  (Bioinformatics,	  2015).Table	  2	  summarizes	  the	  proteome	  information	  described	  above,	  along	  with	  the	  length	  of	  each	  protein	  in	  terms	  of	  amino	  acids.	  
1.2.2	  3D	  Structures	  of	  the	  Proteome	  In	  terms	  of	  three	  dimensional	  (3D)	  structures	  of	  the	  proteins,	  there	  is	  still	  a	  significant	  gap	  in	  the	  knowledge	  in	  this	  area.	  According	  to	  the	  video	  that	  PDB	  (Protein	  Data	  Bank)	  published	  in	  2014	  (PDB,	  2014),	  the	  crystal	  structures	  of	  VP24	  and	  VP40	  have	  been	  fully	  resolved,	  while	  those	  of	  glycoprotein,	  VP30,	  nucleoprotein,	  and	  VP35	  have	  not	  been	  fully	  resolved,	  and	  the	  structure	  of	  large	  structural	  protein	  is	  still	  a	  myth	  yet.	  
1.2.3	  Previous	  Study	  on	  Sequence	  Evolution	  The	  conventional	  way	  to	  study	  the	  evolution	  is	  to	  align	  sequences	  of	  interest	  and	  then	  construct	  the	  phylogenetic	  tree.	  A	  research	  paper	  published	  in	  2013	  analyzed	  the	  molecular	  evolution	  of	  viruses	  in	  the	  family	  Filoviridae	  based	  on	  97	  whole-­‐genome	  sequences	  (Serena	  A.	  Carroll,	  2013).	  Using	  the	  “Bayesian	  coalescent”	  analyses,	  they	  have	  constructed	  phylogenetic	  trees	  for	  major	  genera	  and	  the	  whole	  family.	  The	  result	  also	  predicts	  the	  emergence	  of	  the	  common	  ancestor	  between	  two	  genera.	  However,	  this	  does	  not	  provide	  us	  with	  any	  insight	  on	  the	  structural	  details.	  
1.2.4	  Previous	  Study	  on	  Structural	  Bioinformatics	  In	  terms	  of	  protein	  structures	  in	  this	  family,	  many	  studies	  have	  examined	  the	  crystal	  structures	  of	  the	  proteins;	  one	  study	  examined	  the	  structure	  of	  the	  same	  protein	  VP35	  in	  Zaire	  Ebola	  virus	  in	  various	  forms,	  and	  it	  also	  suggests	  VP35	  is	  a	  potential	  target	  for	  drugs	  (Craig	  S.	  Brown,	  2014);	  some	  studies	  found	  the	  structures	  for	  interactions	  between	  a	  certain	  protein	  and	  other	  proteins,	  such	  as	  the	  interaction	  between	  NP	  and	  VP35.	  However,	  none	  of	  them	  has	  studied	  the	  overall	  evolution	  of	  this	  family	  based	  on	  the	  structural	  information.	  
1.3	  Our	  Approach	  Given	  the	  fact	  that	  the	  family-­‐wise	  evolution	  based	  on	  the	  protein	  structures	  has	  not	  been	  studied,	  we	  aimed	  to	  tackle	  this	  task	  from	  the	  point	  of	  view	  of	  structural	  bioinformatics.	  Inspired	  by	  a	  research	  about	  influenza	  published	  in	  2013,	  we	  decided	  to	  follow	  a	  similar	  approach.	  From	  the	  paper	  about	  influenza,	  the	  researchers	  filtered	  out	  75	  non-­‐redundant	  strains	  from	  1100	  complete	  genomes	  (Samantha	  Warren,	  2013).	  However,	  in	  order	  to	  reduce	  computational	  cost,	  they	  only	  built	  models	  for	  all	  ten	  proteins	  in	  one	  randomly	  selected	  strain.	  	  Then	  they	  identified	  the	  exterior	  residues	  and	  interior	  residues	  using	  CalcSurface.	  Next	  they	  checked	  the	  evolution	  for	  the	  exterior	  and	  interior	  residues	  
separately,	  first	  by	  aligning	  the	  sequences	  and	  finding	  the	  100%	  conserved	  sequences,	  and	  then	  by	  calculating	  the	  Euclidean	  distance	  between	  the	  all	  pairs	  of	  100%	  conserved	  residues.	  They	  also	  constructed	  phylogenetic	  trees	  to	  help	  analyze.	  As	  a	  result,	  they	  found	  that	  the	  highly	  conserved	  regions	  on	  the	  surface	  do	  not	  overlap	  with	  the	  regions	  involved	  in	  host-­‐viral	  interactions.	  However,	  such	  regions	  are	  associated	  with	  the	  intra-­‐viral	  interactions.	  	  Similarly,	  we	  are	  interested	  in	  the	  spatial	  locations	  of	  the	  conserved	  regions	  as	  well	  as	  the	  diverse	  regions	  in	  the	  family	  of	  Filovirus.	  Unlike	  the	  paper	  we	  referred	  to,	  where	  most	  concepts	  are	  defined	  by	  a	  certain	  scientifically	  rigorous	  algorithm,	  such	  as	  the	  definitions	  of	  exterior	  residues	  (surface	  residues),	  interior	  residues	  (core	  residues),	  conserved	  residues,	  and	  diverse	  residues,	  we	  decide	  most	  of	  the	  cutoffs	  by	  intuition.	  To	  start	  with,	  since	  not	  all	  the	  structures	  in	  the	  proteome	  of	  Ebola	  have	  been	  solved,	  we	  constructed	  the	  three-­‐dimensional	  models	  for	  all	  the	  proteins	  based	  on	  homology	  modeling	  method.	  Then	  we	  aligned	  representative	  sequences	  of	  all	  species	  within	  this	  family	  and	  tried	  to	  find	  the	  extremely	  conserved	  residues	  as	  well	  as	  the	  extremely	  diverse	  residues,	  which	  are	  then	  mapped	  back	  to	  the	  three-­‐dimensional	  structures	  we	  built.	  Finally,	  we	  predicted	  the	  functional	  regions	  in	  the	  proteins	  and	  mapped	  back	  to	  the	  models,	  too.	  This	  way,	  we	  can	  compare	  the	  highly	  conserved	  and	  diverse	  regions	  with	  the	  predicted	  functional	  regions.	  	  	  
	  
Figure	  2:	  Overview	  of	  proteins	  in	  Ebolavirus.	  Extracted	  from	  Protein	  Data	  Bank,	  Molecule	  of	  the	  Month:	  
http://www.rcsb.org/pdb/education_discussion/molecule_of_the_month/download/Ebola.pdf	  
Our	  hypothesis	  is	  similar	  to	  the	  conclusion	  in	  the	  reference	  paper	  about	  influenza	  (Samantha	  Warren,	  2013):	  The	  highly	  conserved	  regions	  across	  species	  should	  be	  involved	  in	  intra-­‐viral	  interactions,	  while	  the	  highly	  diverse	  regions	  across	  years	  should	  be	  involved	  in	  host-­‐viral	  interactions.	  The	  logic	  behind	  this	  hypothesis	  is	  intuitive:	  In	  order	  to	  reach	  minimal	  requirement	  for	  survival,	  virus	  has	  to	  keep	  certain	  essential	  regions	  unchanged	  so	  that	  the	  proteins	  within	  this	  virus	  can	  recognize	  itself	  and	  collaborate	  with	  other	  proteins	  or	  RNA.	  On	  the	  other	  hand,	  in	  order	  for	  the	  species	  of	  virus	  to	  survive	  over	  years,	  the	  virus	  has	  to	  “evolve”	  to	  avoid	  being	  detected	  by	  the	  host	  antibodies.	  Therefore,	  the	  interactions	  between	  the	  host	  and	  virus	  are	  unlikely	  to	  stay	  the	  same	  over	  years.	  So,	  the	  residues	  involved	  in	  host-­‐viral	  interactions	  in	  an	  outbreak	  several	  decades	  ago	  should	  be	  found	  extremely	  diverse	  throughout	  the	  years.	  	  	   	  
Chapter	  2:	  Methods	  The	  basic	  methodology	  is	  similar	  to	  the	  one	  regarding	  H1N1	  (Warren	  S,	  2013).	  Overall,	  to	  discover	  the	  conserved	  and	  diverse	  regions	  about	  the	  proteins	  in	  Ebolavirus,	  the	  models	  for	  the	  7	  proteins	  were	  built	  using	  homology	  modeling	  method.	  Then,	  a	  representative	  from	  each	  species	  in	  the	  Filoviridae	  family	  was	  chosen	  and	  highly	  conserved	  and	  highly	  diverse	  residues	  were	  found	  and	  mapped	  back	  to	  the	  models	  built	  in	  the	  previous	  steps.	  Careful	  observations	  were	  made	  and	  the	  potential	  functional	  annotations	  were	  created	  through	  searching	  SCOP	  family	  of	  the	  related	  sequences.	  After	  studying	  the	  conservation	  and	  diversity	  across	  species,	  the	  similar	  approach	  is	  applied	  to	  studying	  the	  conservation	  and	  diversity	  across	  years.	  Detailed	  procedures	  will	  be	  discussed	  in	  each	  section	  below.	  
2.1	  Data	  Collection	  To	  start	  with,	  we	  tried	  to	  collect	  as	  many	  sequences	  in	  the	  Filoviridae	  family	  as	  possible.	  The	  searching	  databases	  used	  to	  find	  the	  sequences	  included	  UniProt,	  founded	  by	  European	  Bioinformatics	  Institute	  et	  al,	  (European	  Bioinformatics	  Institute,	  the	  SIB	  Swiss	  Institute	  of	  Bioinformatics,	  and	  the	  Protein	  Information	  Resource,	  2015)	  and	  NCBI	  founded	  by	  National	  Center	  for	  Biotechnology	  Information	  in	  US	  (National	  Center	  for	  Biotechnology	  Information,	  U.S.	  National	  Library	  of	  Medicine,	  2015).	  For	  each	  species	  found	  in	  the	  Introduction	  section,	  we	  searched	  the	  protein	  names	  combined	  with	  the	  species	  in	  UniProt.	  Then	  the	  summary	  is	  downloaded	  with	  the	  information	  about	  the	  entry,	  entry	  name,	  status,	  protein	  names,	  gene	  name,	  organism,	  length,	  date	  of	  creation,	  place,	  strain,	  and	  year.	  The	  place,	  strain,	  and	  year	  were	  parsed	  from	  the	  strain	  information,	  and	  the	  date	  of	  creation	  was	  the	  date	  the	  entry	  was	  created	  in	  UniProt,	  which	  does	  not	  reflect	  the	  actual	  date	  when	  the	  sequence	  was	  found.	  Sequences	  that	  are	  segments	  of	  a	  protein	  were	  ignored.	  The	  summaries	  can	  be	  found	  in	  the	  appendices.	  	  Similar	  searching	  was	  done	  in	  NCBI.	  However,	  most	  of	  the	  results	  overlapped	  with	  those	  from	  UniProt,	  since	  both	  search	  engines	  share	  the	  data.	  At	  the	  time	  of	  searching,	  NCBI	  provided	  99	  genomes	  of	  Ebolavirus	  from	  2014	  outbreak,	  which	  were	  not	  available	  in	  UniProt,	  and	  the	  protein	  ID	  for	  each	  sequence	  was	  also	  recorded	  in	  the	  appendices.	  
2.2	  Comparative	  Modeling	  After	  finding	  the	  sequences,	  models	  for	  each	  protein	  are	  made	  using	  MODELLER	  (Andrej	  Šali,	  1993)	  in	  order	  to	  further	  study	  the	  3D	  structure	  in	  the	  future	  steps.	  As	  described	  in	  its	  website,	  MODELLER	  uses	  existing	  structures	  as	  template	  and	  build	  the	  target	  model	  by	  satisfaction	  spatial	  restraints	  (Sali	  Lab,	  2015).	  This	  method	  is	  also	  called	  homology	  modeling.	  There	  are	  five	  types	  of	  modeling	  in	  the	  tutorial	  (Sali	  Lab,	  2010).	  In	  this	  project,	  only	  the	  Basic	  Modeling	  method	  and	  the	  Advanced	  Modeling	  method	  were	  used	  to	  construct	  the	  models.	  The	  procedures	  used	  were	  very	  similar	  to	  the	  ones	  described	  in	  the	  tutorial,	  with	  only	  a	  minor	  modification	  in	  the	  first	  two	  steps.	  Here	  is	  a	  basic	  flow	  of	  how	  to	  build	  models	  in	  MODELLER.	  
2.2.1	  Pre-­‐Processing	  Steps	  To	  start	  with,	  the	  target	  sequence	  for	  each	  protein	  was	  to	  be	  determined.	  Here,	  the	  first	  sequence	  for	  each	  protein	  in	  the	  99	  sequences	  found	  in	  the	  2014	  outbreak	  was	  chosen	  as	  our	  targets.	  Their	  sequence	  IDs	  in	  NCBI	  are	  as	  follows:	  AIE11806.1	  (NP),	  AIE11807.1	  (VP35),	  
AIE11808.1	  (VP40),	  AIE11809.1	  (GP),	  AIE11812.1	  (VP30),	  AIE11813.1	  (VP24),	  and	  AIE11814.1	  (L).	  In	  the	  tutorial,	  the	  first	  step	  is	  to	  find	  structures	  related	  to	  the	  target	  sequence	  using	  a	  
binary	  file	  called	  “pdb_95.bin”,	  which	  contains	  structures	  in	  PDB	  that	  are	  less	  than	  95%	  similar.	  However,	  the	  pdb_95.bin	  file	  can	  be	  outdated.	  So,	  in	  this	  project,	  we	  chose	  an	  alternative	  approach.	  For	  each	  sequence,	  PSI-­‐BLAST	  was	  performed	  against	  Protein	  Data	  Bank.	  The	  tool	  we	  used	  is	  the	  internal	  link	  in	  NCBI	  website,	  which	  will	  give	  us	  a	  very	  useful	  graphical	  summary.	  	  	  For	  example,	  Figure	  3	  is	  a	  screenshot	  of	  the	  PSI-­‐BLAST	  result	  of	  NP.	  The	  color	  key	  for	  alignment	  scores	  shows	  that	  a	  red	  sequence	  has	  the	  highest	  score,	  while	  a	  black	  sequence	  has	  a	  relatively	  low	  score.	  The	  red	  bar	  below	  the	  color	  key	  is	  the	  query	  sequence,	  and	  the	  coordinates	  roughly	  show	  the	  positions	  where	  the	  two	  sequences	  are	  aligned.	  Specifically,	  in	  Figure	  3,	  a	  small	  red	  sequence	  is	  found	  to	  align	  with	  our	  query	  near	  the	  end.	  	  While	  in	  Figure	  4,	  more	  than	  one	  red	  sequence	  is	  aligned	  to	  the	  same	  portion	  of	  our	  query	  at	  the	  same	  time.	  In	  this	  case,	  we	  can	  build	  a	  model	  using	  multiple	  templates,	  corresponding	  to	  the	  advanced	  modeling	  method.	  Usually,	  we	  first	  build	  a	  basic	  model	  before	  building	  an	  advanced	  one,	  even	  when	  more	  than	  one	  template	  can	  be	  chosen.	  Then,	  we	  would	  build	  an	  advanced	  model	  and	  compare	  it	  with	  the	  basic	  one	  using	  DOPE	  score,	  which	  will	  be	  further	  discussed	  in	  later	  sections.	  	  
	  
Figure	  3:	  NP	  PSI-­‐BLAST	  Result	  	  
If	  several	  sequences	  can	  be	  chosen	  as	  the	  template,	  but	  they	  vary	  in	  coverage	  and	  identity,	  the	  sequence	  with	  the	  best	  combination	  of	  coverage	  and	  identity	  will	  be	  chosen	  finally.	  	  After	  selecting	  a	  template	  (or	  multiple	  templates)	  for	  the	  target	  sequence,	  we	  then	  can	  build	  models	  using	  the	  template(s).	  
2.2.2	  Basic	  Modeling	  Method	  If	  a	  single	  template	  is	  selected,	  we	  can	  continue	  to	  build	  the	  model	  using	  the	  basic	  modeling	  method,	  which	  is	  comprised	  of	  the	  following	  steps.	  1. Align	  the	  target	  sequence	  with	  the	  template.	  2. Build	  models	  based	  on	  the	  template	  using	  python	  script.	  3. Evaluate	  the	  models.	  	  1.	  Aligning	  the	  Target	  Sequence	  with	  the	  Template	  After	  selecting	  a	  template,	  we	  can	  align	  the	  template	  with	  the	  sequence	  using	  MODELLER	  library	  (See	  align2d.py	  in	  the	  appendices).	  Before	  the	  alignment,	  small	  adjustment	  has	  to	  be	  done	  to	  convert	  the	  “.fasta”	  file	  to	  “.ali”	  file,	  according	  to	  the	  PIR	  format	  instructions	  (Webb,	  2007).	  	  	  2.	  Model	  Building	  Then	  we	  can	  build	  the	  model	  using	  the	  alignment	  file,	  our	  target	  sequence	  and	  our	  template	  (See	  model-­‐single.py	  in	  the	  appendices).	  5	  models	  will	  be	  generated.	  	  
	  
Figure	  4:	  VP40	  PSI-­‐BLAST	  Result	  
	  3.	  Model	  Evaluation	  As	  introduced	  in	  the	  tutorial,	  several	  measurements	  can	  be	  used	  to	  evaluate	  models	  and	  therefore,	  to	  select	  the	  best	  one	  among	  the	  models	  built	  in	  the	  previous	  step.	  One	  of	  them	  is	  DOPE	  (Discrete	  Optimized	  Protein	  Energy)	  score,	  which	  calculates	  the	  potential	  in	  a	  certain	  model.	  The	  lower	  the	  DOPE	  score	  is,	  the	  better	  the	  model	  is.	  To	  evaluate	  whether	  the	  models	  have	  been	  built	  successfully,	  we	  can	  open	  the	  five	  models	  together	  in	  Chimera	  at	  the	  same	  time	  and	  superimpose	  them.	  If	  they	  align	  pretty	  well,	  the	  models	  are	  very	  consistent,	  and	  thus	  the	  models	  are	  generally	  acceptable.	  However,	  if	  the	  models	  differ	  from	  each	  other	  greatly,	  or	  it	  contains	  a	  long	  free	  segment,	  the	  modeling	  process	  has	  not	  been	  very	  successful.	  In	  such	  cases,	  advanced	  modeling	  method	  might	  be	  applied	  if	  more	  than	  one	  template	  can	  be	  found.	  
2.2.3	  Example	  of	  Basic	  Modeling	  Method	  Here	  is	  an	  example	  of	  how	  to	  construct	  a	  basic	  model	  for	  VP40	  using	  one	  template.	  The	  corresponding	  NCBI	  protein	  ID	  is	  AIE11808.	  	  	  First,	  a	  PSI-­‐BLAST	  against	  the	  known	  structures	  in	  PDB	  was	  done.	  Figure	  4	  and	  Table	  3	  summarize	  the	  results.	  (Note	  that	  the	  order	  of	  sequences	  in	  the	  graphical	  summary	  is	  different	  from	  that	  of	  the	  table.	  When	  you	  read	  the	  graphical	  summary	  in	  NCBI,	  the	  sequence	  information	  will	  show	  up	  when	  mouse-­‐over.)	  As	  we	  can	  see,	  1H2D	  and	  1H2C	  have	  the	  highest	  identity	  (100%);	  1ES6,	  4LDB,	  4LDD,	  4LDI,	  and	  4LDM	  are	  almost	  identical	  to	  our	  target	  (99%),	  and	  among	  them1ES6	  has	  the	  longest	  coverage.	  On	  the	  other	  hand,	  3TCQ	  has	  the	  overall	  longest	  coverage,	  but	  it	  is	  only	  75%	  identical	  to	  the	  target.	  	  So,	  in	  order	  to	  have	  the	  best	  model	  possible,	  we	  need	  to	  balance	  the	  identity	  and	  the	  coverage.	  If	  we	  consider	  building	  a	  basic	  model,	  we	  can	  either	  use	  3TCQ	  or	  1ES6.	  Since	  3TCQ	  has	  the	  longest	  coverage	  and	  75%	  is	  a	  decent	  identity.	  However,	  when	  opening	  3TCQ,	  it	  shows	  that	  the	  structure	  corresponding	  to	  the	  first	  44	  residues	  and	  the	  last	  18	  residues	  is	  missing.	  Overall,	  1ES6:	  A	  should	  be	  the	  best	  template,	  with	  a	  99%	  identity	  and	  coverage	  of	  296	  residues	  in	  length.	  After	  selecting	  the	  template,	  we	  aligned	  the	  template	  with	  our	  target	  sequence	  using	  Modeller	  script	  “align2d.py”	  (See	  Appendix	  B.	  1).	  	  The	  alignment	  result	  is	  shown	  below	  in	  pap	  format	  in	  Figure	  5.	  	  	  Then	  we	  could	  construct	  the	  models	  based	  on	  the	  alignment	  by	  running	  the	  script	  “model-­‐single.py”	  (See	  Appendix	  B.	  2).	  Five	  models	  were	  generated	  after	  running	  the	  script.	  Among	  them,	  the	  best	  is	  the	  fifth	  one,	  with	  the	  lowest	  total	  DOPE	  score.	  Below	  is	  the	  summary	  of	  
Table	  3:	  PDB	  Advanced	  Sequence	  Search	  Result	  for	  VP40	  
Code	   Chains E-­‐value Identity Start End Length 
1ES6 A 6.44E-­‐170 294/296	  (99%) 31 326 296 
4LDB A,B,C,D 9.16E-­‐163 282/284	  (99%) 43 326 284 
4LDD A,B,C 9.16E-­‐163 282/284	  (99%) 43 326 284 
4LDI A,B 5.79E-­‐162 281/284	  (99%) 43 326 284 
3TCQ A 3.59E-­‐141 248/329	  (75%) 1 326 329 
4LD8 A 1.16E-­‐136 232/282	  (82%) 45 326 282 
1H2D A,B 7.13E-­‐103 182/182	  (100%) 31 212 182 
4LDM A 6.72E-­‐80 145/146	  (99%) 43 188 146 
1H2C A 1.61E-­‐77 140/140	  (100%) 55 194 140 	  
scores	  for	  each	  model	  produced	  by	  Modeller:	  	   >>	  Summary	  of	  successfully	  produced	  models:	  Filename	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  molpdf	  	  	  	  	  DOPE	  score	  	  	  	  GA341	  score	  -­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐	  AIE11808.B99990001.pdb	  	  	  	  	  	  	  	  2246.65991	  	  	  -­‐32501.79883	  	  	  	  	  	  	  	  1.00000	  AIE11808.B99990002.pdb	  	  	  	  	  	  	  	  2261.87061	  	  	  -­‐32414.62695	  	  	  	  	  	  	  	  1.00000	  AIE11808.B99990003.pdb	  	  	  	  	  	  	  	  2250.31812	  	  	  -­‐32688.30273	  	  	  	  	  	  	  	  1.00000	  AIE11808.B99990004.pdb	  	  	  	  	  	  	  	  2314.44580	  	  	  -­‐32276.85547	  	  	  	  	  	  	  	  1.00000	  AIE11808.B99990005.pdb	  	  	  	  	  	  	  	  2123.74365	  	  	  -­‐32741.74609	  	  	  	  	  	  	  	  1.00000	  	  When	  opening	  the	  five	  models	  in	  Chimera	  at	  the	  same	  time	  and	  superimpose	  all	  of	  them,	  most	  of	  them	  can	  be	  aligned	  well,	  except	  for	  the	  ends,	  as	  shown	  in	  Figure	  6.	  The	  consistency	  of	  models	  indicates	  the	  models	  are	  reliable	  to	  some	  degree.	  Also,	  since	  the	  GA341	  scores	  for	  all	  models	  equal	  1,	  all	  models	  can	  be	  considered	  as	  “good”	  models.	  	  	  Now,	  we	  could	  further	  evaluate	  our	  best	  model	  based	  on	  the	  DOPE	  per-­‐residue	  score,	  and	  plot	  it	  against	  that	  for	  the	  template	  structure.	  Before	  plotting	  the	  DOPE	  scores,	  we	  need	  “profile”	  files	  for	  both	  the	  template	  and	  our	  model.	  Using	  “evaluate_model.py”	  (See	  Appendix	  B.	  3)	  we	  could	  get	  the	  corresponding	  “profile”	  file.	  Then	  we	  could	  generate	  the	  plot	  using	  “plot_profiles.py”	  (See	  Appendix	  B.	  4).	  The	  plot	  generated	  is	  shown	  in	  Figure	  7.	  As	  we	  can	  see,	  there	  is	  space	  for	  improvement	  around	  residue	  280,	  where	  the	  chosen	  template	  does	  not	  have	  a	  corresponding	  structure.	  We	  could	  try	  to	  construct	  an	  advanced	  model	  using	  multiple	  templates.	  
	  
Figure	  5:	  Alignment	  between	  1ES6	  and	  VP40	  (AIE11808-­‐13s6A.pap)	  
2.2.4	  Advanced	  Modeling	  Method	  In	  the	  advanced	  tutorial,	  there	  are	  three	  techniques	  to	  improve	  the	  models:	  multiple	  templates,	  loop	  refining,	  and	  modeling	  ligands	  in	  the	  binding	  site.	  In	  this	  project,	  only	  the	  first	  method	  is	  used	  to	  construct	  better	  models	  because	  of	  time	  constraint.	  As	  illustrated	  in	  the	  pre-­‐processing	  section,	  sometimes,	  we	  can	  find	  more	  than	  one	  sequence	  aligned	  with	  a	  certain	  part	  of	  our	  query.	  Such	  information	  is	  useful	  for	  constructing	  a	  better	  model	  because	  the	  information	  from	  other	  templates	  may	  compliment	  the	  information	  from	  our	  basic	  template.	  The	  steps	  to	  construct	  an	  advanced	  model	  is	  as	  follows:	  	  1.	  Selecting	  Templates	  First,	  we	  need	  to	  determine	  which	  templates	  we	  should	  use.	  In	  the	  tutorial,	  they	  find	  the	  related	  structures	  by	  searching	  the	  family	  members	  for	  the	  template	  used	  in	  the	  basic	  modeling	  method.	  But	  in	  this	  project,	  we	  simply	  continued	  using	  the	  PSI-­‐BLAST	  result.	  	  
	  
Figure	  6:	  Basic	  Models	  for	  VP40	  Aligned	  in	  Chimera	  	  
	  
Figure	  7:	  Model	  Assessment	  Using	  DOPE	  Score	  Per	  Residue	  measure	  	  
2.	  Aligning	  the	  Target	  with	  Multiple	  Templates	  After	  determining	  the	  templates,	  we	  would	  align	  the	  templates	  using	  the	  command	  “salign()”	  (See	  the	  complete	  script	  in	  Appendix	  B.1).	  After	  checking	  the	  alignment	  file,	  we	  can	  align	  our	  query	  sequence	  to	  the	  templates	  (See	  Appendix	  B.	  6).	  	  	  3.	  Model	  Building	  Similar	  to	  what	  we	  have	  done	  in	  the	  basic	  modeling	  method,	  we	  would	  then	  construct	  the	  model	  based	  on	  the	  alignment.	  	  	  4.	  Model	  Evaluation	  Finally,	  we	  would	  evaluate	  the	  model	  using	  DOPE	  score.	  To	  compare	  the	  advanced	  model	  with	  the	  basic	  one,	  we	  can	  plot	  the	  DOPE	  per	  residue	  score	  for	  both	  models,	  and	  see	  whether	  there	  exists	  any	  difference.	  The	  scripts	  used	  for	  the	  last	  two	  steps	  are	  almost	  identical	  to	  those	  used	  in	  the	  basic	  modeling	  method.	  Please	  check	  Appendix	  B.	  3	  and	  4.	  An	  additional	  step	  can	  be	  to	  compare	  the	  best	  model	  we	  constructed	  using	  the	  basic	  method	  with	  that	  using	  the	  advanced	  method.	  
2.2.5	  Example	  of	  Advanced	  Modeling	  Method	  As	  shown	  in	  Figure	  4,	  the	  first	  four	  sequences	  (colored	  red)	  have	  a	  good	  coverage	  of	  our	  query,	  but	  after	  checking	  the	  sequences,	  the	  second	  and	  the	  third	  sequence	  are	  almost	  identical.	  So,	  three	  sequences	  were	  chosen	  to	  build	  the	  model:	  1ES6:A,	  4LDB:B,	  and	  3TCQ:A.	  Then,	  we	  aligned	  the	  templates	  using	  “salign.py”,	  which	  can	  be	  found	  in	  Appendix	  B.	  5.	  Figure	  8	  is	  the	  alignment	  result	  among	  the	  templates.	  Next,	  we	  aligned	  the	  query	  with	  the	  aligned	  templates	  using	  “align2d_mult.py”,	  which	  can	  be	  found	  in	  Appendix	  B.	  6.	  Figure	  8	  is	  the	  alignment	  result	  between	  the	  templates	  and	  the	  query.	  Finally,	  we	  constructed	  the	  model	  using	  the	  script	  “model_mult.py”,	  which	  can	  be	  found	  in	  Appendix	  B.	  7.	  As	  in	  the	  basic	  method,	  MODELLER	  generated	  5	  models.	  The	  DOPE	  scores	  for	  the	  models	  are	  listed	  below:	  	  
	  
Figure	  8:	  Alignment	  Among	  Templates	  (multitemp.pap)	  
	   >>	  Summary	  of	  successfully	  produced	  models:	  Filename	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  molpdf	  	  	  	  	  DOPE	  score	  	  	  	  GA341	  score	  -­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐	  AIE11808.B99990001.pdb	  	  	  	  	  	  	  10951.37500	  	  	  -­‐32580.52734	  	  	  	  	  	  	  	  1.00000	  AIE11808.B99990002.pdb	  	  	  	  	  	  	  10891.88184	  	  	  -­‐32887.29297	  	  	  	  	  	  	  	  1.00000	  AIE11808.B99990003.pdb	  	  	  	  	  	  	  10914.78125	  	  	  -­‐32747.57422	  	  	  	  	  	  	  	  1.00000	  AIE11808.B99990004.pdb	  	  	  	  	  	  	  10882.16211	  	  	  -­‐32652.26562	  	  	  	  	  	  	  	  1.00000	  AIE11808.B99990005.pdb	  	  	  	  	  	  	  10948.46484	  	  	  -­‐32930.75781	  	  	  	  	  	  	  	  1.00000	  	  So,	  the	  best	  model	  according	  to	  the	  DOPE	  score	  is	  the	  fifth	  one.	  When	  opening	  the	  five	  models	  in	  Chimera	  at	  the	  same	  time,	  they	  can	  superimpose	  with	  each	  other	  very	  well,	  which	  indicates	  the	  models	  are	  very	  consistent.	  	  	  Finally,	  we	  can	  compare	  the	  best	  advanced	  model	  with	  the	  best	  basic	  model	  to	  see	  whether	  the	  model	  has	  been	  improved.	  To	  compare	  them,	  we	  could	  plot	  out	  the	  DOPE	  score	  per	  residue	  for	  both	  models.	  As	  we	  can	  see	  from	  Figure	  10,	  the	  advanced	  model	  generally	  has	  a	  lower	  DOPE	  score	  per	  residue.	  Especially	  in	  the	  region	  around	  residue	  270,	  the	  advanced	  model	  has	  a	  lower	  DOPE	  score.	  Therefore,	  the	  advanced	  model	  is	  better.	  
2.3	  Family-­‐Wise	  Sequence	  Alignment	  After	  building	  the	  models,	  we	  want	  to	  find	  out	  how	  much	  similar	  the	  Ebola	  proteome	  is	  to	  those	  from	  other	  species.	  So,	  we	  continued	  to	  align	  the	  Ebola	  protein	  sequence	  one	  by	  one	  with	  the	  corresponding	  sequence	  from	  other	  species	  in	  the	  same	  family,	  and	  then	  score	  the	  alignment	  per	  residue	  based	  on	  trident	  score,	  which	  will	  be	  further	  discussed	  in	  this	  chapter.	  
	  
Figure	  9:	  Advanced	  Models	  for	  VP40	  Aligned	  in	  Chimera	  
	  2.3.1	  Sequence	  Selection	  As	  mentioned	  in	  Section	  2.1,	  we	  collected	  data	  for	  99	  Zaire	  Ebolavirus	  genomes	  from	  2014	  outbreak,	  and	  all	  sequences	  available	  in	  UniProt	  for	  all	  species	  under	  the	  Filoviridae	  family.	  However,	  the	  numbers	  of	  sequences	  from	  different	  species	  differ	  greatly.	  For	  example,	  there	  are	  43	  Marburg	  sequences,	  while	  there	  is	  only	  1	  Lloviu	  cuevavirus	  sequence.	  Besides,	  if	  we	  use	  the	  99	  sequences	  found	  in	  the	  year	  2014,	  we	  would	  have	  more	  than	  100	  Zaire	  
	  
Figure	  10:	  DOPE	  Score	  Per	  Residue	  for	  Both	  Models	  
	  
Figure	  11:	  Filoviridae	  Taxonomy	  from	  NCBI	  
Ebolavirus	  genomes	  in	  the	  end.	  Since	  we	  wanted	  to	  compare	  the	  sequences	  in	  a	  quantitative	  way,	  which	  will	  be	  introduced	  later	  in	  this	  chapter,	  the	  abundance	  of	  each	  species	  would	  introduce	  bias	  for	  the	  analysis	  step.	  Therefore,	  we	  altered	  our	  method.	  Instead	  of	  using	  all	  the	  sequences,	  we	  selected	  one	  genome	  for	  each	  species	  identified	  in	  NCBI	  Taxonomy,	  and	  aligned	  them	  using	  MAFFT	  automatic	  alignment.	  Below	  is	  a	  screenshot	  of	  the	  Filoviridae	  taxonomy	  from	  NCBI.	  	  	  
2.3.2	  Trident	  Score	  Then,	  to	  measure	  the	  degree	  to	  which	  Ebola	  is	  different	  from	  other	  species	  within	  the	  
Filoviridae	  family,	  we	  need	  to	  find	  a	  way	  to	  assess	  the	  alignment	  quantitatively.	  The	  measurement	  we	  used	  is	  called	  “trident”	  score	  (Valdar,	  2002),	  which	  considers	  symbol	  diversity,	  stereochemical	  diversity	  and	  gaps.	  The	  formula	  to	  compute	  the	  trident	  score	  is	  shown	  below:	   𝐶!"#$%&!   𝑥 = (1− 𝑡 𝑥 )!(1− 𝑟 𝑥 )!(1− 𝑔 𝑥 )!	  In	  this	  formula,	  𝑡 𝑥 	  is	  Shannon’s	  entropy,	  or	  symbol	  diversity,	  while	  𝑟 𝑥 	  is	  the	  stereochemical	  diversity,	  and	  𝑔 𝑥 	  is	  the	  fraction	  of	  symbols	  in	  a	  certain	  column	  that	  are	  gaps.	  Each	  of	  them	  is	  continuous	  and	  normalized	  from	  0	  to	  1.	  And	  𝛼,𝛽,𝑎𝑛𝑑  𝛾	  are	  the	  weights	  of	  each	  parameter.	  For	  example,	  if	  𝛼,𝛽,𝑎𝑛𝑑  𝛾	  all	  equal	  1,	  then	  they	  are	  equally	  weighted,	  but	  in	  this	  way	  too	  much	  weight	  is	  on	  stereochemistry	  but	  too	  little	  weight	  is	  on	  gaps.	  Since	  all	  three	  parameters	  range	  from	  0	  to	  1,	  the	  trident	  score	  will	  range	  from	  0	  to	  1	  as	  well.	  The	  advantage	  of	  using	  trident	  score	  lies	  in	  that	  not	  only	  diversity	  is	  considered,	  but	  also	  the	  chemical	  property	  is	  taken	  into	  account.	  	  	  Since	  the	  calculation	  of	  the	  trident	  score	  is	  too	  complicated,	  we	  used	  an	  online	  tool,	  called	  Scorecons	  	  (Valdar,	  2002).	  The	  parameters	  we	  used	  to	  compute	  the	  trident	  score	  are	  shown	  in	  the	  screenshot	  in	  Figure	  12.	  We	  chose	  BLOSUM62	  for	  two	  reasons.	  First,	  Scorecons	  provides	  three	  categories	  of	  substitution	  matrices,	  PAM,	  BLOSUM,	  and	  modified	  PET91,	  and	  among	  the	  three	  categories,	  the	  BLOSUM	  matrices	  match	  our	  purpose	  best,	  since	  they	  were	  designed	  to	  find	  the	  conserved	  regions	  of	  proteins	  (Marketa	  Zvelebil,	  2008).	  Second,	  when	  we	  aligned	  the	  sequences	  through	  MAFFT,	  an	  automatic	  computational	  method	  was	  chosen,	  and	  through	  the	  output	  log,	  BLOSUM62	  was	  chosen	  as	  the	  substitution	  matrix.	  
	  
Figure	  12:	  Parameters	  to	  Compute	  the	  Trident	  Score	  
Therefore,	  in	  order	  to	  keep	  consistent,	  we	  continued	  using	  this	  matrix.	  In	  terms	  of	  the	  parameters	  for	  𝛼,𝛽,𝑎𝑛𝑑  𝛾,	  we	  just	  used	  the	  default,	  1	  for	  diversity,	  0.5	  for	  chemistry,	  and	  3	  for	  gaps.	  After	  getting	  the	  trident	  scores,	  we	  can	  then	  analyze	  the	  distribution	  of	  the	  scores.	  First,	  since	  only	  seven	  species	  are	  chosen,	  if	  more	  than	  two	  gaps	  occur	  at	  the	  same	  position,	  this	  position	  is	  not	  very	  informative.	  In	  other	  words,	  the	  trident	  score	  for	  a	  certain	  position	  will	  be	  omitted,	  if	  nearly	  half	  of	  the	  residues,	  or	  even	  more	  are	  gaps	  (at	  least	  3/7).	  Then,	  we	  need	  to	  find	  the	  distribution	  of	  the	  trident	  scores.	  A	  simple	  and	  common	  way	  to	  analyze	  the	  distribution	  of	  a	  variable	  over	  a	  continuous	  range	  is	  to	  discretize	  the	  range	  into	  bins,	  and	  regard	  each	  bin	  as	  a	  group.	  Then,	  find	  the	  distribution	  for	  the	  bins.	  Here,	  bins	  with	  equal	  width	  are	  used.	  We	  made	  two	  types	  of	  analysis,	  one	  with	  20	  bins	  and	  the	  other	  with	  10	  bins.	  Specifically,	  the	  bin	  width	  is	  set	  to	  0.05	  in	  order	  to	  have	  20	  bins.	  The	  ranges	  are	  (0,	  0.05],	  (0.05,	  0.10],	  …	  ,	  (0.95,	  1].	  The	  bin	  width	  is	  set	  to	  0.1	  in	  order	  to	  have	  10	  bins.	  The	  ranges	  are	  (0,	  0.1],	  (0.1,	  0.2],	  …	  ,	  (0.9,	  1].	  Value	  0	  is	  not	  included	  in	  either	  of	  the	  two	  ways,	  since	  no	  such	  value	  is	  observed	  in	  our	  cases.	  	  Theoretically,	  we	  expect	  there	  to	  be	  three	  types	  of	  trident	  score	  distributions,	  left-­‐skewed,	  normal	  bell-­‐curved,	  and	  right-­‐skewed,	  which	  corresponds	  to	  situations	  where	  there	  are	  too	  many	  scores	  near	  0,	  where	  the	  scores	  are	  normally	  distributed,	  and	  where	  there	  are	  too	  many	  scores	  near	  1,	  respectively.	  (However,	  none	  of	  these	  is	  true	  when	  we	  get	  the	  results,	  which	  will	  be	  further	  discussed	  in	  the	  Results	  Section.)	  
2.3.3	  Mapping	  Conserved	  and	  Diverse	  Regions	  After	  computing	  the	  trident	  scores	  and	  discretizing	  the	  scores,	  we	  plan	  to	  find	  the	  extremely	  conserved	  regions	  and	  diverse	  regions.	  Since	  we	  planned	  to	  fit	  the	  distribution	  into	  a	  normal	  distribution,	  we	  computed	  the	  mean	  and	  standard	  deviation.	  Then,	  for	  each	  remaining	  position,	  Z-­‐score	  is	  computed.	  We	  defined	  the	  residues	  with	  trident	  score=1	  as	  the	  extremely	  conserved	  residues,	  while	  those	  with	  Z-­‐scores	  symmetric	  to	  those	  with	  trident	  score=1	  will	  be	  considered	  as	  extremely	  diverse	  residues.	  (However,	  based	  on	  the	  distributions	  we	  found,	  we	  changed	  our	  methodology.	  Since	  some	  proteins	  are	  really	  consistent	  within	  the	  family,	  very	  few	  diverse	  residues	  can	  be	  found	  in	  this	  way.	  As	  a	  consequence,	  some	  meaningful	  diverse	  regions	  may	  be	  ignored.	  Therefore,	  we	  lowered	  the	  threshold	  by	  considering	  positions	  with	  trident	  scores	  less	  than	  or	  equal	  to	  0.3	  as	  highly	  diverse.)	  Then	  we	  map	  the	  residues	  back	  to	  the	  models	  we	  have	  built	  in	  Section	  2.2,	  and	  try	  to	  find	  the	  relationship	  between	  the	  highly	  conserved	  regions	  or	  diverse	  regions	  and	  functional	  regions.	  
2.4	  Clustering	  and	  Function	  Mapping	  At	  the	  same	  time,	  we	  mapped	  the	  functional	  clusters	  to	  the	  models	  we	  built.	  For	  each	  protein,	  we	  searched	  the	  ID	  of	  the	  template	  used	  to	  build	  the	  protein	  in	  DOMMINO,	  which	  is	  a	  “database	  of	  macromolecular	  interactions”	  (Kuang	  X,	  2012).	  For	  example,	  to	  find	  the	  interaction	  pairs	  for	  protein	  VP30,	  we	  searched	  the	  template	  used	  to	  build	  the	  homology	  model	  for	  this	  protein,	  2I8B.	  DOMMINO	  gave	  us	  an	  undefined	  interaction.	  Then	  we	  downloaded	  the	  interaction	  pairs	  and	  compared	  the	  alignment	  with	  the	  PDB	  residue	  coordinate	  to	  calculate	  the	  corresponding	  coordinate	  in	  the	  model.	  Then,	  we	  search	  for	  related	  structures	  in	  PDB,	  and	  see	  whether	  we	  can	  find	  functional	  annotation	  from	  other	  related	  sequences.	  To	  make	  sure	  that	  the	  related	  structure	  has	  something	  in	  common	  with	  our	  target	  sequence,	  we	  always	  superimpose	  the	  structures	  together	  in	  Chimera.	  If	  they	  
overlap	  with	  each	  other	  to	  a	  great	  portion,	  we	  can	  use	  this	  as	  a	  reference.	  If	  not,	  we	  disregard	  such	  sequences.	  	  	  Finally,	  after	  we	  finish	  collecting	  all	  the	  related	  sequences	  and	  map	  the	  interacting	  residues	  to	  the	  model	  we	  have	  built,	  we	  can	  then	  use	  1	  to	  mark	  the	  residues	  that	  are	  involved	  in	  interactions,	  and	  count	  the	  number	  of	  interactions	  for	  each	  residue.	  We	  intended	  to	  put	  different	  weights	  for	  residues	  involved	  in	  intra-­‐viral	  interactions	  and	  host-­‐viral	  interactions.	  For	  example,	  put	  1	  for	  intra-­‐viral	  interactions,	  and	  2	  for	  host-­‐viral	  interactions.	  However,	  in	  order	  to	  avoid	  ambiguity,	  intra-­‐viral	  interactions	  are	  separated	  from	  host-­‐virus	  interactions.	  	   	  
Chapter	  3:	  Results	  
3.1	  Structural	  modeling	  of	  viral	  proteins	  Homology	  models	  have	  been	  built	  for	  each	  protein	  in	  Ebola.	  As	  a	  result,	  in	  terms	  of	  coverage,	  the	  models	  we	  have	  built	  are	  very	  consistent	  with	  the	  known	  structures	  for	  Ebola	  proteins	  mentioned	  earlier	  in	  Chapter	  1,	  mainly	  because	  the	  models	  are	  constructed	  based	  on	  known	  structures.	  Below	  is	  a	  table	  summarizing	  the	  models	  we	  have	  constructed.	  For	  each	  protein,	  the	  names	  we	  gave	  for	  the	  models	  are	  recorded,	  as	  well	  as	  the	  corresponding	  templates	  used	  to	  construct	  the	  models,	  the	  start	  and	  end	  of	  the	  model	  in	  terms	  of	  the	  loci	  of	  our	  query,	  and	  the	  identity	  to	  the	  template.	  For	  each	  protein	  we	  will	  give	  a	  paragraph	  of	  evaluation	  for	  the	  model.	  As	  described	  in	  Chapter	  2,	  five	  models	  are	  generated	  for	  each	  protein.	  However,	  for	  simplicity,	  only	  the	  models	  with	  the	  lowest	  DOPE	  are	  described.	  Note	  that	  the	  sequence	  identity	  was	  recorded	  from	  the	  result	  of	  PSI-­‐BLAST.	  For	  AIE11807	  (the	  first	  model	  for	  VP35),	  the	  sequence	  identity	  should	  be	  even	  poorer	  than	  19%,	  because	  we	  could	  not	  force	  MODELLER	  to	  get	  the	  same	  result	  as	  that	  from	  NCBI	  PSI-­‐BLAST.	  For	  AIE11811	  (ssGP)	  (the	  first	  model	  for	  GP),	  the	  sequence	  identity	  should	  be	  higher	  than	  67%,	  since	  we	  chopped	  off	  a	  part	  of	  our	  target	  sequence	  and	  the	  final	  model	  for	  GP	  should	  be	  more	  reliable,	  which	  will	  be	  further	  discussed	  in	  the	  later	  parts.	  
3.1.1	  NP	  Three	  models	  were	  constructed	  that	  correspond	  to	  the	  following	  three	  protein	  segments:	  from	  641	  to	  739	  (NP1),	  from	  265	  to	  340	  (NP2),	  and	  from	  45	  to	  110	  (NP3).	  Among	  them,	  the	  most	  informative	  and	  reliable	  structure	  is	  NP1,	  since	  the	  template	  for	  NP1	  is	  a	  solved	  structure	  of	  the	  C-­‐terminal	  domain	  of	  NP.	  According	  to	  this	  paper,	  experiments	  show	  that	  the	  C-­‐terminal	  fragment	  of	  NP	  is	  a	  major	  antigenic	  determinant,	  indicating	  it	  could	  be	  used	  
Table	  4:	  Summary	  of	  Models	  




NP3	   45	   110	   30%	   4GPK:A	  
NP2	   265	   340	   25%	   4CO6:A	  
NP1	   641	   739	   97%	   4QAZ:A	  
VP35	  
AIE11807	   35	   262	   19%*	   4L78:A	  
VP35_1	   213	   340	   98%	   3FKE:A	  









(ssGP)	   1	   297	  
	  
67%*	   3CSY:I	  
GP2	   502	   599	   99%	   3CSY:J	  
VP30	   AIE11812	   1	   288	   98%	   2I8B:A	  
VP24	   AIE11813	   1	   251	   99%	   4M0Q:A	  
L	  
L2	   384	   558	   23%	   2FX0:A	  
L1	   2043	   2154	   24%	   1YXA:A	  	  
in	  diagnosis	  (Paulina	  J.	  Dziuban´ska,	  2014).	  Figure	  13	  contains	  the	  three	  models	  built	  for	  NP,	  as	  well	  as	  the	  DOPE	  score	  per	  residue	  for	  the	  three	  models	  versus	  the	  corresponding	  templates.	  Overall,	  the	  coverage	  is	  not	  very	  good.	  Specifically,	  large	  portion	  of	  N-­‐terminal	  structure	  is	  unsolved.	  
	  	  	   	  
Figure	  13:	  NP	  Models	  and	  DOPE	  Scores	  	  In	  Figure	  13,	  we	  can	  see	  a	  bar	  on	  the	  left	  side,	  which	  represents	  the	  length	  of	  the	  amino	  acid	  sequence	  for	  NP.	  Next	  to	  the	  bar,	  there	  are	  three	  DOPE	  score	  per	  residue	  plots	  of	  the	  protein	  models	  we	  constructed,	  each	  corresponding	  to	  the	  black/red	  portion	  of	  sequence	  on	  the	  left.	  Here,	  and	  throughput	  the	  paper,	  the	  following	  coloring	  notation	  of	  model	  coverage	  is	  used.	  Black	  portion	  represents	  the	  model	  constructed	  with	  low	  identity	  template,	  while	  red	  represents	  the	  model	  constructed	  with	  high	  identity	  template.	  The	  white	  parts	  are	  the	  regions	  that	  do	  not	  have	  structural	  templates.	  The	  red	  line	  in	  the	  DOPE	  score	  plots	  is	  the	  DOPE	  score	  of	  the	  models	  we	  constructed,	  while	  the	  green	  line	  is	  the	  DOPE	  score	  of	  the	  template.	  The	  way	  to	  interpret	  other	  graphs	  in	  the	  following	  sections	  is	  the	  same.	  
3.1.2	  VP35	  Two	  models	  were	  constructed	  for	  VP35,	  one	  corresponding	  to	  the	  portion	  spanning	  from	  residue	  35	  to	  residue	  262,	  and	  the	  other	  from	  213	  to	  340.	  Furthermore,	  there	  is	  an	  overlap	  between	  the	  two	  ranges.	  If	  we	  can	  superimpose	  the	  overlapping	  part,	  we	  can	  get	  a	  hypothetical	  model	  for	  the	  whole	  protein.	  However,	  given	  that	  the	  identity	  between	  the	  first	  model	  and	  the	  template	  (4L78)	  is	  only	  19%,	  the	  first	  model	  is	  not	  very	  successful,	  and	  therefore	  will	  be	  omitted	  in	  later	  steps	  regarding	  conserved	  region	  mapping.	  Figure	  14	  shows	  the	  two	  models	  and	  the	  corresponding	  DOPE	  scores.	  
	  
Figure	  14:	  VP35	  Models	  and	  DOPE	  Scores	  
3.1.3	  VP40	  As	  mentioned	  in	  Chapter	  2,	  one	  model	  using	  multiple	  templates	  was	  constructed	  for	  VP40.	  This	  is	  the	  only	  model	  that	  has	  been	  built	  using	  the	  multiple	  template	  method.	  According	  to	  previous	  studies,	  the	  structure	  of	  VP40	  has	  been	  fully	  resolved	  (Dessen	  A,	  2000).	  Note	  that	  the	  DOPE	  score	  here	  shows	  the	  comparison	  between	  the	  basic	  model	  and	  advanced	  model.	  
	  
Figure	  15:	  VP40	  Model	  and	  DOPE	  Score	  
3.1.4	  GP	  At	  first	  two	  models	  were	  constructed	  for	  GP	  separately	  based	  on	  PDB	  structure	  3CSY,	  Chains	  I	  and	  J.	  As	  shown	  in	  Figure	  16,	  there	  is	  a	  gap	  between	  the	  two	  structures.	  The	  
	  
Figure	  16:	  GP	  Models	  (Original)	  
disadvantage	  of	  building	  model	  in	  this	  way	  lies	  in	  that	  the	  interaction	  between	  the	  two	  parts	  cannot	  be	  shown	  in	  the	  structure.	  After	  discovering	  on	  the	  structure	  of	  the	  chosen	  template	  3CSY,	  we	  find	  that	  a	  composite	  model	  with	  two	  chains	  can	  be	  constructed	  using	  3CSY	  as	  the	  template,	  which	  will	  better	  reveal	  the	  intra-­‐viral	  interactions.	  The	  newly	  constructed	  model	  is	  shown	  in	  Figure	  17.	  The	  chain	  in	  hot	  pink	  is	  Chain	  A,	  while	  that	  in	  cornflower	  blue	  is	  Chain	  B.	  	  
	  
Figure	  17:	  GP	  Model	  (New)	  and	  DOPE	  Score	  Gene	  products	  of	  GP	  here	  can	  be	  referred	  as	  GP1,2,	  and	  two	  other	  gene	  products	  can	  be	  produced	  through	  RNA	  editing	  of	  GP	  gene:	  sGP	  and	  ssGP.	  The	  protein	  product	  of	  ssGP	  is	  almost	  identical	  to	  the	  first	  of	  the	  original	  models	  for	  GP,	  AIE11811,	  with	  only	  three	  residues	  in	  difference.	  And	  this	  is	  why	  the	  first	  model	  of	  GP	  is	  also	  called	  ssGP.	  On	  the	  other	  hand,	  sGP	  differs	  from	  GP	  in	  around	  30	  residues	  (Masfique	  Mehedi,	  2011).	  However,	  since	  we	  did	  not	  focus	  on	  the	  mechanism	  of	  RNA	  editing	  or	  the	  byproducts,	  the	  models	  for	  these	  two	  products	  are	  not	  shown	  here.	  	  
3.1.5	  VP30	  One	  model	  was	  constructed	  for	  VP30,	  and	  large	  part	  of	  the	  model	  (the	  first	  144	  residues	  and	  the	  last	  24	  residues)	  has	  to	  be	  chopped	  off,	  since	  there	  is	  no	  structural	  information	  available	  for	  that	  part.	  Note	  that	  although	  ignored	  in	  the	  model,	  the	  DOPE	  scores	  for	  the	  first	  144	  residues	  were	  plotted	  in	  Figure	  18.	  	  
	  
Figure	  18:	  VP30	  Model	  and	  DOPE	  Score	  
3.1.6	  VP24	  One	  model	  was	  constructed	  for	  VP24,	  and	  this	  is	  the	  model	  with	  the	  highest	  coverage	  and	  identity	  among	  all	  the	  models	  that	  have	  been	  constructed.	  (Weirdly,	  the	  name	  for	  the	  template	  in	  PDB	  is	  called	  “Ebola	  Virus	  VP24	  Structure”,	  while	  the	  primary	  citation	  used	  for	  this	  protein	  is	  called	  “The	  Marburg	  virus	  VP24	  protein	  interacts	  with	  Keap1	  to	  activate	  the	  cytoprotective	  antioxidant	  response	  pathway”.)	  
	  
Figure	  19:	  VP24	  Model	  and	  DOPE	  Score	  
3.1.7	  L	  Two	  models	  were	  constructed	  for	  L,	  but	  unfortunately,	  the	  coverage	  is	  only	  around	  (174+111)/2122=13%,	  and	  the	  identity	  between	  the	  templates	  and	  the	  query	  is	  very	  low	  as	  well.	  The	  result	  is	  very	  consistent	  with	  what	  most	  resources	  comment	  on	  L	  protein:	  Many	  viruses	  have	  the	  large	  polymerase	  protein	  but	  the	  structure	  has	  not	  been	  solved	  yet.	  This	  can	  be	  proven	  by	  the	  fact	  that	  many	  sequences	  can	  be	  found	  with	  high	  coverage	  and	  identity	  if	  a	  PSI-­‐BLAST	  is	  performed	  against	  all	  sequences,	  while	  only	  a	  few	  sequences	  can	  be	  found	  with	  low	  coverage	  and	  identity	  if	  a	  PSI-­‐BLAST	  is	  performed	  against	  PDB	  structures.	  
	  
Figure	  20:	  L	  Models	  and	  DOPE	  Score	  
3.1.8	  Summary	  of	  Models	  In	  general,	  by	  constructing	  the	  models,	  we	  did	  not	  expand	  our	  knowledge	  about	  the	  protein	  structures	  very	  much,	  since	  we	  did	  not	  have	  a	  good	  amount	  of	  templates	  for	  each	  protein.	  So	  far,	  the	  most	  reliable	  model	  should	  be	  VP24,	  since	  it	  has	  the	  longest	  coverage	  and	  highest	  identity.	  Then	  comes	  VP40.	  The	  coverage	  and	  sequence-­‐template	  identity	  for	  VP30	  is	  very	  similar	  to	  GP,	  both	  with	  half	  of	  the	  protein	  structure	  unknown.	  Although	  it	  seems	  that	  we	  have	  a	  good	  coverage	  of	  VP35,	  because	  the	  first	  model	  of	  VP35	  was	  not	  very	  successful	  due	  to	  low	  identity	  to	  the	  template,	  we	  still	  need	  more	  information	  about	  VP35.	  For	  NP,	  although	  we	  have	  three	  separate	  models	  for	  different	  parts,	  how	  the	  three	  parts	  connect	  with	  each	  other	  is	  still	  a	  myth.	  For	  L,	  if	  we	  compare	  the	  known	  portion	  with	  the	  
unknown	  portion,	  it	  seems	  that	  only	  a	  tenth	  of	  the	  whole	  protein	  structure	  can	  be	  predicted	  with	  a	  high	  uncertainty.	  	  
3.2	  Family-­‐Wise	  Sequence	  Alignment	  of	  Filoviridae	  Proteomes	  
3.2.1	  Data	  Selection	  As	  described	  in	  the	  methodology	  part,	  to	  discover	  the	  evolutionary	  pattern	  within	  the	  family	  of	  Filoviridae,	  we	  decided	  to	  perform	  a	  family-­‐wise	  sequence	  alignment	  and	  then	  evaluate	  the	  result.	  One	  representative	  genome	  was	  selected	  from	  each	  species	  within	  the	  family	  Filoviridae.	  The	  genomes	  selected	  are	  the	  reference	  genomes	  from	  NCBI,	  which	  are	  listed	  in	  Appendix	  C.	  Genome	  Selection	  for	  Family-­‐Wise	  Sequence	  Alignment,	  together	  with	  the	  sequence	  ID	  for	  each	  protein.	  	  
3.2.2	  Trident	  Score	  Distribution	  Then,	  for	  each	  protein	  among	  the	  seven	  main	  proteins	  in	  the	  Ebola	  genome,	  sequence	  alignment	  is	  performed.	  Most	  Ebolavirus	  sequences	  align	  well	  with	  each	  other,	  while	  Marburg	  virus	  sequences	  and	  Lloviu	  cuevavirus	  seem	  to	  have	  difficulties	  in	  aligning	  perfectly	  with	  all	  other	  sequences.	  To	  quantitatively	  evaluate	  the	  alignment,	  trident	  scores	  were	  computed,	  and	  then	  the	  data	  were	  discretized	  into	  bins	  to	  find	  out	  the	  distributions.	  Figure	  23	  is	  composed	  of	  distribution	  charts	  for	  all	  seven	  proteins.	  Since	  the	  pattern	  in	  the	  20-­‐bin	  method	  is	  even	  more	  obscure	  than	  that	  in	  the	  10-­‐bin	  method,	  here	  only	  the	  10-­‐bin	  method	  result	  is	  shown.	  From	  the	  charts,	  we	  can	  see	  that	  most	  distributions	  follow	  a	  bimodal	  or	  even	  trimodal	  trend,	  if	  we	  do	  not	  take	  GP	  (8)	  Trident	  Score	  Distribution	  into	  account.	  	  Note	  that	  there	  are	  two	  charts	  for	  one	  protein,	  GP,	  one	  labeled	  as	  GP	  (7)	  and	  the	  other	  GP	  (8).	  This	  is	  due	  to	  the	  genome	  of	  Lloviu	  cuevavirus	  having	  two	  protein	  sequences	  affiliated	  with	  GP,	  YP_004928138.1	  and	  YP_004928139.1,	  both	  of	  which	  fall	  into	  the	  normal	  loci	  for	  gene	  GP	  in	  other	  species	  in	  Filoviradae	  family.	  GP	  (8)	  consider	  the	  two	  sequences	  separately.	  Therefore,	  there	  are	  only	  a	  few	  residues	  with	  trident	  score=1,	  which	  should	  result	  from	  false	  alignment,	  since	  there	  is	  no	  overlap	  in	  the	  two	  sequences	  from	  Lloviu	  
cuevavirus.	  Figure	  21	  and	  Figure	  22	  are	  the	  three	  possible	  Open	  Reading	  Frames	  (ORFs)	  for	  GP1	  and	  GP2	  in	  Lloviu	  cuevavirus.	  In	  both	  cases,	  Frame	  1	  represents	  the	  final	  protein	  sequence.	  However,	  the	  end	  of	  5’3’	  Frame	  3	  in	  Figure	  21	  is	  the	  same	  as	  the	  first	  several	  residues	  in	  5’3’	  Frame	  1	  in	  Figure	  22,	  which	  means	  there	  is	  a	  frame	  shift	  during	  translation,	  and	  therefore	  the	  two	  sequences	  would	  not	  be	  combined	  into	  one.	  A	  naïve	  way	  to	  deal	  with	  this	  problem	  is	  to	  simply	  concatenate	  the	  two	  sequences	  together	  into	  one,	  and	  align	  it	  with	  other	  sequences.	  And	  the	  result	  for	  the	  trident	  score	  distribution	  is	  shown	  in	  GP	  (7)	  Trident	  Score	  Distribution.	  
	  
Figure	  21:	  3	  Possible	  ORFs	  of	  GP1	  in	  Lloviu	  Cuevavirus	  
	   	  
Figure	  22:	  3	  Possible	  ORFs	  of	  GP2	  in	  Lloviu	  Cuevavirus	  
	  	   	  
Figure	  23:	  Trident	  Score	  Distributions	  of	  7	  Proteins	  


































































































GP	  Trident	  Score	  DistribuVon	  	  
Residues	  with	  trident	  score	  less	  than	  or	  equal	  to	  0.4	  are	  considered	  as	  extremely	  diverse	  ones.	  Among	  them,	  if	  no	  gaps	  are	  found	  at	  a	  certain	  locus	  in	  the	  alignment,	  the	  corresponding	  residue	  is	  colored	  in	  red;	  if	  no	  more	  than	  two	  gaps	  are	  found	  at	  a	  certain	  locus	  in	  the	  alignment,	  the	  corresponding	  residue	  is	  colored	  in	  magenta.	  The	  residues	  that	  fall	  into	  each	  category	  (conserved,	  diverse	  without	  gaps,	  or	  diverse	  with	  up	  to	  2	  gaps)	  in	  each	  model	  are	  recorded	  in	  Appendix	  D.	  Conserved	  and	  Diverse	  Residues	  Mapping.	  
3.2.3.1	  NP	  As	  mentioned	  before,	  for	  NP,	  three	  models	  were	  constructed	  separately.	  The	  first	  two	  models	  were	  not	  very	  reliable	  based	  on	  the	  identity	  with	  the	  template	  sequences.	  However,	  we	  can	  see	  a	  large	  amount	  of	  conserved	  regions	  in	  these	  models.	  On	  the	  other	  hand,	  the	  last	  model	  was	  considered	  more	  reliable	  since	  it	  had	  a	  higher	  identity	  to	  the	  template,	  but	  it	  contains	  more	  diverse	  residues.	  	  
	  
Figure	  24:	  NP	  Conserved	  and	  Diverse	  Regions	  Mapping.	  	  Colored	  in	  red	  are	  extremely	  diverse	  residues	  (trident	  
score	  of	  0.4	  and	  lower	  with	  no	  gap);	  colored	  in	  magenta	  are	  diverse	  residues	  (trident	  score	  of	  0.4	  and	  lower	  with	  
up	  to	  2	  gaps);	  colored	  in	  blue	  are	  extremely	  conserved	  residues	  (trident	  score	  of	  1).	  
3.2.3.2	  VP35	  
	  
Figure	  25:	  VP35	  Conserved	  and	  Diverse	  Regions	  Mapping.	  Colored	  in	  red	  are	  extremely	  diverse	  residues	  (trident	  
score	  of	  0.4	  and	  lower	  with	  no	  gap);	  colored	  in	  magenta	  are	  diverse	  residues	  (trident	  score	  of	  0.4	  and	  lower	  with	  
up	  to	  2	  gaps);	  colored	  in	  blue	  are	  extremely	  conserved	  residues	  (trident	  score	  of	  1).	  For	  VP35,	  two	  models	  were	  constructed	  and	  there	  was	  an	  overlap	  between	  the	  models.	  However,	  the	  first	  model	  was	  not	  considered	  successful	  since	  it	  had	  a	  low	  identity	  to	  its	  template.	  But	  from	  the	  color	  code,	  we	  can	  see	  a	  large	  number	  of	  diverse	  residues.	  As	  for	  the	  second	  model,	  we	  can	  see	  clusters	  of	  conserved	  residues	  on	  the	  surface	  of	  the	  molecule.	  
3.2.3.3	  VP40	  
	  
Figure	  26:	  VP40	  Conserved	  and	  Diverse	  Regions	  Mapping.	  Colored	  in	  red	  are	  extremely	  diverse	  residues	  (trident	  
score	  of	  0.4	  and	  lower	  with	  no	  gap);	  colored	  in	  magenta	  are	  diverse	  residues	  (trident	  score	  of	  0.4	  and	  lower	  with	  
up	  to	  2	  gaps);	  colored	  in	  blue	  are	  extremely	  conserved	  residues	  (trident	  score	  of	  1).	  For	  VP40,	  with	  the	  long	  free	  end	  being	  chopped	  off,	  we	  can	  see	  a	  cluster	  of	  conserved	  residues,	  and	  several	  diverse	  residues	  around	  the	  surface.	  
3.2.3.4	  GP	  On	  the	  surface	  of	  GP,	  more	  diverse	  residues	  can	  be	  found	  that	  conserved	  residues.	  This	  is	  mainly	  because	  Lloviu	  cuevavirus	  does	  not	  align	  to	  all	  other	  species	  very	  well,	  and	  since	  we	  only	  defined	  residues	  with	  trident	  score	  strictly	  equal	  to	  1	  as	  “extremely	  conserved”	  ones,	  therefore,	  there	  are	  not	  many	  extremely	  conserved	  ones.	  We	  can	  also	  get	  this	  conclusion	  from	  the	  distribution	  charts.	  As	  we	  can	  see,	  the	  distribution	  of	  trident	  scores	  for	  GP	  (7)	  is	  different	  from	  those	  for	  other	  proteins,	  in	  that	  for	  proteins	  like	  L	  and	  NP,	  more	  residues	  fall	  into	  the	  bin	  of	  (0,	  1],	  while	  for	  GP,	  more	  residues	  fall	  into	  the	  bin	  of	  (0.4,	  0.5].	  
	  
Figure	  27:	  GP	  Conserved	  and	  Diverse	  Regions	  Mapping.	  Colored	  in	  red	  are	  extremely	  diverse	  residues	  (trident	  
score	  of	  0.4	  and	  lower	  with	  no	  gap);	  colored	  in	  magenta	  are	  diverse	  residues	  (trident	  score	  of	  0.4	  and	  lower	  with	  
up	  to	  2	  gaps);	  colored	  in	  blue	  are	  extremely	  conserved	  residues	  (trident	  score	  of	  1).	  
3.2.3.5	  VP30	  
	  
Figure	  28:	  VP30	  Conserved	  and	  Diverse	  Regions	  Mapping.	  Colored	  in	  red	  are	  extremely	  diverse	  residues	  (trident	  
score	  of	  0.4	  and	  lower	  with	  no	  gap);	  colored	  in	  magenta	  are	  diverse	  residues	  (trident	  score	  of	  0.4	  and	  lower	  with	  
up	  to	  2	  gaps);	  colored	  in	  blue	  are	  extremely	  conserved	  residues	  (trident	  score	  of	  1).	  For	  VP30,	  only	  half	  of	  the	  whole	  protein	  was	  modeled.	  As	  shown	  in	  Figure	  28,	  one	  region	  can	  be	  considered	  as	  highly	  conserved	  while	  two	  clusters	  can	  be	  considered	  highly	  diverse.	  
3.2.3.6	  VP24	  For	  VP24,	  the	  model	  is	  almost	  complete.	  However,	  the	  pattern	  of	  conserved	  and	  diverse	  regions	  seems	  to	  be	  random.	  
	  
Figure	  29:	  VP24	  Conserved	  and	  Diverse	  Regions	  Mapping.	  Colored	  in	  red	  are	  extremely	  diverse	  residues	  (trident	  
score	  of	  0.4	  and	  lower	  with	  no	  gap);	  colored	  in	  magenta	  are	  diverse	  residues	  (trident	  score	  of	  0.4	  and	  lower	  with	  
up	  to	  2	  gaps);	  colored	  in	  blue	  are	  extremely	  conserved	  residues	  (trident	  score	  of	  1).	  
3.2.3.7	  L	  For	  L,	  as	  shown	  in	  Figure	  30,	  more	  residues	  are	  found	  to	  be	  highly	  conserved	  in	  the	  first	  model,	  while	  more	  are	  found	  to	  be	  diverse	  in	  the	  second	  model.	  It	  is	  note	  worthy	  that	  there	  are	  two	  putative	  conserved	  domain	  in	  the	  protein	  L,	  Mononeg_RNA_pol	  superfamily	  and	  Paramyx_RNAcap	  superfamily,	  as	  shown	  in	  Figure	  31.	  
	  
Figure	  30:	  L	  Conserved	  and	  Diverse	  Regions	  Mapping.	  Colored	  in	  red	  are	  extremely	  diverse	  residues	  (trident	  
score	  of	  0.4	  and	  lower	  with	  no	  gap);	  colored	  in	  magenta	  are	  diverse	  residues	  (trident	  score	  of	  0.4	  and	  lower	  with	  
up	  to	  2	  gaps);	  colored	  in	  blue	  are	  extremely	  conserved	  residues	  (trident	  score	  of	  1).	  
3.3	  Result	  for	  Clustering	  and	  Function	  Mapping	  	  In	  order	  to	  test	  our	  hypothesis	  that	  the	  evolutionary	  pattern	  within	  the	  family	  Filoviridae	  is	  potentially	  related	  to	  the	  functional	  clusters,	  we	  then	  went	  on	  and	  mapped	  all	  the	  potential	  biding	  sites	  by	  finding	  related	  structures	  in	  DOMMINO	  and	  aligning	  the	  functional	  sites	  
	  
Figure	  31:	  Screen	  Shot	  of	  Putative	  Conserved	  Domains	  in	  L	  
with	  our	  models.	  Detailed	  study	  notes	  can	  be	  found	  in	  Appendix	  E.	  Model	  Check	  and	  Functional	  Annotation,	  which	  records	  the	  related	  structures	  we	  found	  for	  each	  protein.	  Then,	  based	  on	  the	  alignment,	  we	  recorded	  the	  score	  for	  each	  residue	  to	  be	  involved	  in	  intra-­‐viral	  interactions	  or	  host-­‐viral	  interactions	  separately,	  and	  mapped	  the	  binding	  sites	  to	  the	  models	  we	  built	  using	  the	  following	  color	  code:	  The	  base	  model	  is	  rendered	  in	  light	  gray;	  the	  residues	  involved	  in	  intra-­‐viral	  interactions	  are	  colored	  in	  yellow,	  while	  those	  involved	  in	  human-­‐viral	  interactions	  are	  colored	  in	  light	  green.	  Now,	  we	  will	  show	  the	  binding	  site	  mapping	  result	  for	  each	  protein.	  And	  here	  is	  a	  table	  for	  the	  color	  code	  in	  general.	  Basically,	  we	  will	  render	  the	  models	  in	  the	  following	  way.	  If	  a	  residue	  is	  only	  classified	  as	  conserved,	  it	  will	  be	  colored	  in	  blue;	  if	  a	  residue	  is	  only	  classified	  as	  diverse,	  it	  will	  be	  colored	  in	  red;	  if	  a	  residue	  is	  only	  involved	  in	  intra-­‐viral	  functional	  sites,	  it	  will	  be	  colored	  in	  yellow;	  if	  a	  residue	  is	  only	  involved	  in	  host-­‐viral	  functional	  sites,	  it	  will	  be	  colored	  in	  orange.	  If	  a	  residue	  is	  both	  conserved	  and	  involved	  in	  functional	  sites	  (either	  intra-­‐viral	  or	  host-­‐viral	  or	  both),	  it	  will	  be	  colored	  in	  cyan.	  If	  a	  residue	  is	  both	  diverse	  and	  involved	  in	  functional	  sites	  (either	  intra-­‐viral	  or	  host-­‐viral	  or	  both),	  it	  will	  be	  colored	  in	  magenta.	  Here,	  we	  do	  not	  distinguish	  within	  the	  diverse	  residues	  based	  on	  the	  number	  of	  gaps	  as	  we	  did	  in	  Section	  3.2,	  since	  we	  altered	  our	  focus	  here.	  	  
3.3.1	  NP	  For	  NP,	  it	  shows	  that	  two	  solved	  crystal	  structures	  can	  be	  found	  in	  PDB,	  4QAZ	  and	  4QB0.	  We	  tried	  DOMMINO,	  SUPERFAMILY,	  and	  PDB	  to	  find	  its	  related	  structures.	  Unfortunately,	  no	  functional	  domains	  have	  been	  found.	  
3.3.2	  VP35	  For	  VP35,	  although	  two	  models	  were	  built,	  since	  the	  first	  model	  had	  a	  really	  poor	  identity	  to	  the	  template,	  here	  only	  the	  second	  model	  is	  considered	  (what	  we	  called	  “basic”,	  or	  “VP35_1”).	  For	  this	  model,	  we	  chose	  3FKE	  as	  its	  template,	  which	  contains	  1	  intra-­‐viral	  interaction.	  Also,	  3KS8,	  4LG2,	  3L25,	  3L28,	  and	  4GHL	  are	  considered	  as	  related	  structures.	  Only	  intra-­‐viral	  interactions	  and	  RNA-­‐RNA	  interactions	  are	  found	  in	  these	  structures.	  Figure	  32	  shows	  the	  model	  in	  surface	  mode	  with	  all	  the	  residues	  involved	  in	  intra-­‐viral	  interactions	  highlighted	  in	  yellow.	  Furthermore,	  among	  all	  128	  residues	  in	  the	  model,	  there	  are	  49	  residues	  that	  are	  categorized	  as	  extremely	  conserved	  ones,	  and	  34	  of	  them	  overlap	  with	  those	  that	  are	  potentially	  involved	  in	  intra-­‐viral	  interactions.	  On	  the	  other	  hand,	  9	  residues	  are	  categorized	  as	  extremely	  diverse	  ones,	  and	  8	  of	  them	  overlap	  with	  those	  
Table	  5:	  Color	  Code	  for	  Figures	  in	  Section	  3.3	  
Color	   Conserved	   Diverse	   Intra-­‐viral	   Host-­‐viral	  
Blue	   √	  
	   	   	  Red	  
	  
√	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√	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Cyan	   √	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  Cyan	   √	  
	   	  
√	  
Cyan	   √	  
	  
√	   √	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√	   √	   √	  	  
involved	  in	  intra-­‐viral	  interactions.	  Figure	  33	  is	  the	  model	  with	  conserved,	  diverse	  regions	  mapped	  together	  with	  the	  intra-­‐viral	  functional	  sites.	  
	  
Figure	  32:	  Residues	  in	  VP35	  that	  Are	  Potentially	  Involved	  in	  Intra-­‐viral	  Interactions.	  In	  this	  figure,	  only	  the	  
residues	  involved	  in	  intra-­‐viral	  interactions	  are	  highlighted	  in	  yellow.	  	  
	  
Figure	  33:	  Conserved	  and	  Diverse	  Regions	  in	  VP35	  Mapped	  with	  Intra-­‐viral	  Interactions.	  Colored	  in	  red	  are	  
extremely	  diverse	  residues	  (trident	  score	  of	  0.4	  and	  lower),	  and	  only	  1	  residue	  is	  colored	  in	  red;	  colored	  in	  blue	  
are	  extremely	  conserved	  residues	  (trident	  score	  of	  1),	  and	  15	  residues	  belong	  to	  this	  category;	  colored	  in	  
magenta	  are	  the	  common	  residues	  between	  the	  diverse	  and	  intra-­‐viral	  functional	  sites,	  and	  8	  residues	  belong	  to	  
this	  category;	  colored	  in	  cyan	  are	  the	  common	  residues	  between	  the	  conserved	  and	  intra-­‐viral	  functional	  sites,	  
and	  34	  residues	  belong	  to	  this	  category.	  
3.3.3	  VP40	  For	  VP40,	  since	  we	  constructed	  the	  model	  by	  the	  advanced	  method,	  we	  already	  have	  three	  templates,	  which	  are	  3TCQ,	  4LDB,	  and	  4LDI/4LDD.	  The	  three	  templates	  share	  the	  SCOP	  family	  50013.	  In	  fact,	  there	  are	  7	  proteins	  under	  this	  SCOP	  family,	  but	  they	  are	  highly	  redundant,	  and	  only	  the	  templates	  are	  studied,	  since	  they	  can	  represent	  monomer,	  tetramer,	  and	  dimer	  respectively.	  Figure	  34	  shows	  the	  residues	  potentially	  involved	  in	  intra-­‐viral	  interactions.	  Among	  all	  326	  residues	  in	  the	  model,	  65	  residues	  are	  categorized	  as	  extremely	  conserved	  ones,	  and	  41	  of	  them	  overlap	  with	  those	  that	  are	  potentially	  involved	  in	  intra-­‐viral	  interactions.	  (But	  since	  some	  residues	  are	  not	  in	  the	  model,	  only	  61	  residues	  from	  the	  conserved	  are	  shown.	  Among	  them,	  20	  are	  colored	  in	  blue,	  and	  the	  rest	  41	  residues	  are	  colored	  in	  cyan	  because	  they	  overlap	  with	  intra-­‐viral	  functional	  sites.)	  On	  the	  other	  hand,	  79	  residues	  are	  categorized	  as	  extremely	  diverse	  ones,	  and	  25	  of	  them	  overlap	  with	  those	  involved	  in	  intra-­‐viral	  interactions.	  (But	  32	  out	  of	  the	  79	  residues	  are	  missing	  in	  the	  model.	  So,	  47	  diverse	  residues	  are	  shown.	  Among	  them,	  22	  residues	  are	  colored	  in	  red,	  and	  the	  rest	  25	  residues	  are	  colored	  in	  cyan	  because	  they	  overlap	  with	  the	  intra-­‐viral	  functional	  sites.)	  
	  
Figure	  34:	  Residues	  in	  VP40	  that	  Are	  Potentially	  Involved	  in	  Intra-­‐viral	  Interactions.	  In	  this	  figure,	  only	  the	  
residues	  involved	  in	  intra-­‐viral	  interactions	  are	  highlighted	  in	  yellow.	  
	  
Figure	  35:	  Conserved	  and	  Diverse	  Regions	  in	  VP40	  Mapped	  with	  Intra-­‐viral	  Interactions.	  Colored	  in	  red	  are	  
extremely	  diverse	  residues	  (trident	  score	  of	  0.4	  and	  lower),	  and	  22	  residues	  are	  colored	  in	  red;	  colored	  in	  blue	  
are	  extremely	  conserved	  residues	  (trident	  score	  of	  1),	  and	  20	  residues	  belong	  to	  this	  category;	  colored	  in	  
magenta	  are	  the	  common	  residues	  between	  the	  diverse	  and	  intra-­‐viral	  functional	  sites,	  and	  8	  residues	  belong	  to	  
this	  category;	  colored	  in	  cyan	  are	  the	  common	  residues	  between	  the	  conserved	  and	  intra-­‐viral	  functional	  sites,	  
and	  34	  residues	  belong	  to	  this	  category.	  
3.3.4	  GP	  For	  GP,	  as	  mentioned	  previously,	  a	  model	  based	  on	  3CSY	  has	  been	  built.	  According	  to	  the	  cited	  paper,	  3CSY	  is	  the	  crystal	  structure	  of	  glycoprotein	  in	  Ebola	  in	  the	  form	  of	  trimeric	  prefusion	  with	  an	  antibody	  from	  a	  human	  survivor.	  This	  reveals	  that	  we	  have	  found	  host-­‐viral	  interactions	  in	  GP.	  We	  also	  found	  another	  three	  related	  structures,	  3S88,	  3VE0,	  and	  1EBO.	  However,	  after	  reading	  the	  paper	  about	  1EBO,	  we	  found	  that	  1EBO	  is	  a	  hybrid	  trimer	  between	  GP2	  and	  modified	  GCN4	  (Winfried	  Weissenhorn,	  1998),	  so	  as	  a	  result,	  we	  did	  not	  consider	  this	  structure	  any	  more.	  As	  shown	  in	  Figure	  36,	  the	  residues	  involved	  in	  intra-­‐viral	  interactions	  are	  in	  yellow.	  Those	  involved	  in	  host-­‐viral	  interactions	  should	  be	  colored	  in	  orange.	  However,	  since	  all	  residues	  belonging	  to	  this	  category	  are	  also	  involved	  in	  intra-­‐viral	  interactions	  expect	  for	  Residue	  39.	  Therefore,	  to	  emphasize	  the	  overlap,	  residues	  involved	  in	  both	  interactions	  are	  colored	  in	  orange	  red.	  However,	  residue	  39,	  which	  is	  only	  involved	  in	  host-­‐viral	  interaction,	  is	  colored	  in	  orange,	  and	  circled	  in	  dark	  red.	  This	  overlap	  between	  the	  two	  types	  of	  interactions	  does	  not	  give	  us	  a	  significant	  difference	  between	  the	  intra-­‐viral	  interactions	  and	  host-­‐viral	  interactions	  as	  expected.	  
	  	  
	  
Figure	  36:	  Residues	  in	  GP	  that	  Are	  Potentially	  Involved	  in	  Functional	  Sites.	  In	  this	  figure,	  the	  residues	  involved	  in	  
intra-­‐viral	  interactions	  are	  highlighted	  in	  yellow,	  while	  those	  only	  involved	  in	  host-­‐viral	  interactions	  are	  
supposed	  to	  be	  colored	  in	  orange	  according	  to	  the	  color	  code	  mentioned	  before.	  Residue	  39	  is	  the	  only	  one	  
involved	  in	  host-­‐viral	  interaction.	  So,	  we	  colored	  it	  in	  orange	  and	  circled	  it	  with	  dark	  red.	  The	  overlap	  between	  
the	  two	  kinds	  of	  functional	  sites	  are	  colored	  in	  orange	  red.	  In	  GP,	  all	  residues	  involved	  in	  host-­‐viral	  interactions	  
are	  involved	  in	  intra-­‐viral	  interactions	  as	  well,	  with	  the	  exception	  of	  Residue	  39	  mentioned	  before.	  
	  
Figure	  37:	  Conserved	  and	  Diverse	  Regions	  in	  GP	  Mapped	  with	  Intra-­‐viral	  Interactions.	  Colored	  in	  red	  are	  
extremely	  diverse	  residues	  (trident	  score	  of	  0.4	  and	  lower);	  colored	  in	  blue	  are	  extremely	  conserved	  residues	  
(trident	  score	  of	  1);	  colored	  in	  yellow	  are	  residues	  involved	  in	  intra-­‐viral	  interactions;	  colored	  in	  magenta	  are	  the	  
common	  residues	  between	  the	  diverse	  and	  intra-­‐viral	  functional	  sites;	  colored	  in	  cyan	  are	  the	  common	  residues	  
between	  the	  conserved	  and	  intra-­‐viral	  functional	  sites.	  
	  
Figure	  38:	  Conserved	  and	  Diverse	  Regions	  in	  GP	  Mapped	  with	  Host-­‐viral	  Interactions.	  Colored	  in	  red	  are	  
extremely	  diverse	  residues	  (trident	  score	  of	  0.4	  and	  lower);	  colored	  in	  blue	  are	  extremely	  conserved	  residues	  
(trident	  score	  of	  1);	  colored	  in	  orange	  are	  residues	  involved	  in	  host-­‐viral	  interactions;	  colored	  in	  magenta	  are	  the	  
common	  residues	  between	  the	  diverse	  and	  host-­‐viral	  functional	  sites;	  colored	  in	  cyan	  are	  the	  common	  residues	  
between	  the	  conserved	  and	  host-­‐viral	  functional	  sites.	  	  
3.3.5	  VP30	  We	  built	  the	  model	  for	  VP30	  using	  the	  template	  2I8B.	  Another	  structure	  considered	  related	  to	  VP30	  is	  3V7O.	  We	  found	  a	  SCOP	  family	  54237	  in	  3V7O,	  but	  none	  of	  the	  organisms	  inside	  this	  family	  is	  closely	  related	  to	  Ebola	  virus	  except	  3V7O.	  72	  out	  of	  288	  residues	  are	  classified	  as	  highly	  conserved	  residues.	  However,	  only	  22	  of	  them	  overlap	  with	  the	  residues	  involved	  in	  intra-­‐viral	  interactions.	  On	  the	  other	  hand,	  90	  residues	  are	  classified	  as	  diverse,	  but	  18	  of	  them	  overlap	  with	  those	  involved	  in	  intra-­‐viral	  interactions.	  
	  
Figure	  39:	  Residues	  in	  VP30	  that	  Are	  Potentially	  Involved	  in	  Intra-­‐viral	  Interactions.	  In	  this	  figure,	  only	  the	  
residues	  involved	  in	  intra-­‐viral	  interactions	  are	  highlighted	  in	  yellow.	  	  
	   	  
Figure	  40:	  Conserved	  and	  Diverse	  Regions	  in	  VP30	  Mapped	  with	  Intra-­‐viral	  Interactions.	  Colored	  in	  red	  are	  
extremely	  diverse	  residues	  (trident	  score	  of	  0.4	  and	  lower);	  colored	  in	  blue	  are	  extremely	  conserved	  residues	  
(trident	  score	  of	  1);	  colored	  in	  yellow	  are	  the	  residues	  involved	  in	  intra-­‐viral	  interactions;	  colored	  in	  magenta	  are	  
the	  common	  residues	  between	  the	  diverse	  and	  intra-­‐viral	  functional	  sites;	  colored	  in	  cyan	  are	  the	  common	  
residues	  between	  the	  conserved	  and	  intra-­‐viral	  functional	  sites.	  
3.3.6	  VP24	  Besides	  our	  template	  4M0Q,	  which	  contains	  one	  intra-­‐viral	  interaction,	  we	  used	  4U2X	  as	  a	  related	  structure	  to	  VP24	  as	  well,	  which	  reveals	  both	  intra-­‐viral	  interactions	  and	  host-­‐viral	  interactions.	  As	  shown	  in	  Figure	  41,	  unlike	  the	  situation	  in	  GP,	  residues	  involved	  in	  intra-­‐viral	  interactions	  are	  almost	  mutually	  exclusive	  to	  those	  involved	  in	  host-­‐viral	  interactions,	  with	  the	  exception	  of	  5	  residues	  highlighted	  in	  orange	  red.	  	  
	  
Figure	  41:	  Residues	  in	  VP24	  that	  Are	  Potentially	  Involved	  in	  Functional	  Sites.	  In	  this	  figure,	  the	  residues	  involved	  
in	  intra-­‐viral	  interactions	  are	  highlighted	  in	  yellow,	  while	  those	  involved	  in	  host-­‐viral	  interactions	  are	  colored	  in	  
orange.	  Residues	  involved	  in	  both	  host-­‐viral	  interaction	  and	  intra-­‐viral	  interactions	  will	  be	  colored	  in	  orange	  red.	  	  
	  
Figure	  42:	  Conserved	  and	  Diverse	  Regions	  in	  VP24	  Mapped	  with	  Intra-­‐viral	  Interactions.	  Colored	  in	  red	  are	  
extremely	  diverse	  residues	  (trident	  score	  of	  0.4	  and	  lower);	  colored	  in	  blue	  are	  extremely	  conserved	  residues	  
(trident	  score	  of	  1);	  colored	  in	  yellow	  are	  residues	  involved	  in	  intra-­‐viral	  interactions;	  colored	  in	  magenta	  are	  the	  
common	  residues	  between	  the	  diverse	  and	  intra-­‐viral	  functional	  sites;	  colored	  in	  cyan	  are	  the	  common	  residues	  
between	  the	  conserved	  and	  intra-­‐viral	  functional	  sites.	  
	  
Figure	  43:	  Conserved	  and	  Diverse	  Regions	  in	  VP24	  Mapped	  with	  Host-­‐viral	  Interactions.	  Colored	  in	  red	  are	  
extremely	  diverse	  residues	  (trident	  score	  of	  0.4	  and	  lower);	  colored	  in	  blue	  are	  extremely	  conserved	  residues	  
(trident	  score	  of	  1);	  colored	  in	  orange	  are	  residues	  involved	  in	  host-­‐viral	  interactions;	  colored	  in	  magenta	  are	  the	  
common	  residues	  between	  the	  diverse	  and	  host-­‐viral	  functional	  sites;	  colored	  in	  cyan	  are	  the	  common	  residues	  
between	  the	  conserved	  and	  host-­‐viral	  functional	  sites.	  
3.3.7	  L	  Since	  we	  did	  not	  get	  good	  templates	  for	  L,	  we	  could	  not	  perform	  a	  legitimate	  search	  in	  DOMMINO.	  Instead,	  we	  chose	  PDB	  advanced	  searching	  method	  for	  L.	  However,	  no	  significant	  result	  has	  shown.	  	  (The	  residues	  that	  are	  potentially	  involved	  in	  functional	  sites	  can	  be	  found	  in	  Appendix	  F.	  Functional	  Residues	  Mapping.)	  	   	  
Chapter	  4:	  Conclusions	  In	  this	  project	  motivated	  by	  a	  recent	  2014	  Ebola	  outbreak,	  we	  aimed	  to	  find	  evolutionary	  patterns	  within	  the	  family	  of	  Filoviridae.	  Inspired	  by	  a	  study	  on	  influenza	  (Warren	  S,	  2013),	  we	  posed	  a	  hypothesis	  similar	  to	  the	  one	  based	  on	  the	  conclusions	  from	  the	  influenza	  study:	  	  the	  highly	  conserved	  residues	  across	  the	  species	  of	  Filoviridae	  family	  should	  be	  associated	  with	  the	  intra-­‐viral	  interaction	  regions.	  Indeed,	  intuitively,	  in	  order	  for	  a	  virus	  to	  survive,	  it	  has	  to	  maintain	  minimal	  set	  of	  critical	  functions,	  such	  as	  replication	  of	  RNA,	  where	  the	  viral	  proteins	  interact	  with	  each	  other	  and	  are	  supposed	  to	  work	  together	  synergistically.	  Thus,	  genetic	  variations	  in	  the	  RNA	  sequence	  that	  lead	  to	  the	  change	  in	  the	  protein	  sequence	  might	  affect	  those	  interactions,	  potentially	  resulting	  in	  the	  reduced	  functional	  efficiency	  of	  the	  proteins.	  In	  contrast,	  the	  extremely	  diverse	  residues	  from	  a	  single	  viral	  species	  sampled	  over	  multiple	  years	  are	  likely	  to	  be	  associated	  with	  the	  host-­‐viral	  interactions	  binding	  sites,	  specifically	  the	  antibody	  binding	  sites.	  To	  reach	  our	  goal,	  we	  determined	  and	  analyzed	  conserved	  and	  diverse	  regions	  both	  across	  species	  and	  across	  years.	  Also,	  in	  order	  to	  compare	  the	  conserved/diverse	  regions	  with	  the	  functional	  sites	  and	  ultimately	  to	  test	  our	  hypothesis,	  we	  also	  needed	  to	  annotate	  the	  viral	  proteins	  with	  the	  protein	  binding	  sites.	  	  Overall,	  the	  proposed	  research	  could	  be	  split	  into	  three	  major	  steps.	  First,	  we	  would	  build	  three-­‐dimensional	  models	  for	  the	  seven	  proteins	  in	  Ebola	  virus	  using	  the	  homology	  modeling	  method.	  Second,	  we	  would	  find	  the	  conserved	  and	  diverse	  regions	  across	  family,	  and	  map	  them	  to	  the	  models.	  At	  the	  same	  time,	  we	  would	  find	  the	  potential	  binding	  sites	  on	  each	  model	  by	  checking	  the	  binding	  sites	  on	  related	  structures	  for	  each	  model,	  and	  map	  them	  to	  the	  models.	  Residues	  involved	  in	  intra-­‐viral	  interactions	  and	  in	  host-­‐viral	  interactions	  will	  be	  recorded	  separately.	  Then,	  we	  would	  compare	  the	  conserved	  and	  diverse	  regions	  with	  the	  residues	  involved	  in	  the	  two	  types	  of	  functional	  sites,	  to	  test	  the	  first	  part	  of	  our	  hypothesis.	  Third,	  we	  would	  do	  the	  same	  for	  each	  species	  across	  years,	  and	  compare	  the	  conserved	  and	  diverse	  regions	  with	  the	  residues	  involved	  in	  the	  two	  types	  of	  interactions	  to	  test	  the	  second	  half	  of	  our	  hypothesis.	  However,	  due	  to	  the	  time	  limitation,	  in	  this	  project	  we	  have	  successfully	  achieved	  the	  firs	  two	  major	  steps.	  	  	  We	  first	  made	  models	  for	  each	  of	  the	  seven	  main	  proteins	  in	  the	  Ebola	  proteome	  using	  the	  homology	  modeling	  approach.	  Specifically,	  we	  built	  3	  separate	  models	  for	  NP,	  2	  for	  VP35,	  1	  for	  VP40,	  2	  for	  GP,	  1	  for	  VP30,	  1	  for	  VP24,	  and	  2	  for	  L.	  Due	  to	  the	  limitation	  in	  the	  number	  of	  structural	  templates	  and	  in	  their	  coverage	  of	  the	  target	  sequences,	  for	  most	  proteins,	  we	  could	  not	  build	  a	  complete	  model	  covering	  the	  whole	  protein.	  For	  instance,	  the	  structural	  coverage	  for	  NP	  and	  L	  is	  very	  low.	  Then,	  we	  selected	  one	  representative	  from	  each	  species	  within	  the	  Filoviridae	  family,	  aligned	  the	  sequences	  for	  each	  protein,	  and	  calculated	  the	  trident	  score	  for	  each	  position.	  We	  then	  found	  the	  distributions	  of	  trident	  scores	  for	  each	  protein	  and	  determined	  the	  cutoff	  for	  highly	  conserved	  residues	  to	  be	  trident	  score	  strictly	  equal	  to	  1	  and	  that	  for	  diverse	  residues	  to	  be	  trident	  score	  less	  than	  or	  equal	  to	  0.4.	  Then,	  we	  mapped	  the	  highly	  conserved	  and	  highly	  diverse	  residues	  back	  to	  the	  models	  we	  built	  in	  the	  first	  step.	  In	  most	  cases,	  one	  can	  clearly	  see	  clusters	  of	  the	  conserved	  residues	  (e.g.,	  see	  the	  conserved	  and	  diverse	  regions	  mapping	  for	  NP2	  and	  L2	  –	  the	  upper	  model	  for	  L.)	  However,	  the	  diverse	  residues	  are	  somewhat	  randomly	  scattered	  on	  the	  protein	  surfaces	  for	  most	  proteins	  (e.g.,	  see	  the	  conserved	  and	  diverse	  regions	  mapping	  for	  VP40	  and	  VP24).	  Finally,	  we	  annotated	  each	  model	  with	  its	  potential	  functional	  sites	  by	  searching	  for	  
existing	  related	  structures	  in	  the	  DOMMINO	  database	  {ref].	  For	  NP	  and	  L,	  no	  related	  structures	  have	  been	  found.	  For	  VP35,	  VP40,	  and	  VP30,	  only	  intra-­‐viral	  interactions	  have	  been	  found.	  For	  GP	  and	  VP24,	  both	  intra-­‐viral	  interactions	  and	  host-­‐viral	  interactions	  have	  been	  found.	  	  	  Finally,	  in	  order	  to	  test	  the	  our	  hypothesis	  that	  intra-­‐viral	  interactions	  would	  be	  highly	  associated	  with	  the	  conserved	  regions,	  while	  the	  host-­‐viral	  interactions	  would	  be	  associated	  with	  the	  diverse	  regions,	  we	  analyze	  the	  binding	  site	  annotation	  results.	  From	  the	  results,	  intra-­‐viral	  interactions	  are	  only	  predicted	  on	  five	  models,	  which	  are	  VP35,	  VP40,	  GP,	  VP30,	  and	  VP24.	  Among	  those	  proteins,	  we	  also	  found	  those	  ones,	  GP	  and	  VP24,	  involved	  in	  the	  inter-­‐viral	  binding	  sites.	  The	  results	  show	  that	  intra-­‐viral	  binding	  sites	  have	  indeed	  a	  higher	  proportion	  of	  conserved	  residues	  that	  the	  diverse	  ones,	  while	  the	  reverse	  is	  also	  true	  for	  the	  host-­‐virus	  binding	  sites.	  For	  some	  of	  the	  proteins	  it	  is	  harder	  to	  draw	  this	  conclusion	  than	  for	  the	  others.	  This	  is	  likely	  due	  to	  the	  lack	  of	  structural	  information	  and	  contrasts	  with	  the	  annotation	  of	  influenza	  proteome	  whose	  proteins	  are	  mostly	  structurally	  resolved.	  These	  results	  also	  suggest	  that	  an	  accurate	  measure	  is	  needed	  that	  estimates	  the	  proportion	  of	  the	  conserved	  and	  diverse	  residues	  and	  compares	  it	  to	  the	  background	  distribution	  of	  such	  residues	  on	  the	  entire	  protein	  surface.	  	  	  
Chapter	  5:	  Potential	  Problems	  and	  Future	  Studies	  1. As	  the	  research	  goes,	  more	  and	  more	  data	  come	  out.	  However,	  due	  to	  time	  limitation,	  we	  did	  not	  include	  the	  newest	  data,	  e.g.,	  the	  structure	  of	  the	  newly	  discovered	  NP	  structure	  from	  Bundibugyo	  and	  Tai,	  and	  the	  VP35	  structure	  from	  Ebola	  virus.	  2. In	  this	  project,	  there	  are	  many	  steps	  involving	  protein	  sequence	  alignment.	  However,	  because	  different	  software	  packages	  are	  involved,	  we	  did	  not	  keep	  it	  consistent	  on	  which	  alignment	  method	  we	  used.	  If	  we	  had	  done	  an	  alignment	  for	  all	  the	  procedures,	  what	  would	  the	  results	  be?	  Will	  it	  be	  highly	  affected?	  3. We	  assumed	  that	  after	  concatenating	  the	  two	  chunks	  of	  proteins	  we	  would	  get	  the	  corresponding	  structure	  of	  GP	  in	  Lloviu	  cuevavirus.	  However,	  from	  the	  perspective	  of	  mutation,	  we	  know	  that	  mutations	  started	  from	  RNA.	  Even	  one	  insertion	  could	  completely	  alter	  the	  open	  reading	  frame	  sequence.	  Hence,	  a	  better	  approach	  needs	  to	  be	  designed.	  	  Finally,	  although	  the	  scores	  are	  calculated	  when	  we	  find	  the	  related	  structures	  for	  functional	  sites,	  the	  scores	  were	  not	  used	  in	  the	  visualizations,	  instead	  simpler	  binary	  annotation	  was	  implemented	  that	  identifies	  a	  residue	  as	  a	  binding	  residue	  or	  not.	  This	  avoids	  the	  problem	  of	  how	  much	  weight	  we	  should	  put	  on	  each	  interaction,	  since	  for	  some	  solved	  structures,	  there	  are	  redundant	  interactions,	  and	  we	  have	  not	  defined	  a	  proper	  way	  to	  take	  care	  of	  this.	  This	  will	  bring	  in	  many	  residues	  that	  may	  not	  be	  actively	  involved	  in	  interactions	  and	  should	  be	  resolved	  as	  one	  of	  the	  future	  steps.	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  UniProt	  (NP)	  
Entry Entry name 
Stat
us Organism Length 
Date of 
creation Place Strain Year 
B8XCM7 
B8XCM7_9MO









Lake Victoria marburgvirus 
- Ci67 695 2/5/08 




Lake Victoria marburgvirus 









Lake Victoria marburgvirus 









Lake Victoria marburgvirus 









Lake Victoria marburgvirus 





Lake Victoria marburgvirus 
(strain Angola/2005) 
(MARV) 695 5/16/06 
 
Angola 2005 
Q1PD53 NCAP_MABVA R 
Lake Victoria marburgvirus 
(strain Angola/2005) 
(MARV) 695 1/15/08 
 
Angola 2005 
P27588 NCAP_MABVM R 
Lake Victoria marburgvirus 
(strain Musoke-80) 
(MARV) (Marburg virus 
(strain 





Q6UY69 NCAP_MABVO R 
Lake Victoria marburgvirus 
(strain Ozolin-75) (MARV) 
(Marburg virus (strain 





P35263 NCAP_MABVP R 
Lake Victoria marburgvirus 
(strain Popp-67) (MARV) 
(Marburg virus (strain West 








Lake Victoria marburgvirus 
(strain Ravn-87) (MARV) 
(Marburg virus (strain 






Lake Victoria marburgvirus 
(strain Ravn-87) (MARV) 
(Marburg virus (strain 






Lake Victoria marburgvirus 
(strain Ravn-87) (MARV) 
(Marburg virus (strain 
Kenya/Ravn/1987)) 695 2/5/08 Ravn, Kenya 
Ravn-
89 1987 
Q1PDD0 NCAP_MABVR R 
Lake Victoria marburgvirus 
(strain Ravn-87) (MARV) 
(Marburg virus (strain 






Lloviu cuevavirus (isolate 
Bat/Spain/Asturias-








NO U Marburg marburgvirus 695 1/9/13 
   
K4N3C7 
K4N3C7_9MO
NO U Marburg marburgvirus 695 1/9/13 
   
C7B248 
C7B248_9MON
O U Marburg marburgvirus 695 9/22/09 
   
E0X104 E0X104_9MON U Marburg marburgvirus 695 11/2/10 




O U Marburg marburgvirus 695 11/2/10 
   
E0X0Z7 
E0X0Z7_9MON
O U Marburg marburgvirus 695 11/2/10 
   
K4MT16 
K4MT16_9MO
NO U Marburg marburgvirus 695 1/9/13 
   
K4MRA8 
K4MRA8_9MO
NO U Marburg marburgvirus 695 1/9/13 
   
C7B283 
C7B283_9MON
O U Marburg marburgvirus 695 9/22/09 
   
C7B276 
C7B276_9MON
O U Marburg marburgvirus 695 9/22/09 
   
K4N3V7 
K4N3V7_9MO
NO U Marburg marburgvirus 695 1/9/13 
   
K4MQC5 
K4MQC5_9MO
NO U Marburg marburgvirus 695 1/9/13 
   
K4MSZ0 
K4MSZ0_9MO
NO U Marburg marburgvirus 695 1/9/13 
   
K4MQ25 
K4MQ25_9MO
NO U Marburg marburgvirus 695 1/9/13 
   
K4N3K2 
K4N3K2_9MO
NO U Marburg marburgvirus 695 1/9/13 
   
K4MR07 
K4MR07_9MO
NO U Marburg marburgvirus 695 1/9/13 
   
K4MR89 
K4MR89_9MO
NO U Marburg marburgvirus 695 1/9/13 
   
K4MQY0 
K4MQY0_9MO
NO U Marburg marburgvirus 695 1/9/13 
   
C7B269 
C7B269_9MON
O U Marburg marburgvirus 695 9/22/09 
   
K4MQF4 
K4MQF4_9MO
NO U Marburg marburgvirus 695 1/9/13 
   A0A077D
355 
A0A077D355_9
MONO U Marburg marburgvirus 695 10/29/14 
   
K4N3V7 
K4N3V7_9MO
NO U Marburg marburgvirus 695 1/9/13 
   
E0X111 
E0X111_9MON
O U Marburg marburgvirus 695 11/2/10 
   
K4MQC5 
K4MQC5_9MO
NO U Marburg marburgvirus 695 1/9/13 
   
K4MSZ0 
K4MSZ0_9MO
NO U Marburg marburgvirus 695 1/9/13 
   
K4MQ25 
K4MQ25_9MO
NO U Marburg marburgvirus 695 1/9/13 
   
K4N3K2 
K4N3K2_9MO
NO U Marburg marburgvirus 695 1/9/13 
   
K4MR07 
K4MR07_9MO
NO U Marburg marburgvirus 695 1/9/13 
   
K4MR89 
K4MR89_9MO
NO U Marburg marburgvirus 695 1/9/13 
   
E0X0Z7 
E0X0Z7_9MON
O U Marburg marburgvirus 695 11/2/10 
   
K4MQY0 
K4MQY0_9MO
NO U Marburg marburgvirus 695 1/9/13 
   
K4MQF4 
K4MQF4_9MO
NO U Marburg marburgvirus 695 1/9/13 
   
C7B269 
C7B269_9MON
O U Marburg marburgvirus 695 9/22/09 
   
L7RI74 
L7RI74_9MON
O U Reston ebolavirus 739 4/3/13 
   
L7REU1 
L7REU1_9MO
NO U Reston ebolavirus 739 4/3/13 




Reston ebolavirus (strain 
Philippines-96) (REBOV) 









Reston ebolavirus (strain 
Philippines-96) (REBOV) 









Reston ebolavirus (strain 





(Reston Ebola virus) 96 
Q91DE1 NCAP_EBORE R 
Reston ebolavirus (strain 
Philippines-96) (REBOV) 






Q8JPY1 NCAP_EBORR R 
Reston ebolavirus (strain 
Reston-89) (REBOV) 







O U Sudan ebolavirus 738 3/18/08 
   
C4PK55 
C4PK55_9MO
NO U Sudan ebolavirus 738 7/7/09 
   
M4J9H3 
M4J9H3_9MO
NO U Sudan ebolavirus 738 5/29/13 
   
R4QTJ0 
R4QTJ0_9MO
NO U Sudan ebolavirus 738 7/24/13 
   
R4NSX3 
R4NSX3_9MO
NO U Sudan ebolavirus 738 7/24/13 
   
R4QTJ0 
R4QTJ0_9MO
NO U Sudan ebolavirus 738 7/24/13 




Sudan ebolavirus - 
Nakisamata 738 10/3/12 Nakisamata 
  
Q9QP77 NCAP_EBOSB R 
Sudan ebolavirus (strain 
Boniface-76) (SEBOV) 





Q5XX08 NCAP_EBOSU R 
Sudan ebolavirus (strain 
Uganda-00) (SEBOV) 







NO U Tai Forest ebolavirus 739 3/3/09 
   
L7QI51 
L7QI51_9MON
O U Zaire ebolavirus 739 4/3/13 
   
L7QHT6 
L7QHT6_9MO
NO U Zaire ebolavirus 739 4/3/13 
   
I0DHA6 
I0DHA6_9MON
O U Zaire ebolavirus 739 6/13/12 
   
L7QIA8 
L7QIA8_9MON
O U Zaire ebolavirus 739 4/3/13 
   
L7QI42 
L7QI42_9MON
O U Zaire ebolavirus 739 4/3/13 
   
L7QHU5 
L7QHU5_9MO
NO U Zaire ebolavirus 739 4/3/13 
   
G8DB37 
G8DB37_9MO
NO U Zaire ebolavirus 739 1/25/12 
   A0A068J
945 
A0A068J945_9
MONO U Zaire ebolavirus 739 10/1/14 
   
X5GXS8 
X5GXS8_9MO
NO U Zaire ebolavirus 739 6/11/14 
   A0A075
WG99 
A0A075WG99_
9MONO U Zaire ebolavirus 739 10/29/14 
   
A9QPL6 
A9QPL6_9MO
NO U Zaire ebolavirus 739 2/5/08 
   
X5HMY5 
X5HMY5_9MO
NO U Zaire ebolavirus 739 6/11/14 
   A0A075
W933 
A0A075W933_
9MONO U Zaire ebolavirus 739 10/29/14 
   A0A068J
9B9 
A0A068J9B9_9
MONO U Zaire ebolavirus 739 10/1/14 
   
Q9QCE9 NCAP_EBOG4 R 
Zaire ebolavirus (strain 
Gabon-94) (ZEBOV) (Zaire 





O72142 NCAP_EBOZ5 R 
Zaire ebolavirus (strain 
Kikwit-95) (ZEBOV) (Zaire 





P18272 NCAP_EBOZM R 
Zaire ebolavirus (strain 
Mayinga-76) (ZEBOV) 




 	  	   	  
Appendix	  A2.	  Protein	  Sequences	  Found	  in	  UniProt	  (VP35)	  
Entry Entry name Stat
us 
Organism Length Date of 
creation 
Place Strain Year 
B8XCM8 B8XCM8_9MON
O 
U Bundibugyo ebolavirus 341 3/3/09    
R4QGV8 R4QGV8_9MON
O 
U Bundibugyo ebolavirus 341 7/24/13    
A9Q1H3 A9Q1H3_9MON
O 
U Lake Victoria marburgvirus 
- Ci67 
329 2/5/08    
Q1PDB5 Q1PDB5_9MON
O 
U Lake Victoria marburgvirus 
- DRC1999 






U Lake Victoria marburgvirus 
- DRC1999 






U Lake Victoria marburgvirus 
- Leiden 
329 2/22/12 Leiden   
Q1PD52 VP35_MABVA R Lake Victoria marburgvirus 
(strain Angola/2005) 
(MARV) 
329 1/15/08 Angola  2005 
P35259 VP35_MABVM R Lake Victoria marburgvirus 
(strain Musoke-80) 
(MARV) (Marburg virus 
(strain 
Kenya/Musoke/1980)) 





Q6UY68 VP35_MABVO R Lake Victoria marburgvirus 
(strain Ozolin-75) (MARV) 
(Marburg virus (strain 
South Africa/Ozolin/1975)) 





Q03039 VP35_MABVP R Lake Victoria marburgvirus 
(strain Popp-67) (MARV) 
(Marburg virus (strain West 
Germany/Popp/1967)) 





Q1PDC9 VP35_MABVR R Lake Victoria marburgvirus 
(strain Ravn-87) (MARV) 
(Marburg virus (strain 
Kenya/Ravn/1987)) 





U Lake Victoria marburgvirus 
(strain Ravn-87) (MARV) 
(Marburg virus (strain 
Kenya/Ravn/1987)) 
329 2/5/08 Ravn, Kenya Ravn-
87 
1987 
C0IT77 C0IT77_MABVR U Lake Victoria marburgvirus 
(strain Ravn-87) (MARV) 
(Marburg virus (strain 
Kenya/Ravn/1987)) 
329 5/5/09 Ravn, Kenya Ravn-
87 
1987 
C0IT91 C0IT91_MABVR U Lake Victoria marburgvirus 
(strain Ravn-87) (MARV) 
(Marburg virus (strain 
Kenya/Ravn/1987)) 
329 5/5/09 Ravn, Kenya Ravn-
87 
1987 
G8EFI2 G8EFI2_LLOVA U Lloviu cuevavirus (isolate 
Bat/Spain/Asturias-
Bat86/2003) (LLOV) 








U Marburg marburgvirus 329 9/22/09    
K4MSU6 K4MSU6_9MON
O 
U Marburg marburgvirus 329 1/9/13    
E0X0Z8 E0X0Z8_9MON
O 
U Marburg marburgvirus 329 11/2/10    
C7B249 C7B249_9MON
O 
U Marburg marburgvirus 329 9/22/09    
C7B277 C7B277_9MON
O 
U Marburg marburgvirus 329 9/22/09    
C7B256 C7B256_9MON
O 
U Marburg marburgvirus 329 9/22/09    
K4MQB0 K4MQB0_9MON
O 
U Marburg marburgvirus 329 1/9/13    
K4MST7 K4MST7_9MON
O 
U Marburg marburgvirus 329 1/9/13    
K4MTB0 K4MTB0_9MON
O 
U Marburg marburgvirus 329 1/9/13    
K4MQU1 K4MQU1_9MON
O 
U Marburg marburgvirus 329 1/9/13    
K4MTE0 K4MTE0_9MON
O 





U Marburg marburgvirus 329 10/29/14    
O36427 O36427_9MON
O 
U Marburg marburgvirus 329 1/1/98    
L7RFC8 L7RFC8_9MON
O 
U Reston ebolavirus 329 4/3/13    
L7RF08 L7RF08_9MON
O 
U Reston ebolavirus 329 4/3/13    
Q91DE0 VP35_EBORE R Reston ebolavirus (strain 
Philippines-96) (REBOV) 
(Reston Ebola virus) 






U Reston ebolavirus (strain 
Philippines-96) (REBOV) 
(Reston Ebola virus) 






U Reston ebolavirus (strain 
Philippines-96) (REBOV) 
(Reston Ebola virus) 






U Reston ebolavirus (strain 
Philippines-96) (REBOV) 
(Reston Ebola virus) 




Q8JPY0 VP35_EBORR R Reston ebolavirus (strain 
Reston-89) (REBOV) 
(Reston Ebola virus) 






U Sudan ebolavirus 329 3/18/08    
C4PK56 C4PK56_9MON
O 
U Sudan ebolavirus 329 7/7/09    
R4NUK7 R4NUK7_9MON
O 
U Sudan ebolavirus 329 7/24/13    
R4QGR7 R4QGR7_9MON
O 
U Sudan ebolavirus 329 7/24/13    
I7FLL9 I7FLL9_9MONO U Sudan ebolavirus - 
Nakisamata 
329 10/3/12 Nakisamata   
Q5XX07 VP35_EBOSU R Sudan ebolavirus (strain 
Uganda-00) (SEBOV) 
(Sudan Ebola virus) 





U Tai Forest ebolavirus 341 3/3/09    
A9QPL7 A9QPL7_9MON
O 
U Zaire ebolavirus 340 2/5/08    
G8DB47 G8DB47_9MON
O 
U Zaire ebolavirus 340 1/25/12    
X5GXU1 X5GXU1_9MON
O 





U Zaire ebolavirus 340 10/1/14    
G8DB38 G8DB38_9MON
O 
U Zaire ebolavirus 340 1/25/12    
Q6V1Q9 VP35_EBOZ5 R Zaire ebolavirus (strain 
Kikwit-95) (ZEBOV) (Zaire 
Ebola virus) 
340 7/11/06  Kikwit-
95 
 
Q05127 VP35_EBOZM R Zaire ebolavirus (strain 
Mayinga-76) (ZEBOV) 
(Zaire Ebola virus) 
340 2/1/94  Mayin
ga-76 
 	  
Appendix	  A3.	  Protein	  Sequences	  Found	  in	  UniProt	  (VP40)	  
Entry Entry name Stat
us 
Organism Length Date of 
creation 
Place Strain Year 
B8XCM9 B8XCM9_9MON
O 
U Bundibugyo ebolavirus 326 3/3/09    
R4QGW8 R4QGW8_9MO
NO 
U Bundibugyo ebolavirus 326 7/24/13    
A9Q1H4 A9Q1H4_9MON
O 
U Lake Victoria marburgvirus 
- Ci67 
303 2/5/08    
Q1PDB4 Q1PDB4_9MON
O 
U Lake Victoria marburgvirus 
- DRC1999 






U Lake Victoria marburgvirus 
- DRC1999 






U Lake Victoria marburgvirus 
- Leiden 
303 2/22/12 Leiden   
Q1PD51 VP40_MABVA R Lake Victoria marburgvirus 
(strain Angola/2005) 
(MARV) 
303 1/15/08 Angola  2005 
P35260 VP40_MABVM R Lake Victoria marburgvirus 
(strain Musoke-80) 
(MARV) (Marburg virus 
(strain 
Kenya/Musoke/1980)) 





Q6UY67 VP40_MABVO R Lake Victoria marburgvirus 
(strain Ozolin-75) (MARV) 
(Marburg virus (strain 
South Africa/Ozolin/1975)) 





Q03040 VP40_MABVP R Lake Victoria marburgvirus 
(strain Popp-67) (MARV) 
(Marburg virus (strain West 
Germany/Popp/1967)) 





Q1PDC8 VP40_MABVR R Lake Victoria marburgvirus 
(strain Ravn-87) (MARV) 
(Marburg virus (strain 
Kenya/Ravn/1987)) 
303 1/15/08 Ravn, Kenya Ravn-
87 
1987 
C0IT92 C0IT92_MABVR U Lake Victoria marburgvirus 
(strain Ravn-87) (MARV) 
(Marburg virus (strain 
Kenya/Ravn/1987)) 





U Lake Victoria marburgvirus 
(strain Ravn-87) (MARV) 
(Marburg virus (strain 
Kenya/Ravn/1987)) 
303 2/5/08 Ravn, Kenya Ravn-
87 
1987 
C0IT78 C0IT78_MABVR U Lake Victoria marburgvirus 
(strain Ravn-87) (MARV) 
(Marburg virus (strain 
Kenya/Ravn/1987)) 
303 5/5/09 Ravn, Kenya Ravn-
87 
1987 
C0IT85 C0IT85_MABVR U Lake Victoria marburgvirus 
(strain Ravn-87) (MARV) 
(Marburg virus (strain 
Kenya/Ravn/1987)) 
303 5/5/09 Ravn, Kenya Ravn-
87 
1987 
G8EFI3 G8EFI3_LLOVA U Lloviu cuevavirus (isolate 
Bat/Spain/Asturias-
Bat86/2003) (LLOV) 








U Marburg marburgvirus 303 9/22/09    
C7B278 C7B278_9MON
O 
U Marburg marburgvirus 303 9/22/09    
C7B250 C7B250_9MON
O 
U Marburg marburgvirus 303 9/22/09    
E0X113 E0X113_9MON
O 
U Marburg marburgvirus 303 11/2/10    
K4MQT4 K4MQT4_9MON
O 
U Marburg marburgvirus 303 1/9/13    
C7B285 C7B285_9MON
O 
U Marburg marburgvirus 303 9/22/09    
E0X0Z9 E0X0Z9_9MON
O 
U Marburg marburgvirus 303 11/2/10    
K4MQ95 K4MQ95_9MON
O 
U Marburg marburgvirus 303 1/9/13    
E0X106 E0X106_9MON
O 
U Marburg marburgvirus 303 11/2/10    
K4MR86 K4MR86_9MON
O 





U Marburg marburgvirus 303 10/29/14    
L7RDZ6 L7RDZ6_9MON
O 
U Reston ebolavirus 331 4/3/13    
L7REV2 L7REV2_9MON
O 
U Reston ebolavirus 331 4/3/13    
Q91DD9 VP40_EBORE R Reston ebolavirus (strain 
Philippines-96) (REBOV) 
(Reston Ebola virus) 






U Reston ebolavirus (strain 
Philippines-96) (REBOV) 
(Reston Ebola virus) 






U Reston ebolavirus (strain 
Philippines-96) (REBOV) 
(Reston Ebola virus) 






U Reston ebolavirus (strain 
Philippines-96) (REBOV) 
(Reston Ebola virus) 




Q8JPX9 VP40_EBORR R Reston ebolavirus (strain 
Reston-89) (REBOV) 
(Reston Ebola virus) 






U Sudan ebolavirus 326 3/18/08    
R4QRB1 R4QRB1_9MON
O 
U Sudan ebolavirus 326 7/24/13    
I7F2J6 I7F2J6_9MONO U Sudan ebolavirus - 
Nakisamata 
326 10/3/12 Nakisamata   
Q5XX06 VP40_EBOSU R Sudan ebolavirus (strain 
Uganda-00) (SEBOV) 
(Sudan Ebola virus) 





U Tai Forest ebolavirus 326 3/3/09    
A9QPL8 A9QPL8_9MON
O 
U Zaire ebolavirus 326 2/5/08    
X5H596 X5H596_9MON
O 
U Zaire ebolavirus 326 6/11/14    
G8DB48 G8DB48_9MON
O 





U Zaire ebolavirus 326 10/29/14    
Q2PDK5 VP40_EBOG4 R Zaire ebolavirus (strain 
Gabon-94) (ZEBOV) (Zaire 
Ebola virus) 
326 7/11/06  Gabon
-94 
 
Q77DJ6 VP40_EBOZ5 R Zaire ebolavirus (strain 
Kikwit-95) (ZEBOV) (Zaire 
Ebola virus) 
326 7/11/06  Kikwit-
95 
 
Q05128 VP40_EBOZM R Zaire ebolavirus (strain 
Mayinga-76) (ZEBOV) 
(Zaire Ebola virus) 
326 2/1/94  Mayin
ga-76 
 	  	   	  
Appendix	  A4.	  Protein	  Sequences	  Found	  in	  UniProt	  (GP)	  
Entry Entry name Stat
us 
Organism Length Date of 
creation 
Place Strain Year 
B8XCN2 B8XCN2_9MON
O 
U Bundibugyo ebolavirus 302 3/3/09    
B8XCN0 B8XCN0_9MON
O 
U Bundibugyo ebolavirus 676 3/3/09    
B8XCN1 B8XCN1_9MON
O 
U Bundibugyo ebolavirus 373 3/3/09    
R4QGV6 R4QGV6_9MON
O 
U Bundibugyo ebolavirus 676 7/24/13    
R4QRC0 R4QRC0_9MON
O 
U Bundibugyo ebolavirus 676 7/24/13    
A9Q1H5 A9Q1H5_9MON
O 
U Lake Victoria marburgvirus 
- Ci67 
681 2/5/08    
Q1PDA6 Q1PDA6_9MON
O 
U Lake Victoria marburgvirus 
- DRC1999 






U Lake Victoria marburgvirus 
- DRC1999 






U Lake Victoria marburgvirus 
- DRC1999 






U Lake Victoria marburgvirus 
- Leiden 
681 2/22/12 Leiden   
Q1PD50 VGP_MABVA R Lake Victoria marburgvirus 
(strain Angola/2005) 
(MARV) 
681 1/15/08 Angola  2005 
P35253 VGP_MABVM R Lake Victoria marburgvirus 
(strain Musoke-80) 
(MARV) (Marburg virus 
(strain 
Kenya/Musoke/1980)) 





Q6UY66 VGP_MABVO R Lake Victoria marburgvirus 
(strain Ozolin-75) (MARV) 
(Marburg virus (strain 
South Africa/Ozolin/1975)) 





P35254 VGP_MABVP R Lake Victoria marburgvirus 
(strain Popp-67) (MARV) 
(Marburg virus (strain West 
Germany/Popp/1967)) 





Q1PDC7 VGP_MABVR R Lake Victoria marburgvirus 
(strain Ravn-87) (MARV) 
(Marburg virus (strain 
Kenya/Ravn/1987)) 
681 1/15/08 Ravn, Kenya Ravn-
87 
1987 
C0IT79 C0IT79_MABVR U Lake Victoria marburgvirus 
(strain Ravn-87) (MARV) 
(Marburg virus (strain 
Kenya/Ravn/1987)) 





U Lake Victoria marburgvirus 
(strain Ravn-87) (MARV) 
(Marburg virus (strain 
Kenya/Ravn/1987)) 
681 2/5/08 Ravn, Kenya Ravn-
87 
1987 
G8EFI4 G8EFI4_LLOVA U Lloviu cuevavirus (isolate 
Bat/Spain/Asturias-
Bat86/2003) (LLOV) 






G8EFI5 G8EFI5_LLOVA U Lloviu cuevavirus (isolate 
Bat/Spain/Asturias-
Bat86/2003) (LLOV) 








U Marburg marburgvirus 681 1/9/13    
K4MR14 K4MR14_9MON
O 
U Marburg marburgvirus 681 1/9/13    
K4N3N9 K4N3N9_9MON
O 
U Marburg marburgvirus 681 1/9/13    
C7B251 C7B251_9MON
O 
U Marburg marburgvirus 681 9/22/09    
Q71VM1 Q71VM1_9MON
O 
U Marburg marburgvirus 681 7/5/04    
K4MSG5 K4MSG5_9MON
O 
U Marburg marburgvirus 681 1/9/13    
C7B286 C7B286_9MON
O 
U Marburg marburgvirus 681 9/22/09    
K4N3G2 K4N3G2_9MON
O 





U Marburg marburgvirus 681 10/29/14    
K4MQA7 K4MQA7_9MON
O 
U Marburg marburgvirus 681 1/9/13    
K4MT22 K4MT22_9MON
O 
U Marburg marburgvirus 681 1/9/13    
K4MQ81 K4MQ81_9MON
O 
U Marburg marburgvirus 681 1/9/13    
K4MR75 K4MR75_9MON
O 
U Marburg marburgvirus 681 1/9/13    
K4MSZ7 K4MSZ7_9MON
O 
U Marburg marburgvirus 681 1/9/13    
C7B272 C7B272_9MON
O 
U Marburg marburgvirus 681 9/22/09    
K4MSY0 K4MSY0_9MON
O 
U Marburg marburgvirus 681 1/9/13    
K4MST4 K4MST4_9MON
O 
U Marburg marburgvirus 681 1/9/13    
C7B279 C7B279_9MON
O 
U Marburg marburgvirus 681 9/22/09    
K4N3W4 K4N3W4_9MON
O 
U Marburg marburgvirus 681 1/9/13    
K4MSV6 K4MSV6_9MON
O 
U Marburg marburgvirus 681 1/9/13    
K4MTD6 K4MTD6_9MON
O 
U Marburg marburgvirus 681 1/9/13    
K4N3L1 K4N3L1_9MON
O 
U Marburg marburgvirus 681 1/9/13    
K4MR55 K4MR55_9MON
O 
U Marburg marburgvirus 681 1/9/13    
K4MT76 K4MT76_9MON
O 
U Marburg marburgvirus 681 1/9/13    
C7B293 C7B293_9MON
O 
U Marburg marburgvirus 681 9/22/09    
E0X100 E0X100_9MON
O 
U Marburg marburgvirus 681 11/2/10    
K4MSU2 K4MSU2_9MON
O 
U Marburg marburgvirus 681 1/9/13    
K4MR93 K4MR93_9MON
O 
U Marburg marburgvirus 681 1/9/13    
K4MTA6 K4MTA6_9MON
O 
U Marburg marburgvirus 681 1/9/13    
K4N3Z7 K4N3Z7_9MON
O 
U Marburg marburgvirus 681 1/9/13    
R4QGR2 R4QGR2_9MON
O 
U Marburg marburgvirus 681 7/24/13    
L7REV7 L7REV7_9MON
O 
U Reston ebolavirus 677 4/3/13    
L7RFD3 L7RFD3_9MON
O 
U Reston ebolavirus 381 4/3/13    
L7RF11 L7RF11_9MON
O 
U Reston ebolavirus 367 4/3/13    
Q91DD8 VGP_EBORE R Reston ebolavirus (strain 
Philippines-96) (REBOV) 
(Reston Ebola virus) 




Q91DD7 VSGP_EBORE R Reston ebolavirus (strain 
Philippines-96) (REBOV) 
(Reston Ebola virus) 




P0C770 VSSGP_EBORE R Reston ebolavirus (strain 
Philippines-96) (REBOV) 
(Reston Ebola virus) 






U Reston ebolavirus (strain 
Philippines-96) (REBOV) 
(Reston Ebola virus) 




C6G8E5 C6G8E5_EBOR U Reston ebolavirus (strain 367 9/1/09  Philipp  
E Philippines-96) (REBOV) 





U Reston ebolavirus (strain 
Philippines-96) (REBOV) 
(Reston Ebola virus) 






U Reston ebolavirus (strain 
Philippines-96) (REBOV) 
(Reston Ebola virus) 






U Reston ebolavirus (strain 
Philippines-96) (REBOV) 
(Reston Ebola virus) 






U Reston ebolavirus (strain 
Philippines-96) (REBOV) 
(Reston Ebola virus) 






U Reston ebolavirus (strain 
Philippines-96) (REBOV) 
(Reston Ebola virus) 






U Reston ebolavirus (strain 
Philippines-96) (REBOV) 
(Reston Ebola virus) 






U Reston ebolavirus (strain 
Philippines-96) (REBOV) 
(Reston Ebola virus) 




Q66799 VGP_EBORR R Reston ebolavirus (strain 
Reston-89) (REBOV) 
(Reston Ebola virus) 
677 5/30/00  Resto
n-89 
 
Q66800 VSGP_EBORR R Reston ebolavirus (strain 
Reston-89) (REBOV) 
(Reston Ebola virus) 
367 12/1/00  Resto
n-89 
 
P0C771 VSSGP_EBORR R Reston ebolavirus (strain 
Reston-89) (REBOV) 
(Reston Ebola virus) 
332 2/9/10  Resto
n-89 
 
Q89853 VGP_EBORS R Reston ebolavirus (strain 
Siena/Philippine-92) 
(REBOV) (Reston Ebola 
virus) 
677 5/30/00  Philipp
ine-92 
 
Q89569 VSGP_EBORS R Reston ebolavirus (strain 
Siena/Philippine-92) 
(REBOV) (Reston Ebola 
virus) 





U Sudan ebolavirus 372 3/18/08    
B0LPL7 B0LPL7_9MON
O 
U Sudan ebolavirus 676 3/18/08    
M4JBD3 M4JBD3_9MON
O 
U Sudan ebolavirus 676 5/29/13    
C4PK58 C4PK58_9MON
O 
U Sudan ebolavirus 676 7/7/09    
C4PK59 C4PK59_9MON
O 
U Sudan ebolavirus 372 7/7/09    
R4P4N7 R4P4N7_9MON
O 
U Sudan ebolavirus 676 7/24/13    
R4QJ45 R4QJ45_9MON
O 
U Sudan ebolavirus 676 7/24/13    
I7FLM2 I7FLM2_9MONO U Sudan ebolavirus - 
Nakisamata 
372 10/3/12 Nakisamata   
I7F2J9 I7F2J9_9MONO U Sudan ebolavirus - 
Nakisamata 
676 10/3/12 Nakisamata   
Q66814 VGP_EBOSB R Sudan ebolavirus (strain 
Boniface-76) (SEBOV) 
(Sudan Ebola virus) 
676 5/30/00  Bonifa
ce-76 
 
P60172 VSGP_EBOSB R Sudan ebolavirus (strain 
Boniface-76) (SEBOV) 
(Sudan Ebola virus) 
372 12/15/03  Bonifa
ce-76 
 
Q66798 VGP_EBOSM R Sudan ebolavirus (strain 
Maleo-79) (SEBOV) 
(Sudan Ebola virus) 
676 5/30/00  Maleo-
79 
 
P60173 VSGP_EBOSM R Sudan ebolavirus (strain 
Maleo-79) (SEBOV) 
(Sudan Ebola virus) 
372 12/15/03  Maleo-
79 
 
Q7T9D9 VGP_EBOSU R Sudan ebolavirus (strain 
Uganda-00) (SEBOV) 
676 2/5/08  Ugand
a-00 
 
(Sudan Ebola virus) 
P0C772 VSSGP_EBOSU R Sudan ebolavirus (strain 
Uganda-00) (SEBOV) 
(Sudan Ebola virus) 
319 2/9/10  Ugand
a-00 
 
Q7T9E0 VSGP_EBOSU R Sudan ebolavirus (strain 
Uganda-00) (SEBOV) 
(Sudan Ebola virus) 





U Tai Forest ebolavirus 365 3/3/09    
B8XCN9 B8XCN9_9MON
O 
U Tai Forest ebolavirus 676 3/3/09    
B8XCP1 B8XCP1_9MON
O 
U Tai Forest ebolavirus 302 3/3/09    
Q66810 VGP_TAFVC R Tai Forest ebolavirus 
(strain Cote d'Ivoire-94) 
(TAFV) (Cote d'Ivoire 
Ebola virus) 




Q66811 VSGP_TAFVC R Tai Forest ebolavirus 
(strain Cote d'Ivoire-94) 
(TAFV) (Cote d'Ivoire 
Ebola virus) 






U Zaire ebolavirus 297 4/3/13    
A9QPM0 A9QPM0_9MON
O 
U Zaire ebolavirus 364 2/5/08    
A9QPL9 A9QPL9_9MON
O 
U Zaire ebolavirus 676 2/5/08    
G8DB50 G8DB50_9MON
O 
U Zaire ebolavirus 364 1/25/12    
G8DB49 G8DB49_9MON
O 
U Zaire ebolavirus 676 1/25/12    
X5HMX4 X5HMX4_9MON
O 















U Zaire ebolavirus 364 10/1/14    
G8DB42 G8DB42_9MON
O 
U Zaire ebolavirus 297 1/25/12    
X5H5I7 X5H5I7_9MONO U Zaire ebolavirus 364 6/11/14    
X5HMZ0 X5HMZ0_9MON
O 





U Zaire ebolavirus 676 10/1/14    
X5HL92 X5HL92_9MON
O 
U Zaire ebolavirus 364 6/11/14    
X5H5A9 X5H5A9_9MON
O 










U Zaire ebolavirus 297 10/1/14    
V9TJ34 V9TJ34_9MON
O 
U Zaire ebolavirus 410 3/19/14    
V9TJ39 V9TJ39_9MON
O 
U Zaire ebolavirus 298 3/19/14    
P87671 VGP_EBOEC R Zaire ebolavirus (strain 
Eckron-76) (ZEBOV) (Zaire 
Ebola virus) 
676 5/30/00  Eckron
-76 
 
P87670 VSGP_EBOEC R Zaire ebolavirus (strain 
Eckron-76) (ZEBOV) (Zaire 
Ebola virus) 
364 12/1/00  Eckron
-76 
 
O11457 VGP_EBOG4 R Zaire ebolavirus (strain 
Gabon-94) (ZEBOV) (Zaire 
Ebola virus) 
676 5/30/00  Gabon
-94 
 
O11458 VSGP_EBOG4 R Zaire ebolavirus (strain 
Gabon-94) (ZEBOV) (Zaire 
Ebola virus) 
364 12/1/00  Gabon
-94 
 
P87666 VGP_EBOZ5 R Zaire ebolavirus (strain 
Kikwit-95) (ZEBOV) (Zaire 
Ebola virus) 
676 5/30/00  Kikwit-
95 
 
P60171 VSGP_EBOZ5 R Zaire ebolavirus (strain 
Kikwit-95) (ZEBOV) (Zaire 
Ebola virus) 
364 12/15/03  Kikwit-
95 
 
P0C773 VSSGP_EBOZ5 R Zaire ebolavirus (strain 
Kikwit-95) (ZEBOV) (Zaire 
Ebola virus) 





U Zaire ebolavirus (strain 
Kikwit-95) (ZEBOV) (Zaire 
Ebola virus) 
297 7/5/04  Kikwit-
95 
 
Q05320 VGP_EBOZM R Zaire ebolavirus (strain 
Mayinga-76) (ZEBOV) 
(Zaire Ebola virus) 
676 2/1/94  Mayin
ga-76 
 
P60170 VSGP_EBOZM R Zaire ebolavirus (strain 
Mayinga-76) (ZEBOV) 
(Zaire Ebola virus) 
364 12/15/03  Mayin
ga-76 
 
Q9YMG2 VSSGP_EBOZM R Zaire ebolavirus (strain 
Mayinga-76) (ZEBOV) 
(Zaire Ebola virus) 
298 2/9/10  Mayin
ga-76 
 
Appendix	  A5.	  Protein	  Sequences	  Found	  in	  UniProt	  (VP30)	  
Entry Entry name Stat
us 
Organism Length Date of 
creation 
Place Strain Year 
B8XCN3 B8XCN3_9MON
O 
U Bundibugyo ebolavirus 289 3/3/09    
R4QUH9 R4QUH9_9MON
O 
U Bundibugyo ebolavirus 289 7/24/13    
A9Q1H6 A9Q1H6_9MON
O 
U Lake Victoria marburgvirus 
- Ci67 
281 2/5/08    
Q1PDB9 Q1PDB9_9MON
O 
U Lake Victoria marburgvirus 
- DRC1999 






U Lake Victoria marburgvirus 
- DRC1999 






U Lake Victoria marburgvirus 
- DRC1999 






U Lake Victoria marburgvirus 
- Leiden 
281 2/22/12 Leiden   
Q1PD56 VP30_MABVA R Lake Victoria marburgvirus 
(strain Angola/2005) 
(MARV) 
281 1/15/08  Angola 2005 
Q1PD49 Q1PD49_MABV
A 
U Lake Victoria marburgvirus 
(strain Angola/2005) 
(MARV) 
281 5/16/06  Angola 2005 
P35258 VP30_MABVM R Lake Victoria marburgvirus 
(strain Musoke-80) 
(MARV) (Marburg virus 
(strain 
Kenya/Musoke/1980)) 





Q6UY65 VP30_MABVO R Lake Victoria marburgvirus 
(strain Ozolin-75) (MARV) 
(Marburg virus (strain 
South Africa/Ozolin/1975)) 
281 1/15/08  Ozolin
-75 
 
P41326 VP30_MABVP R Lake Victoria marburgvirus 
(strain Popp-67) (MARV) 
(Marburg virus (strain West 
Germany/Popp/1967)) 





Q1PDC6 VP30_MABVR R Lake Victoria marburgvirus 
(strain Ravn-87) (MARV) 
(Marburg virus (strain 
Kenya/Ravn/1987)) 





U Lake Victoria marburgvirus 
(strain Ravn-87) (MARV) 
(Marburg virus (strain 
Kenya/Ravn/1987)) 
281 2/5/08 Ravn, Kenya Ravn-
88 
1987 
C0IT80 C0IT80_MABVR U Lake Victoria marburgvirus 
(strain Ravn-87) (MARV) 
(Marburg virus (strain 
Kenya/Ravn/1987)) 
281 5/5/09 Ravn, Kenya Ravn-
89 
1987 
G8EFI6 G8EFI6_LLOVA U Lloviu cuevavirus (isolate 
Bat/Spain/Asturias-
Bat86/2003) (LLOV) 








U Marburg marburgvirus 281 1/9/13    
C7B280 C7B280_9MON
O 
U Marburg marburgvirus 281 9/22/09    
C7B273 C7B273_9MON
O 
U Marburg marburgvirus 281 9/22/09    
K4MSZ1 K4MSZ1_9MON
O 
U Marburg marburgvirus 281 1/9/13    
K4MQ93 K4MQ93_9MON
O 
U Marburg marburgvirus 281 1/9/13    
K4N3M2 K4N3M2_9MON
O 
U Marburg marburgvirus 281 1/9/13    
C7B252 C7B252_9MON
O 
U Marburg marburgvirus 281 9/22/09    
E0X101 E0X101_9MON
O 
U Marburg marburgvirus 281 11/2/10    
K4N3J5 K4N3J5_9MON
O 
U Marburg marburgvirus 281 1/9/13    
K4MT90 K4MT90_9MON
O 
U Marburg marburgvirus 281 1/9/13    
K4MQE5 K4MQE5_9MON
O 
U Marburg marburgvirus 281 1/9/13    
K4MSM3 K4MSM3_9MON
O 
U Marburg marburgvirus 281 1/9/13    
K4MR00 K4MR00_9MON
O 
U Marburg marburgvirus 281 1/9/13    
K4MQB7 K4MQB7_9MON
O 
U Marburg marburgvirus 281 1/9/13    
K4MSU4 K4MSU4_9MON
O 
U Marburg marburgvirus 281 1/9/13    
R4QIZ8 R4QIZ8_9MON
O 





U Marburg marburgvirus 281 10/29/14    
L7RI71 L7RI71_9MONO U Reston ebolavirus 281 4/3/13    
L7RFD4 L7RFD4_9MON
O 
U Reston ebolavirus 287 4/3/13    
Q91DD6 VP30_EBORE R Reston ebolavirus (strain 
Philippines-96) (REBOV) 
(Reston Ebola virus) 






U Reston ebolavirus (strain 
Philippines-96) (REBOV) 
(Reston Ebola virus) 






U Reston ebolavirus (strain 
Philippines-96) (REBOV) 
(Reston Ebola virus) 






U Reston ebolavirus (strain 
Philippines-96) (REBOV) 
(Reston Ebola virus) 




Q8JPX6 VP30_EBORR R Reston ebolavirus (strain 
Reston-89) (REBOV) 
(Reston Ebola virus) 






U Sudan ebolavirus 288 3/18/08    
M4J9H6 M4J9H6_9MON
O 
U Sudan ebolavirus 288 5/29/13    
R4QUF0 R4QUF0_9MON
O 
U Sudan ebolavirus 288 7/24/13    
R4P2H0 R4P2H0_9MON
O 
U Sudan ebolavirus 288 7/24/13    
I7FWC9 I7FWC9_9MON
O 
U Sudan ebolavirus - 
Nakisamata 
288 10/3/12 Nakisamata   
Q5XX03 VP30_EBOSU R Sudan ebolavirus (strain 
Uganda-00) (SEBOV) 
(Sudan Ebola virus) 





U Tai Forest ebolavirus 289 3/3/09    
A9QPM2 A9QPM2_9MON
O 
U Zaire ebolavirus 288 2/5/08    
Q77DJ5 VP30_EBOZ5 R Zaire ebolavirus (strain 
Kikwit-95) (ZEBOV) (Zaire 
Ebola virus) 
288 7/11/06  Kikwit-
95 
 
Q05323 VP30_EBOZM R Zaire ebolavirus (strain 
Mayinga-76) (ZEBOV) 
(Zaire Ebola virus) 
288 2/1/94  Mayin
ga-76 
 
Appendix	  A6.	  Protein	  Sequences	  Found	  in	  UniProt	  (VP24)	  
Entry Entry name Stat
us 
Organism Length Date of 
creation 
Place Strain Year 
B8XCN4 B8XCN4_9
MONO 
U Bundibugyo ebolavirus 251 3/3/09    
R4QRB9 R4QRB9_9
MONO 
U Bundibugyo ebolavirus 251 7/24/13    
A9Q1H7 A9Q1H7_9M
ONO 
U Lake Victoria marburgvirus 
- Ci67 
253 2/5/08    
Q1PDB1 Q1PDB1_9
MONO 
U Lake Victoria marburgvirus 
- DRC1999 






U Lake Victoria marburgvirus 
- DRC1999 






U Lake Victoria marburgvirus 
- Leiden 
253 2/22/12 Leiden   
Q1PD62 VP24_MAB
VA 
R Lake Victoria marburgvirus 
(strain Angola/2005) 
(MARV) 
253 1/15/08  Angola 2005 
Q1PD48 Q1PD48_M
ABVA 
U Lake Victoria marburgvirus 
(strain Angola/2005) 
(MARV) 
253 5/16/06  Angola 2005 
P35256 VP24_MAB
VM 
R Lake Victoria marburgvirus 
(strain Musoke-80) 
(MARV) (Marburg virus 
(strain 
Kenya/Musoke/1980)) 







R Lake Victoria marburgvirus 
(strain Ozolin-75) (MARV) 
(Marburg virus (strain 
South Africa/Ozolin/1975)) 





R Lake Victoria marburgvirus 
(strain Popp-67) (MARV) 
(Marburg virus (strain West 
Germany/Popp/1967)) 







R Lake Victoria marburgvirus 
(strain Ravn-87) (MARV) 
(Marburg virus (strain 
Kenya/Ravn/1987)) 





U Lake Victoria marburgvirus 
(strain Ravn-87) (MARV) 
(Marburg virus (strain 
Kenya/Ravn/1987)) 





U Lloviu cuevavirus (isolate 
Bat/Spain/Asturias-
Bat86/2003) (LLOV) 








U Marburg marburgvirus 253 11/2/10    
C7B288 C7B288_9M
ONO 
U Marburg marburgvirus 253 9/22/09    
C7B253 C7B253_9M
ONO 
U Marburg marburgvirus 253 9/22/09    
C7B281 C7B281_9M
ONO 
U Marburg marburgvirus 253 9/22/09    
C7B295 C7B295_9M
ONO 
U Marburg marburgvirus 253 9/22/09    
K4MT73 K4MT73_9M
ONO 
U Marburg marburgvirus 253 1/9/13    
K4MQD0 K4MQD0_9
MONO 
U Marburg marburgvirus 253 1/9/13    
R4QGQ6 R4QGQ6_9
MONO 
U Marburg marburgvirus 253 7/24/13    
A0A077D3Q8 A0A077D3Q
8_9MONO 
U Marburg marburgvirus 253 10/29/14    
L7RF04 L7RF04_9M
ONO 
U Reston ebolavirus 251 4/3/13    
L7RE03 L7RE03_9M
ONO 
U Reston ebolavirus 251 4/3/13    
Q91DD5 VP24_EBO
RE 
R Reston ebolavirus (strain 
Philippines-96) (REBOV) 
(Reston Ebola virus) 






U Reston ebolavirus (strain 
Philippines-96) (REBOV) 
(Reston Ebola virus) 






U Reston ebolavirus (strain 
Philippines-96) (REBOV) 
(Reston Ebola virus) 






U Reston ebolavirus (strain 
Philippines-96) (REBOV) 
(Reston Ebola virus) 






R Reston ebolavirus (strain 
Reston-89) (REBOV) 
(Reston Ebola virus) 






U Sudan ebolavirus 251 3/18/08    
R4QUG5 R4QUG5_9
MONO 
U Sudan ebolavirus 251 7/24/13    
I7ETY5 I7ETY5_9M
ONO 
U Sudan ebolavirus - 
Nakisamata 
251 10/3/12 Nakisamata   
Q5XX02 VP24_EBOS
U 
R Sudan ebolavirus (strain 
Uganda-00) (SEBOV) 
(Sudan Ebola virus) 





U Tai Forest ebolavirus 251 3/3/09    
L7QHW5 L7QHW5_9
MONO 
U Zaire ebolavirus 251 4/3/13    
G8DB44 G8DB44_9M
ONO 
U Zaire ebolavirus 251 1/25/12    
L7QI07 L7QI07_9M
ONO 
U Zaire ebolavirus 251 4/3/13    
A9QPM3 A9QPM3_9
MONO 










U Zaire ebolavirus 251 10/29/14    
O11459 VP24_EBO
G4 
R Zaire ebolavirus (strain 
Gabon-94) (ZEBOV) (Zaire 
Ebola virus) 






R Zaire ebolavirus (strain 
Kikwit-95) (ZEBOV) (Zaire 
Ebola virus) 





R Zaire ebolavirus (strain 
Mayinga-76) (ZEBOV) 
(Zaire Ebola virus) 
251 2/1/94  Mayin
ga-76 
 
Appendix	  A7.	  Protein	  Sequences	  Found	  in	  UniProt	  (L)	  
Entry Entry name Stat
us 
Organism Length Date of 
creation 
Place Strain Year 
B8XCN5 B8XCN5_9M
ONO 
U Bundibugyo ebolavirus 2210 3/3/09    
R4QUH5 R4QUH5_9M
ONO 
U Bundibugyo ebolavirus 2210 7/24/13    
A9Q1H8 A9Q1H8_9M
ONO 
U Lake Victoria marburgvirus 
- Ci67 
2331 2/5/08    
Q1PDA3 Q1PDA3_9M
ONO 
U Lake Victoria marburgvirus 
- DRC1999 





U Lake Victoria marburgvirus 
- DRC1999 





U Lake Victoria marburgvirus 
- DRC1999 





U Lake Victoria marburgvirus 
- Leiden 
2331 2/22/12 Leiden   
Q1PD54 L_MABVA R Lake Victoria marburgvirus 
(strain Angola/2005) 
(MARV) 
2331 1/15/08  Angola 2005 
Q1PD47 Q1PD47_MA
BVA 
U Lake Victoria marburgvirus 
(strain Angola/2005) 
(MARV) 
2331 5/16/06  Angola 2005 
P31352 L_MABVM R Lake Victoria marburgvirus 
(strain Musoke-80) 
(MARV) (Marburg virus 
(strain 
Kenya/Musoke/1980)) 





Q6UY63 L_MABVO R Lake Victoria marburgvirus 
(strain Ozolin-75) (MARV) 
(Marburg virus (strain 
South Africa/Ozolin/1975)) 
2331 1/15/08  Ozolin-
75 
 
P35262 L_MABVP R Lake Victoria marburgvirus 
(strain Popp-67) (MARV) 
(Marburg virus (strain West 
Germany/Popp/1967)) 





Q1PDC4 L_MABVR R Lake Victoria marburgvirus 
(strain Ravn-87) (MARV) 
(Marburg virus (strain 
Kenya/Ravn/1987)) 





U Lake Victoria marburgvirus 
(strain Ravn-87) (MARV) 
(Marburg virus (strain 
Kenya/Ravn/1987)) 





U Lloviu cuevavirus (isolate 
Bat/Spain/Asturias-
Bat86/2003) (LLOV) 








U Marburg marburgvirus 2331 1/9/13    
K4MST1 K4MST1_9M
ONO 
U Marburg marburgvirus 2331 1/9/13    
K4MQ40 K4MQ40_9M
ONO 
U Marburg marburgvirus 2331 1/9/13    
C7B254 C7B254_9M
ONO 
U Marburg marburgvirus 2327 9/22/09    
K4MQ89 K4MQ89_9M
ONO 
U Marburg marburgvirus 2331 1/9/13    
K4MQ15 K4MQ15_9M
ONO 
U Marburg marburgvirus 2331 1/9/13    
K4MR20 K4MR20_9M
ONO 
U Marburg marburgvirus 2331 1/9/13    
K4MR98 K4MR98_9M
ONO 
U Marburg marburgvirus 2331 1/9/13    
K4N3X4 K4N3X4_9M
ONO 
U Marburg marburgvirus 2331 1/9/13    
K4MSY7 K4MSY7_9M
ONO 
U Marburg marburgvirus 2327 1/9/13    
K4MSU1 K4MSU1_9M
ONO 
U Marburg marburgvirus 2331 1/9/13    
K4MQE0 K4MQE0_9M
ONO 
U Marburg marburgvirus 2331 1/9/13    
K4N3H7 K4N3H7_9M
ONO 
U Marburg marburgvirus 2331 1/9/13    
C7B296 C7B296_9M
ONO 
U Marburg marburgvirus 2331 9/22/09    
K4MT06 K4MT06_9M
ONO 
U Marburg marburgvirus 2331 1/9/13    
K4MSW9 K4MSW9_9
MONO 
U Marburg marburgvirus 2331 1/9/13    
K4MSM0 K4MSM0_9M
ONO 
U Marburg marburgvirus 2331 1/9/13    
C7B275 C7B275_9M
ONO 
U Marburg marburgvirus 2327 9/22/09    
K4MSW2 K4MSW2_9
MONO 
U Marburg marburgvirus 2331 1/9/13    
K4N3U7 K4N3U7_9M
ONO 
U Marburg marburgvirus 2331 1/9/13    
K4MSH4 K4MSH4_9M
ONO 
U Marburg marburgvirus 2331 1/9/13    
K4MTE3 K4MTE3_9M
ONO 
U Marburg marburgvirus 2331 1/9/13    
K4MQB3 K4MQB3_9M
ONO 
U Marburg marburgvirus 2331 1/9/13    
K4MR82 K4MR82_9M
ONO 
U Marburg marburgvirus 2331 1/9/13    
C7B261 C7B261_9M
ONO 
U Marburg marburgvirus 2327 9/22/09    
K4MTB4 K4MTB4_9M
ONO 
U Marburg marburgvirus 2331 1/9/13    
C7B289 C7B289_9M
ONO 
U Marburg marburgvirus 2331 9/22/09    
C7B282 C7B282_9M
ONO 





U Marburg marburgvirus 2331 10/29/14    
R4QIZ2 R4QIZ2_9M
ONO 
U Marburg marburgvirus 2331 7/24/13    
E0X103 E0X103_9M
ONO 
U Marburg marburgvirus 2331 11/2/10    
L7REU7 L7REU7_9M
ONO 
U Reston ebolavirus 2212 4/3/13    
L7RI78 L7RI78_9MO
NO 
U Reston ebolavirus 2212 4/3/13    
C6G8E8 C6G8E8_EB
ORE 
U Reston ebolavirus (strain 
Philippines-96) (REBOV) 
(Reston Ebola virus) 





U Reston ebolavirus (strain 
Philippines-96) (REBOV) 
(Reston Ebola virus) 





U Reston ebolavirus (strain 
Philippines-96) (REBOV) 
(Reston Ebola virus) 
2212 9/1/09  Philippi
nes-96 
 
Q91DD4 L_EBORE R Reston ebolavirus (strain 
Philippines-96) (REBOV) 
(Reston Ebola virus) 
2212 7/11/06  Philippi
nes-96 
 
Q8JPX5 L_EBORR R Reston ebolavirus (strain 
Reston-89) (REBOV) 
(Reston Ebola virus) 






U Sudan ebolavirus 2210 3/18/08    
M4JA89 M4JA89_9M
ONO 
U Sudan ebolavirus 2210 5/29/13    
C4PK62 C4PK62_9M
ONO 
U Sudan ebolavirus 2210 7/7/09    
R4NUL2 R4NUL2_9M
ONO 
U Sudan ebolavirus 2210 7/24/13    
R4QGU1 R4QGU1_9M
ONO 
U Sudan ebolavirus 2210 7/24/13    
I7FUR5 I7FUR5_9M
ONO 
U Sudan ebolavirus - 
Nakisamata 
2210 10/3/12 Nakisamata   
Q66802 L_EBOSM R Sudan ebolavirus (strain 
Maleo-79) (SEBOV) 
(Sudan Ebola virus) 




Q5XX01 L_EBOSU R Sudan ebolavirus (strain 
Uganda-00) (SEBOV) 
(Sudan Ebola virus) 





U Tai Forest ebolavirus 2210 3/3/09    
G8DB45 G8DB45_9M
ONO 
U Zaire ebolavirus 2212 1/25/12    
A0A068J9B1 A0A068J9B1
_9MONO 










U Zaire ebolavirus 2212 10/29/14    
A0A068J465 A0A068J465
_9MONO 





U Zaire ebolavirus 2212 10/29/14    
L7QHR8 L7QHR8_9M
ONO 
U Zaire ebolavirus 2212 4/3/13    
X5H5B6 X5H5B6_9M
ONO 
U Zaire ebolavirus 2212 6/11/14    
G8DB54 G8DB54_9M
ONO 
U Zaire ebolavirus 2212 1/25/12    
A9QPM4 A9QPM4_9M
ONO 
U Zaire ebolavirus 2212 2/5/08    
Q6V1Q2 L_EBOZ5 R Zaire ebolavirus (strain 
Kikwit-95) (ZEBOV) (Zaire 
Ebola virus) 
2212 7/11/06  Kikwit-
95 
 
Q05318 L_EBOZM R Zaire ebolavirus (strain 
Mayinga-76) (ZEBOV) 
(Zaire Ebola virus) 
2212 2/1/94  Maying
a-76 
 	   	  
Appendix	  B.	  Modeller	  Scripts	  Note:	  all	  the	  scripts	  are	  adapted	  from	  the	  Modeller	  tutorial.	  
1. align2d.py	  	  /*	  This	  is	  the	  script	  to	  align	  two	  sequences	  together.	  The	  template	  is	  in	  pdb	  format,	  while	  	  	  	  *	  the	  target	  is	  in	  PIR	  (ali)	  format.	  	  	  *	  All	  the	  text	  in	  green	  should	  be	  substituted	  by	  proper	  names	  corresponding	  to	  either	  the	  	  	  *	  	  template	  or	  the	  target	  sequence.	  	  	  */	  	  from	  modeller	  import	  *	  	  env	  =	  environ()	  aln	  =	  alignment(env)	  #	  If	  a	  chain	  other	  than	  A	  is	  selected	  as	  template,	  please	  change	  the	  letter	  correspondingly.	  mdl	  =	  model(env,	  file='1es6',	  model_segment=('FIRST:A','LAST:A'))	  aln.append_model(mdl,	  align_codes='1es6A',	  atom_files='1es6.pdb')	  aln.append(file='AIE11808.ali',	  align_codes='AIE11808')	  aln.align2d()	  aln.write(file='AIE11808-­‐1es6A.ali',	  alignment_format='PIR')	  aln.write(file='AIE11808-­‐1es6A.pap',	  alignment_format='PAP')	  	  
2. model-­‐single.py	  	  /*	  This	  script	  will	  build	  5	  models	  based	  on	  the	  alignment	  file	  in	  ali	  format.	  	  	  	  *	  All	  the	  text	  in	  green	  should	  be	  substituted	  by	  proper	  names	  corresponding	  to	  either	  the	  	  	  *	  	  template	  or	  the	  target	  sequence.	  	  	  */	  	  from	  modeller	  import	  *	  from	  modeller.automodel	  import	  *	  #from	  modeller	  import	  soap_protein_od	  	  env	  =	  environ()	  a	  =	  automodel(env,	  alnfile='AIE11808-­‐1es6A.ali',	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  knowns='1es6A',	  sequence='AIE11808',	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  assess_methods=(assess.DOPE,	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  #soap_protein_od.Scorer(),	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  assess.GA341))	  a.starting_model	  =	  1	  a.ending_model	  =	  5	  a.make()	  	   	  
	  
3. evaluate_model.py	  	  /*	  This	  script	  generates	  the	  “profile”	  file	  for	  the	  corresponding	  sequence	  using	  the	  pdb	  file.	  	  	  *	  All	  text	  in	  green	  should	  be	  substituted	  with	  proper	  file	  names.	  	  	  */	  	  	  from	  modeller	  import	  *	  from	  modeller.scripts	  import	  complete_pdb	  	  log.verbose()	  	  	  	  #	  request	  verbose	  output	  env	  =	  environ()	  env.libs.topology.read(file='$(LIB)/top_heav.lib')	  #	  read	  topology	  env.libs.parameters.read(file='$(LIB)/par.lib')	  #	  read	  parameters	  	  #	  read	  model	  file	  mdl	  =	  complete_pdb(env,	  'AIE11808.B99990005.pdb')	  	  #	  Assess	  with	  DOPE:	  s	  =	  selection(mdl)	  	  	  #	  all	  atom	  selection	  s.assess_dope(output='ENERGY_PROFILE	  NO_REPORT',	  file='AIE11808.profile',	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  normalize_profile=True,	  smoothing_window=15)	  	  
4. plot_profiles.py	  	  /*	  This	  script	  plots	  the	  DOPE	  score	  per	  residue	  for	  both	  the	  template	  and	  the	  model,	  so	  	  	  	  *	  that	  we	  can	  see	  the	  places	  that	  need	  improvement	  in	  terms	  of	  model-­‐constructing.	  	  	  *	  All	  the	  text	  in	  green	  should	  be	  substituted	  by	  proper	  names	  corresponding	  to	  either	  the	  	  	  *	  	  template	  or	  the	  target	  sequence.	  	  	  */	  	  import	  pylab	  import	  modeller	  	  def	  r_enumerate(seq):	  	  	  	  	  """Enumerate	  a	  sequence	  in	  reverse	  order"""	  	  	  	  	  #	  Note	  that	  we	  do	  not	  use	  reversed()	  since	  Python	  2.3	  does	  not	  have	  it	  	  	  	  	  num	  =	  len(seq)	  -­‐	  1	  	  	  	  	  while	  num	  >=	  0:	  	  	  	  	  	  	  	  	  yield	  num,	  seq[num]	  	  	  	  	  	  	  	  	  num	  -­‐=	  1	  	  def	  get_profile(profile_file,	  seq):	  	  	  	  	  """Read	  `profile_file`	  into	  a	  Python	  array,	  and	  add	  gaps	  corresponding	  to	  	  	  	  	  	  	  	  the	  alignment	  sequence	  `seq`."""	  	  	  	  	  #	  Read	  all	  non-­‐comment	  and	  non-­‐blank	  lines	  from	  the	  file:	  
	  	  	  	  f	  =	  file(profile_file)	  	  	  	  	  vals	  =	  []	  	  	  	  	  for	  line	  in	  f:	  	  	  	  	  	  	  	  	  if	  not	  line.startswith('#')	  and	  len(line)	  >	  10:	  	  	  	  	  	  	  	  	  	  	  	  	  spl	  =	  line.split()	  	  	  	  	  	  	  	  	  	  	  	  	  vals.append(float(spl[-­‐1]))	  	  	  	  	  #	  Insert	  gaps	  into	  the	  profile	  corresponding	  to	  those	  in	  seq:	  	  	  	  	  for	  n,	  res	  in	  r_enumerate(seq.residues):	  	  	  	  	  	  	  	  	  for	  gap	  in	  range(res.get_leading_gaps()):	  	  	  	  	  	  	  	  	  	  	  	  	  vals.insert(n,	  None)	  	  	  	  	  #	  Add	  a	  gap	  at	  position	  '0',	  so	  that	  we	  effectively	  count	  from	  1:	  	  	  	  	  vals.insert(0,	  None)	  	  	  	  	  return	  vals	  	  e	  =	  modeller.environ()	  a	  =	  modeller.alignment(e,	  file='AIE11808-­‐1es6A.ali')	  	  template	  =	  get_profile('1ES6.profile',	  a['1es6A'])	  model	  =	  get_profile('AIE11808.profile',	  a['AIE11808'])	  	  #	  Plot	  the	  template	  and	  model	  profiles	  in	  the	  same	  plot	  for	  comparison:	  pylab.figure(1,	  figsize=(10,6))	  pylab.xlabel('Alignment	  position')	  pylab.ylabel('DOPE	  per-­‐residue	  score')	  pylab.plot(model,	  color='red',	  linewidth=2,	  label='Model')	  pylab.plot(template,	  color='green',	  linewidth=2,	  label='Template')	  pylab.legend()	  pylab.savefig('dope_profile.png',	  dpi=65)	  	  
5. salign.py	  #	  Illustrates	  the	  SALIGN	  multiple	  structure/sequence	  alignment	  	  /*	  This	  script	  aligns	  the	  templates	  together.	  	  	  *	  All	  the	  text	  in	  green	  should	  be	  substituted	  by	  proper	  names	  corresponding	  to	  either	  the	  	  	  *	  	  template	  or	  the	  target	  sequence.	  	  	  */	  	  from	  modeller	  import	  *	  	  log.verbose()	  env	  =	  environ()	  env.io.atom_files_directory	  =	  './:../atom_files/'	  	  aln	  =	  alignment(env)	  for	  (code,	  chain)	  in	  (('1es6',	  'A'),	  ('4ldb',	  'B'),	  ('3tcq',	  'A')):	  	  	  	  	  mdl	  =	  model(env,	  file=code,	  model_segment=('FIRST:'+chain,	  'LAST:'+chain))	  	  	  	  	  aln.append_model(mdl,	  atom_files=code,	  align_codes=code+chain)	  
	  for	  (weights,	  write_fit,	  whole)	  in	  (((1.,	  0.,	  0.,	  0.,	  1.,	  0.),	  False,	  True),	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  ((1.,	  0.5,	  1.,	  1.,	  1.,	  0.),	  False,	  True),	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  ((1.,	  1.,	  1.,	  1.,	  1.,	  0.),	  True,	  False)):	  	  	  	  	  aln.salign(rms_cutoff=3.5,	  normalize_pp_scores=False,	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  rr_file='$(LIB)/as1.sim.mat',	  overhang=30,	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  gap_penalties_1d=(-­‐450,	  -­‐50),	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  gap_penalties_3d=(0,	  3),	  gap_gap_score=0,	  gap_residue_score=0,	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  dendrogram_file='multitemp.tree',	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  alignment_type='tree',	  #	  If	  'progresive',	  the	  tree	  is	  not	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  #	  computed	  and	  all	  structues	  will	  be	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  #	  aligned	  sequentially	  to	  the	  first	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  feature_weights=weights,	  #	  For	  a	  multiple	  sequence	  alignment	  only	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  #	  the	  first	  feature	  needs	  to	  be	  non-­‐zero	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  improve_alignment=True,	  fit=True,	  write_fit=write_fit,	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  write_whole_pdb=whole,	  output='ALIGNMENT	  QUALITY')	  	  aln.write(file='multitemp.pap',	  alignment_format='PAP')	  aln.write(file='multitemp.ali',	  alignment_format='PIR')	  	  aln.salign(rms_cutoff=1.0,	  normalize_pp_scores=False,	  	  	  	  	  	  	  	  	  	  	  	  rr_file='$(LIB)/as1.sim.mat',	  overhang=30,	  	  	  	  	  	  	  	  	  	  	  	  gap_penalties_1d=(-­‐450,	  -­‐50),	  gap_penalties_3d=(0,	  3),	  	  	  	  	  	  	  	  	  	  	  	  gap_gap_score=0,	  gap_residue_score=0,	  dendrogram_file='1is3A.tree',	  	  	  	  	  	  	  	  	  	  	  	  alignment_type='progressive',	  feature_weights=[0]*6,	  	  	  	  	  	  	  	  	  	  	  	  improve_alignment=False,	  fit=False,	  write_fit=True,	  	  	  	  	  	  	  	  	  	  	  	  write_whole_pdb=False,	  output='QUALITY')	  	  
6. align2d_mult.py	  	  /*	  This	  script	  aligns	  our	  query	  with	  the	  templates.	  	  	  *	  All	  the	  text	  in	  green	  should	  be	  substituted	  by	  proper	  names	  corresponding	  to	  either	  the	  	  	  *	  	  template	  or	  the	  target	  sequence.	  	  	  */	  	  from	  modeller	  import	  *	  	  log.verbose()	  env	  =	  environ()	  	  env.libs.topology.read(file='$(LIB)/top_heav.lib')	  	  #	  Read	  aligned	  structure(s):	  aln	  =	  alignment(env)	  aln.append(file='multitemp.ali',	  align_codes='all')	  aln_block	  =	  len(aln)	  	  
#	  Read	  aligned	  sequence(s):	  aln.append(file='AIE11808.ali',	  align_codes='AIE11808')	  	  #	  Structure	  sensitive	  variable	  gap	  penalty	  sequence-­‐sequence	  alignment:	  aln.salign(output='',	  max_gap_length=20,	  	  	  	  	  	  	  	  	  	  	  	  gap_function=True,	  	  	  #	  to	  use	  structure-­‐dependent	  gap	  penalty	  	  	  	  	  	  	  	  	  	  	  	  alignment_type='PAIRWISE',	  align_block=aln_block,	  	  	  	  	  	  	  	  	  	  	  	  feature_weights=(1.,	  0.,	  0.,	  0.,	  0.,	  0.),	  overhang=0,	  	  	  	  	  	  	  	  	  	  	  	  gap_penalties_1d=(-­‐450,	  0),	  	  	  	  	  	  	  	  	  	  	  	  gap_penalties_2d=(0.35,	  1.2,	  0.9,	  1.2,	  0.6,	  8.6,	  1.2,	  0.,	  0.),	  	  	  	  	  	  	  	  	  	  	  	  similarity_flag=True)	  	  aln.write(file='VP40-­‐mult.ali',	  alignment_format='PIR')	  aln.write(file='VP40-­‐mult.pap',	  alignment_format='PAP')	  	  
7. model_mult.py	  	  /*	  This	  script	  builds	  the	  model	  using	  the	  alignment	  information.	  	  	  *	  All	  the	  text	  in	  green	  should	  be	  substituted	  by	  proper	  names	  corresponding	  to	  either	  the	  	  	  *	  	  template	  or	  the	  target	  sequence.	  	  	  */	  	  from	  modeller	  import	  *	  from	  modeller.automodel	  import	  *	  	  env	  =	  environ()	  a	  =	  automodel(env,	  alnfile='VP40-­‐mult.ali',	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  knowns=('1es6A','4ldbB','3tcqA'),	  sequence='AIE11808')	  a.starting_model	  =	  1	  a.ending_model	  =	  5	  a.make()	  	   	  
Appendix	  C.	  Genome	  Selection	  for	  Family-­‐Wise	  Sequence	  Alignment	  Genomes:	  Lloviu	  cuevavirus	   	  	   http://www.ncbi.nlm.nih.gov/nuccore/355469071?report=graph	  Marburg	  Marburgvirus	  	   http://www.ncbi.nlm.nih.gov/nuccore/158539108?report=graph	  Sudan	  Ebolavirus	   	  	   http://www.ncbi.nlm.nih.gov/nuccore/55770807?report=graph	  Reston	  Ebolavirus	   	  	   http://www.ncbi.nlm.nih.gov/nuccore/22789222?report=graph	  Zaire	  Ebolavirus	   	  	   http://www.ncbi.nlm.nih.gov/nuccore/10313991?report=graph	  Tai	  Forest	  Ebolavirus	  	   http://www.ncbi.nlm.nih.gov/nuccore/302315369?report=graph	  Bundibugyo	  virus	   	  	   http://www.ncbi.nlm.nih.gov/nuccore/302371213?report=graph	  
1. NP	  Lloviu	  cuevavirus	   	   	   YP_004928135.1	  Marburg	  Marburgvirus	   	   YP_001531153.1	  Sudan	  Ebolavirus	   	   	   YP_138520.1	  Reston	  Ebolavirus	   	   	   NP_690580.1	  Zaire	  Ebolavirus	   	   	   NP_066243.1	  Tai	  Forest	  Ebolavirus	   	   YP_003815423.1	  Bundibugyo	  virus	   	   	   YP_003815432.1	  
2. VP35	  Lloviu	  cuevavirus	   	   	   YP_004928136.1	  Marburg	  Marburgvirus	   	   YP_001531154.1	  Sudan	  Ebolavirus	   	   	   YP_138521.1	  Reston	  Ebolavirus	   	   	   NP_690581.1	  Zaire	  Ebolavirus	   	   	   NP_066244.1	  Tai	  Forest	  Ebolavirus	   	   YP_003815424.1	  Bundibugyo	  virus	   	   	   YP_003815433.1	  
3. VP40	  Lloviu	  cuevavirus	   	   	   YP_004928137.1	  Marburg	  Marburgvirus	   	   YP_001531155.1	  Sudan	  Ebolavirus	   	   	   YP_138522.1	  Reston	  Ebolavirus	   	   	   NP_690582.1	  Zaire	  Ebolavirus	   	   	   NP_066245.1	  Tai	  Forest	  Ebolavirus	   	   YP_003815425.1	  Bundibugyo	  virus	   	   	   YP_003815434.1	  
4. GP	  Lloviu	  cuevavirus	   	   	   YP_004928138.1	  &	  YP_004928139.1	  Marburg	  Marburgvirus	   	   YP_001531156.1	  
Sudan	  Ebolavirus	   	   	   YP_138523.1	  Reston	  Ebolavirus	   	   	   NP_690583.1	  Zaire	  Ebolavirus	   	   	   NP_066246.1	  Tai	  Forest	  Ebolavirus	   	   YP_003815426.1	  Bundibugyo	  virus	   	   	   YP_003815435.1	  
5. VP30	  Lloviu	  cuevavirus	   	   	   YP_004928140.1	  Marburg	  Marburgvirus	   	   YP_001531157.1	  Sudan	  Ebolavirus	   	   	   YP_138525.1	  Reston	  Ebolavirus	   	   	   NP_690585.1	  Zaire	  Ebolavirus	   	   	   NP_066249.1	  Tai	  Forest	  Ebolavirus	   	   YP_003815429.1	  Bundibugyo	  virus	   	   	   YP_003815438.1	  
6. VP24	  Lloviu	  cuevavirus	   	   	   YP_004928142.1	  Marburg	  Marburgvirus	   	   YP_001531158.1	  Sudan	  Ebolavirus	   	   	   YP_138526.1	  Reston	  Ebolavirus	   	   	   NP_690586.1	  Zaire	  Ebolavirus	   	   	   NP_066250.1	  Tai	  Forest	  Ebolavirus	   	   YP_003815430.1	  Bundibugyo	  virus	   	   	   YP_003815439.1	  
7. L	  Lloviu	  cuevavirus	   	   	   YP_004928143.1	  Marburg	  Marburgvirus	   	   YP_001531159.1	  Sudan	  Ebolavirus	   	   	   YP_138527.1	  Reston	  Ebolavirus	   	   	   NP_690587.1	  Zaire	  Ebolavirus	   	   	   NP_066251.1	  Tai	  Forest	  Ebolavirus	   	   YP_003815431.1	  Bundibugyo	  virus	   	   	   YP_003815440.1	  	   	  
Appendix	  D.	  Conserved	  and	  Diverse	  Residues	  Mapping	  
Color	  Code:	  Basic	  color	  -­‐>	  Light	  grey	  Conserved	  residues	  -­‐>	  Blue	  Diverse	  residues	  with	  no	  gaps	  -­‐>	  Red	  Diverse	  residues	  with	  up	  to	  2	  gaps	  -­‐>	  Magenta	  
1. GP	  Conserved:	  26,34,49,52,53,57,60,67,70,72,82,84,85,86,88,89,92,94,95,97,102,103,108,109,110,118,122,126,133,135,139,143,146,152,154,157,159,160,161,162,166,167,168,171,176,178,179,182,185,250,286,359,363,366,374,376,379,380,381,384,385,388,389,399,404,406,407,409,410,411,413,417,419,421,422,424,425,426,428,429,434,435,437,438,439,440,441,442,444,445,446,447,448,449,452,453,454,456,457,458,462,466,467,471,474,477,493,494,496,503,510,515,516,518,520	  	  Diverse	  (No	  Gaps):	  15,31,32,37,39,44,45,47,50,61,64,73,79,98,112,116,124,151,156,187,189,190,191,192,194,195,197,199,203,207,212,214,216,219,221,222,223,224,227,228,229,231,232,235,236,238,239,241,243,245,246,248,254,261,262,263,264,265,266,269,282,283,284,285,297,299,302,310,311,312,316,325,326,327,329,330,334,335,338,339,340,343,344,345,347,348,350,351,352,353,354,356,357,368,369,371,372,375,401,479,482,485,486,487,488,490,496,506,517,523,524	  	  Diverse	  (Up	  to	  2	  Gaps):	  1,2,3,4,5,6,7,8,10,11,12,13,14,43,51,205,206,272,273,274,275,276,277,278,279,280,281,308,309,313,314,315,317,318,319,320,321,337,478	  	  Note:	  	  1. 1	  residue	  classified	  as	  conserved,	  80	  residues	  classified	  as	  diverse	  ones	  with	  no	  gaps,	  and	  51	  residues	  classified	  as	  diverse	  ones	  with	  up	  to	  2	  gaps	  cannot	  be	  mapped	  in	  the	  model,	  because	  when	  constructing	  the	  models,	  we	  deleted	  the	  150	  residues	  in	  the	  middle	  in	  order	  to	  have	  it	  aligned	  better	  with	  our	  template.	  	  2. The	  red	  numbers	  at	  the	  end	  are	  not	  shown	  in	  the	  visualization,	  since	  the	  file	  GP_No_free_end.pdb	  only	  contains	  residues	  up	  to	  449.	  (The	  original	  pdb	  file	  GP.B99990003.pdb	  has	  up	  to	  524	  residues	  but	  contains	  large	  amount	  of	  free	  ends,	  which	  are	  not	  significantly	  useful.)	  3. There	  is	  one	  mutation	  in	  our	  model	  in	  the	  conserved	  residues,	  82.	  (All	  the	  representatives	  from	  different	  species	  give	  us	  A,	  but	  our	  model	  is	  V.)	  
2. L	  
L2	  (In	  Query:	  384-­‐558;	  In	  Aln:	  394-­‐568)	  Conserved:	  2,5,6,7,9,14,16,18,22,24,26,27,28,29,34,41,43,44,49,52,53,54,56,60,63,65,66,75,76,77,79,83,86,87,88,89,90,92,93,94,95,96,97,98,99,100,101,102,103,104,105,106,110,111,112,114,1
15,119,120,121,122,124,125,128,131,132,133,134,135,136,137,138,140,143,144,152,155,157,158,160,163,164,165,166,167,168,169,170,171,172,173,174,175	  	  Diverse	  (No	  Gaps):	  1,12,19,31,57,61,73,82,108,126,129,147,150,156,161	  	  Diverse	  (Up	  to	  2	  Gaps):	  None	  	  
L1	  (In	  Query:	  2043-­‐2154;	  In	  Aln:	  2187-­‐2299)	  Conserved:	  1,10,11,18,19,20,22,29,30,40,57,60,61,73,74,75,80,82,83,84,87,88,90,94,98	  	  Diverse	  (No	  Gaps):	  3,7,8,9,12,13,16,36,37,41,44,45,48,49,51,59,64,66,78,93,97,101,103,104,106,107,110,111	  	  Diverse	  (Up	  to	  2	  Gaps):	  None	  	  
3. NP	  
NP3	  (In	  Query:	  45-­‐110;	  In	  Aln:	  46-­‐111)	  Conserved:	  9,13,19,21,30,33,34,37,39,42,46,49,54,55,59,62	  	  Diverse	  (No	  Gaps):	  1,3,7,11,25,43,44,50,61,64,65	  	  Diverse	  (Up	  to	  2	  Gaps):	  None	  
NP2	  (In	  Query:	  265-­‐340;	  In	  Aln:	  266-­‐341)	  Conserved:	  1,2,3,5,6,8,9,12,16,17,19,20,23,24,26,28,29,30,31,32,33,34,36,37,38,39,40,42,43,44,45,46,47,48,50,51,52,53,54,55,56,57,58,59,60,61,62,63,64,65,66,67,68,69,70,71,72,74,75,76	  	  Diverse	  (No	  Gaps):	  14,21,25	  	  Diverse	  (Up	  to	  2	  Gaps):	  None	  	  
NP1	  (In	  Query:	  641-­‐739;	  In	  Aln:	  695-­‐793)	  Conserved:	  35,49,57,58,82,85	  	  
Diverse	  (No	  Gaps):	  1,2,3,5,6,8,9,13,17,30,32,33,37,41,42,47,54,55,56,61,65,66,67,72,73,74,75,76,77,81,87,88,94	  	  Diverse	  (Up	  to	  2	  Gaps):	  7,99	  	  
4. VP24	  Conserved:	  1,2,7,8,9,37,38,40,42,47,53,56,57,60,61,67,69,72,74,75,76,78,79,80,82,85,90,94,95,98,104,105,110,111,125,126,127,149,160,167,168,169,171,174,177,178,180,181,188,189,190,192,194,195,196,198,199,200,205,219,221,224,241,246,247,250,251	  	  Diverse	  (No	  Gaps):	  11,12,17,19,32,39,45,50,70,84,88,89,91,103,116,120,130,132,139,140,158,165,173,184,185,186,210,211,212,213,229,230,232,233,234,235,237,239,240	  	  Diverse	  (Up	  to	  2	  Gaps):	  231	  	  
5. VP30	  Conserved:	  1,7,8,9,26,29,31,51,65,66,68,69,70,72,78,81,86,89,90,92,95,99,100,101,102,103,105,106,123,126,133,143,144,147,167,168,169,171,173,179,180,184,191,193,197,199,201,202,203,211,215,217,218,219,220,222,223,224,225,226,227,228,230,231,234,238,241,243,251,252,253,254	  	  Diverse	  (No	  Gaps):	  2,5,12,13,16,17,18,19,21,22,23,24,25,30,33,34,35,36,37,39,40,41,42,45,48,52,53,56,84,112,114,115,116,117,124,130,132,137,138,139,145,146,148,149,153,156,157,158,160,161,165,166,188,192,205,206,221,240,244,262,263,265,267,269,270,271,272,273	  	  Diverse	  (Up	  to	  2	  Gaps):	  3,4,14,60,61,62,63,119,274,275,276,277,278,279,280,281,282,283,284,285,286,287	  	  Note:	  The	  red	  numbers	  at	  the	  beginning	  and	  the	  end	  are	  not	  shown	  in	  the	  visualization,	  since	  in	  the	  file	  VP30_nf.pdb	  residues	  before	  145	  and	  after	  270	  are	  chopped	  off.	  (The	  original	  pdb	  file	  AIE11812.B99990005.pdb	  has	  288	  residues	  but	  contains	  large	  amount	  of	  free	  ends,	  which	  are	  not	  significantly	  useful.)	  	  
6. VP35	  
Black/AIE11807	  (In	  Query:	  35-­‐262;	  In	  Aln:	  36-­‐291)	  Conserved:	  
1,2,41,52,66,84,103,104,106,107,108,109,111,112,115,116,117,119,122,123,124,127,128,131,132,136,137,139,158,165,177,180,183,186,187,188,190,197,198,199,200,203,205,206,208,210,211,214	  	  Diverse	  (No	  Gaps):	  7,8,21,22,23,24,25,26,27,28,29,31,33,34,35,36,37,43,44,47,48,49,51,53,54,55,57,58,60,61,62,63,64,65,67,68,69,70,75,78,79,82,88,89,93,100,130,134,145,149,152,153,154,155,156,157,160,161,163,167,170,173,174,184,192,220,221	  	  Diverse	  (Up	  to	  2	  Gaps):	  11,12,13,14,15,16,18,19,20,45,46,50,224	  	  
Basic/VP35_1	  (In	  Query:	  213-­‐340;	  In	  Aln:	  238-­‐369)	  Conserved:	  2,5,8,9,10,12,19,20,21,22,25,27,28,30,32,33,36,38,39,44,45,51,55,58,62,64,65,75,80,81,92,95,96,97,98,99,100,103,104,106,108,111,112,113,114,121,126,127,128	  	  Diverse	  (No	  Gaps):	  6,14,42,43,79,115,117,118	  	  Diverse	  (Up	  to	  2	  Gaps):	  46	  	  
7. VP40	  Conserved:	  1,10,11,13,53,72,73,75,76,77,90,93,95,96,97,98,99,106,111,114,119,120,121,123,125,133,134,136,137,138,139,141,142,143,145,146,147,150,151,153,154,155,156,157,159,162,164,172,173,176,177,179,181,187,191,205,208,211,213,215,218,219,264,273,290	  	  Diverse	  (No	  Gaps):	  4,5,14,34,35,36,37,38,40,41,42,43,44,46,50,54,58,62,67,70,78,105,128,129,152,182,197,198,199,200,202,209,220,222,227,228,241,243,245,259,266,269,276,277,278,293,298,299,300,320,322,323,324,325	  	  Diverse	  (Up	  to	  2	  Gaps):	  9,16,17,18,20,21,22,23,24,25,26,27,28,29,30,31,308,309,310,311,312,313,315,316,318	  	  Note:	  The	  red	  numbers	  at	  the	  beginning	  and	  the	  end	  are	  not	  shown	  in	  the	  visualization,	  since	  in	  the	  file	  VP40_nf.pdb	  residues	  before	  44	  and	  after	  321	  are	  chopped	  off.	  (The	  original	  pdb	  file	  AIE11808.B99990005.pdb	  has	  326	  residues	  but	  contains	  large	  amount	  of	  free	  ends,	  which	  are	  not	  significantly	  useful.)	  	   	  
Appendix	  E.	  Model	  Check	  and	  Functional	  Annotation	  	  Based	  on	  the	  meeting	  with	  Professor	  Korkin	  on	  the	  following	  two	  dates:	  05/19/2015:	  VP30,	  VP40,	  VP35,	  VP24,	  GP	  05/21/2015:	  GP,	  NP,	  L	  
1.	  VP30	  
1	  Model,	  1	  Template	  
Model:	  	  Average	  quality	  
Annotation:	  	  1).	  Template:	  2I8B	  Interactions:	  1	  intra-­‐virus	  interaction	  http://kestrel2.rnet.missouri.edu/dommino/index.php/result/show_interaction/2I8B	  2I8B:	  A	  interacts	  with	  2I8B:	  B,	  which	  should	  be	  identical	  to	  A.	  	  In	  the	  pdb	  file,	  the	  two	  chains	  start	  from	  different	  residues,	  A	  from	  140,	  B	  from	  135,	  but	  they	  both	  end	  at	  266.	  The	  interacting	  residues	  in	  Chain	  A	  are	  exactly	  the	  same	  as	  those	  in	  Chain	  B.	  
	  
Figure	  44:	  2I8B	  B1	  A1	  Interaction	  
	  
Figure	  45:	  3V7O	  Chain	  A	  (Cyan)	  and	  Chain	  B	  (Red)	  
2).	  Template:	  3V7O	  
Interactions:	  2	  intra-­‐virus	  interactions	  http://kestrel2.rnet.missouri.edu/dommino/index.php/result/show_interaction/3V7O	  Chain	  A	  is	  identical	  to	  Chain	  B.	  	  The	  two	  chains	  both	  start	  from	  -­‐95.	  In	  the	  interaction,	  Chain	  A	  starts	  from	  0	  and	  ends	  at	  125,	  and	  Chain	  B	  starts	  from	  -­‐76	  and	  ends	  at	  0.	  The	  structures	  available	  for	  Chain	  A	  and	  Chain	  B	  are	  different.	  	  
SCOP	  Family:	  54237	  However,	  none	  of	  the	  organisms	  except	  Reston	  Ebolavirus	  is	  closely	  related	  to	  our	  target.	  
2.	  VP40	  
1	  Model,	  3	  Templates	  
Model:	  	  Cleave	  residues	  before	  locus	  44	  and	  after	  321.	  	  
Annotation:	  SCOP	  family:	  50013	  
	  
Figure	  47:	  SCOP	  Family	  50013	  1).	  Template:	  3TCQ	  (monomer)	   	  	  
	  
Figure	  46:	  3V7O	  Interaction	  
Interaction:	  1	  intra-­‐virus	  interaction	  http://kestrel2.rnet.missouri.edu/dommino/index.php/result/show_network/3TCQ	  3TCQ	  only	  has	  chain	  A.	  	  
	  
Figure	  48:	  SCOP	  Family	  54237	  	  
	  
Figure	  49:	  3TCQ	  Interaction	  2).	  Template:	  4LDB	  (tetramer),	  	  12	  intra-­‐virus	  interactions	  http://kestrel2.rnet.missouri.edu/dommino/index.php/result/show_network/4LDB	  
	  
Figure	  50:	  4LDB	  Interaction	  A,	  B,	  C,	  and	  D	  chains	  are	  identical	  in	  terms	  of	  sequence,	  but	  they	  are	  slightly	  different	  in	  terms	  of	  structure.	  Since	  the	  sequences	  are	  identical,	  there	  is	  no	  need	  to	  align	  them	  one	  by	  one	  with	  our	  target.	  A	  single	  alignment	  with	  the	  template	  would	  suffice.	  The	  alignment	  shows	  that	  the	  untruncated	  sequence	  has	  the	  exactly	  same	  residue	  at	  each	  position	  after	  position	  44.	  
	   	  
Figure	  51:	  Alignment	  Between	  4LDB	  and	  VP40	  
	  
Figure	  52:	  Structure	  of	  4LDB	  3).	  4LDI/4LDD	  (dimer)	   	   -­‐>	  3	  interactions	  Interaction:	  3	  intra-­‐virus	  interactions	  http://kestrel2.rnet.missouri.edu/dommino/index.php/result/show_interaction/4LDI	  4LDI	  has	  two	  identical	  chains.	  The	  alignment	  result	  shows	  that	  4LDI	  is	  exactly	  the	  same	  as	  4LDB	  except	  at	  one	  position	  (212).	  	  
	  
3.	  VP35	  
2	  Models,	  1	  Template	  for	  Each	  -­‐>	  1	  Model,	  1	  Template	  (See	  Model	  section)	  
Model:	  Remove	  the	  first	  model,	  since	  the	  template	  is	  too	  bad.	  The	  main	  model	  is	  of	  average	  quality.	  





Figure	  53:	  3FKE	  Interaction	  Chain	  A	  and	  Chain	  B	  are	  identical	  to	  each	  other.	  	  	  2).	  Other	  candidate	  template:	  3KS8	  Interactions:	  2	  undefined	  intra-­‐virus	  interactions,	  1	  RNA-­‐RNA	  interaction	  http://kestrel2.rnet.missouri.edu/dommino/index.php/result/show_network/3KS8	  
	  
Figure	  54:	  3KS8	  Interaction	  A,	  B,	  C,	  and	  D	  chains	  are	  identical.	  The	  four	  chains	  are	  almost	  identical	  in	  terms	  of	  structure.	  There	  are	  also	  two	  chains	  of	  RNA.	  As	  a	  result,	  the	  interaction	  pairs	  between	  Chain	  A	  and	  Chain	  B	  are	  exactly	  the	  same	  as	  those	  between	  Chain	  C	  and	  Chain	  D.	  	  3).	  Other	  candidate	  template:	  4LG2	  Interactions:	  3	  undefined	  intra-­‐virus	  interactions,	  1	  RNA-­‐RNA	  interaction	  http://kestrel2.rnet.missouri.edu/dommino/index.php/result/show_network/4LG2	  
	  
Figure	  55:	  4LG2	  Interaction	  A,	  B,	  C,	  and	  D	  Chains	  are	  identical.	  The	  four	  chains	  are	  almost	  identical	  in	  terms	  of	  structure.	  There	  are	  also	  four	  chains	  of	  RNA.	  	  4).	  Other	  candidate	  template:	  3L25	  Interactions:	  4	  undefined	  intra-­‐virus	  interaction	  http://kestrel2.rnet.missouri.edu/dommino/index.php/result/show_network/3L25	  
	  
Figure	  56:	  3L25	  Interaction	  A,	  B,	  C,	  and	  D	  Chains	  are	  identical.	  The	  four	  chains	  are	  almost	  identical	  in	  terms	  of	  structure.	  There	  are	  also	  two	  chains	  of	  RNA.	  	  The	  residues	  involved	  in	  the	  interaction	  between	  Chain	  A	  and	  Chain	  E	  are	  the	  same	  as	  those	  between	  Chain	  B	  and	  Chain	  D.	  	  5).	  Other	  candidate	  template:	  3L28	  Interactions:	  6	  undefined	  intra-­‐virus	  interactions	  http://kestrel2.rnet.missouri.edu/dommino/index.php/result/show_network/3L28	  
	  
Figure	  57:	  3L28	  Interaction	  There	  are	  6	  identical	  chains	  in	  this	  protein.	  The	  sequence	  in	  each	  chain	  is	  also	  identical	  to	  that	  in	  3L25,	  differing	  only	  at	  position	  339	  (3L25:	  K;	  3L28:	  A).	  So,	  the	  alignment	  is	  similar	  to	  that	  with	  3L25.	  	  6).	  Other	  candidate	  template:	  4GHL	  Interactions:	  3	  undefined	  intra-­‐virus	  interactions,	  1	  RNA-­‐RNA	  interaction	  http://kestrel2.rnet.missouri.edu/dommino/index.php/result/show_network/4GHL	  
	  
Figure	  58:	  4GHL	  Interaction	  There	  are	  four	  identical	  chains	  and	  two	  RNA	  chains	  in	  this	  protein.	  
Note,	  that	  since	  the	  template	  we	  used	  to	  build	  this	  model	  only	  contains	  1	  undefined	  interaction,	  we	  continued	  to	  search	  for	  related	  structures	  in	  PDB	  using	  advanced	  search.	  	  
4.	  VP24	  
Model:	  Average	  quality.	  All	  termini	  were	  cleaved.	  
Annotation:	  1).	  Template:	  4M0Q	   	  Interactions:	  1	  undefined	  intra-­‐virus	  interaction	  http://kestrel2.rnet.missouri.edu/dommino/index.php/result/show_network/4M0Q	  
	  
Figure	  59:	  4M0Q	  Interaction	  The	  two	  chains	  are	  identical.	  The	  interaction	  pairs	  are	  almost	  symmetric	  between	  Chain	  A	  and	  Chain	  B.	  	  2).	  Other	  candidate	  template:	  4U2X	  (human-­‐viral	  interaction)	  	  Interactions:	  2	  U-­‐U	  intra-­‐virus	  interactions,	  3	  D-­‐U	  host-­‐viral	  interactions	  http://kestrel2.rnet.missouri.edu/dommino/index.php/result/show_network/4U2X	  
	  
Figure	  60:	  4U2X	  Interaction	  
Chains	  A,	  B,	  and	  C	  are	  identical	  and	  are	  from	  Zaire	  Ebolavirus,	  while	  Chains	  D,	  E,	  and	  F	  are	  identical	  and	  are	  from	  homo	  sapiens.	  	  
5.	  GP	  
Model:	  Cleaved	  the	  middle	  part	  and	  rebuilt	  the	  model	  based	  on	  3CSY	  template.	  
Annotation:	  1).	  Template:	  3CSY	  Interactions:	  D-­‐N	  (16),	  D-­‐D	  (23),	  D-­‐L	  (7),	  D-­‐U	  (11),	  N-­‐U	  (4)	  http://kestrel2.rnet.missouri.edu/dommino/index.php/result/show_network/3CSY	  
	  
Figure	  61:	  3CSY	  Interaction	  
The structure 3CSY has in total 16 chains. These are represented by 4 sequence-unique entities.  
[Crystal structure of the trimeric prefusion Ebola virus glycoprotein (GP1+GP2) in complex with a 
neutralizing antibody from a human survivor] 
 
Fab KZ52 heavy chain:  ACEG   
Fab KZ52 light chain:  BDFH  
Envelop Glycoprotein GP2:  JLNP  
Envelop Glycoprotein GP1:  IKMO 
 There	  are	  21	  intra-­‐virus	  interactions	  and	  13	  host-­‐virus	  interactions.	  	  
	  
Figure	  62:	  3CSY	  Interaction	  Map	  Enlarged	  
	  
Figure	  63:	  3CSY	  Interaction	  Partners	  Enlarged	  2).	  3S88	  (Sudan	  Ebolavirus)	  Interactions:	  D-U (2), D-L (2), D-D (6), N-U (1), D-C (1), D-N (1) http://kestrel2.rnet.missouri.edu/dommino/index.php/result/show_network/3S88	  
The structure 3S88 has in total 4 chains. These are represented by 4 sequence-unique entities. 16F6	  heavy	  chain:	   	   H	  16F6	  light	  chain;	   	   L	  Envelop	  glycoprotein:	  	   I,	  J	  There	  are	  3	  intra-­‐viral	  interactions	  and	  3	  host-­‐virus	  interactions.	  
	  
Figure	  64:	  3S88	  Interaction	  It	  seems	  that	  the	  cutoff	  between	  the	  two	  chains	  in	  3S88	  is	  different	  from	  the	  one	  in	  3CSY.	  The	  alignment	  therefore	  is	  a	  little	  different.	  As	  shown	  in	  the	  two	  pictures	  below,	  the	  missing	  part	  in	  Chain	  J	  corresponds	  to	  part	  of	  Chain	  A	  in	  our	  models.	  	  
	  Below	  is	  a	  screenshot	  of	  the	  superimposed	  GP	  model	  and	  3S88.	  But	  the	  misaligned	  part	  does	  not	  have	  structural	  information	  in	  3S88.	  So,	  it	  will	  not	  affect	  the	  calculation	  of	  the	  scores.	  
	  3).	  3VE0	  (Sudan	  Ebolavirus)	  Interactions:	  D-U (2), D-N (1), D-D (5), D-L (2), N-U (1) http://kestrel2.rnet.missouri.edu/dommino/index.php/result/show_network/3VE0	  
The structure 3VE0 has in total 4 chains. These are represented by 4 sequence-unique entities. 
	  
Figure	  65:	  3VE0	  Interaction	  16F6	  Antibody	  	   	   A	  16F6	  Antibody	  	   	   B	  Envelope	  glycoprotein	   I	  
Envelope	  glycoprotein	   J	  	  Similar	  to	  3S88,	  the	  beginning	  of	  Chain	  J	  in	  3EV0	  can	  probably	  be	  aligned	  to	  the	  portion	  excluded	  in	  the	  model,	  but	  since	  the	  structural	  information	  for	  that	  part	  is	  missing	  in	  PDB,	  this	  will	  not	  affect	  our	  result.	  So,	  there	  is	  no	  need	  to	  reconstruct	  the	  model.	  	  4).	  1EBO	  Interactions:	  D-D (8) http://kestrel2.rnet.missouri.edu/dommino/index.php/result/show_network/1EBO	  
The structure 1EBO has in total 6 chains. These are represented by 1 sequence-unique entity. 
	  
Figure	  66:	  1EBO	  Interactions	  	  	  
	  
Figure	  67:	  Template	  3CSY	  
	  
Figure	  68:	  Model	  
6.	  NP	  
Model:	  Average	  quality.	  
Annotation:	  1).	  4QAZ	  -­‐>	  0	  interactions	  2).	  4QB0	  -­‐>	  0	  interactions	  
7.	  L	  
Model:	  Poor	  quality	  due	  to	  the	  lack	  of	  structural	  templates	  with	  high	  target-­‐template	  sequence	  identity.	  
Annotation:	  PDB	  advanced	  search	  did	  not	  provide	  any	  significant	  result.	  This	  protein	  was	  discarded	  from	  the	  further	  analysis.	  
8.	  RNA-­‐Protein	  Interactions	  Search	  in	  Dommino	  using	  advanced	  search:	  Minimal	  number	  of	  contact	  pairs:	  0	  Interaction	  Type:	  U-­‐RNA	  Organism:	  virus	  
Annotation:	  1).	  3KS8	  (Reston	  Ebolavirus)	  -­‐>	  11	  interactions	  (8	  U-­‐RNA)	  2).	  4GHL	  (Lake	  Victoria	  Marburgvirus)	  -­‐>	  8	  interactions	  (2	  U-­‐RNA)	  3).	  3L26	  (Zaire	  Ebolavirus)	  -­‐>	  3	  interactions	  (2	  U-­‐RNA)	  4).	  4GHA	  (Marburg	  virus)	  -­‐>	  13	  interactions	  (8	  U-­‐RNA)	  5).	  4LG2	  (Reston	  Ebolavirus)	  -­‐>	  10	  interactions	  (4	  U-­‐RNA)	  6).	  3L25	  (Zaire	  Ebolavirus)	  -­‐>	  13	  interactions	  (8	  U-­‐RNA)	   	  
Appendix	  F.	  Functional	  Residues	  Mapping	  
VP35	  Intra-­‐viral	  interactions:	  10,13-­‐15,17-­‐25,27-­‐29,32-­‐33,36-­‐37,40-­‐43,45-­‐46,50,53-­‐64,66-­‐67,70-­‐71,73-­‐74,76-­‐94,96-­‐112,114-­‐124,127-­‐128	  
VP40	  Intra-­‐viral	  interactions:	  44,46-­‐64,70,72-­‐74,76,85,91-­‐100,107-­‐119,121,123,125,127,130,132,134,136-­‐142,146-­‐148,151-­‐152,154-­‐165,171,178-­‐194,196-­‐197,199-­‐202,210,212-­‐214,217-­‐221,247,249-­‐259,262-­‐263,267-­‐268,271-­‐272,274,279-­‐294,309-­‐321	  
GP	  Host-­‐viral	  interactions:	  32-­‐35,39-­‐47,50,52,350-­‐363,396-­‐410,412	  	  Intra-­‐viral	  interactions:	  31-­‐38,40-­‐61,63-­‐75,86-­‐105,126-­‐134,136,153-­‐159,162-­‐166,168,179-­‐185,191-­‐192,212-­‐213,283,285,350-­‐447,454-­‐458	  	  Overlap	  between	  HV	  and	  IV	  interactions:	  32-­‐35,40-­‐47,50,52,350-­‐363,396-­‐410,412	  
VP30	  Intra-­‐viral	  interactions:	  46-­‐51,95,133-­‐150,152-­‐154,156,165-­‐170,172-­‐174,176-­‐177,179-­‐183,185,187-­‐188,190-­‐192,194-­‐195,199-­‐202,204-­‐205,218,223,246-­‐266	  
VP24	  Host-­‐viral	  interactions:	  88,113-­‐114,116-­‐118,121-­‐122,124,125,127-­‐131,134-­‐141,184-­‐186,201-­‐205,207,210,216-­‐218	  	  Intra-­‐viral	  interactions:	  10-­‐15,17-­‐22,24-­‐25,28-­‐34,38-­‐41,43-­‐46,54-­‐56,58-­‐59,63-­‐71,73-­‐79,81-­‐83,91-­‐92,95,125,129-­‐133,147-­‐148,150-­‐152,154-­‐155,171-­‐174,208-­‐212,214	  	  Overlap	  between	  HV	  and	  IV	  interactions:	  125,129-­‐131,210	  	  
